Family matters in diabetes prevention: Communication about familial risk of type 2 diabetes by Esch, S.C.M. van
Family matters in diabetes prevention 
Communication about familial risk of type 2 diabetes
Suzanne van Esch
The research described in this thesis was funded by the Dutch Diabetes Research Foundation 
(Diabetes Fonds Nederland; grant no. 2005_13_003) and the department of Medical Psychology of 
the VU University medical center in Amsterdam, the Netherlands.
The studies presented in this thesis were conducted within the department of Medical Psychology 
and the department of Clinical Genetics of the VU University medical center in Amsterdam, the 
Netherlands. Both departments participate in the EMGO Institute for Health and Care Research 
in Amsterdam (www.emgo.nl). The EMGO Institute participates in the Netherlands School of 
Primary Care Research (CaRe), which was re-acknowledged in 2005 by the Royal Netherlands 
Academy of Arts and Sciences (KNAW). In 2010, the EMGO Institute received an excellent 
review by the international external evaluation committee of all Dutch university research, as 
organized by the universities in the Netherlands.
Financial support for the publication of this thesis was kindly provided by:
VU University Amsterdam
Department of Medical Psychology, VU University medical center Amsterdam
EMGO Institute for Health and Care Research
Family matters in diabetes prevention.  
Communication about familial risk of type 2 diabetes
Thesis, VU medisch centrum - Vrije Universiteit
ISBN: 978-94-6182-201-7
© S.C.M. van Esch, Haarlem, the Netherlands, 2012
All rights reserved. No part of this publication may be reproduced or transmitted in any form or 
by any means, electronic or mechanical, including photocopy, recording or any other information 
storage or retrieval system, without permission in writing from the author. 
Cover design and layout: Suzanne van Esch and Off Page
Printed by: Off Page, Amsterdam. www.offpage.nl
VRIJE UNIVERSITEIT
Family matters in diabetes prevention 
Communication about familial risk of type 2 diabetes
ACADEMISCH PROEFSCHRIFT
ter verkrijging van de graad Doctor aan
de Vrije Universiteit Amsterdam,
op gezag van de rector magnificus
prof.dr. L.M. Bouter,
in het openbaar te verdedigen
ten overstaan van de promotiecommissie
van de Faculteit der Geneeskunde
op vrijdag 1 februari 2013 om 13.45 uur
in de aula van de universiteit,
De Boelelaan 1105
door
Suzanne Clasina Maria van Esch
geboren te Bergen op Zoom
promotoren   prof.dr. F.J. Snoek 
prof.dr. M.C. Cornel
Leescommissie:    prof. dr. ir. J.M. Dekker 
prof. dr. A.C.J.W. Janssens  
prof. dr. A.A. Kaptein 
prof. dr. B.J.C. Middelkoop 
prof. dr. N. Qureshi  
prof. dr. D.R.M. Timmermans

ITHAKA
As you set out for Ithaka 
hope the voyage is a long one, 
full of adventure, full of discovery. 
Laistrygonians and Cyclops, 
angry Poseidon—don’t be afraid of them: 
you’ll never find things like that on your way 
as long as you keep your thoughts raised high, 
as long as a rare excitement 
stirs your spirit and your body. 
Laistrygonians and Cyclops, 
wild Poseidon—you won’t encounter them 
unless you bring them along inside your soul, 
unless your soul sets them up in front of you. 
  
Hope the voyage is a long one. 
May there be many a summer morning when, 
with what pleasure, what joy, 
you come into harbours seen for the first time; 
may you stop at Phoenician trading stations 
to buy fine things, 
mother of pearl and coral, amber and ebony, 
sensual perfume of every kind— 
as many sensual perfumes as you can; 
and may you visit many Egyptian cities 
to gather stores of knowledge from their scholars. 
  
Keep Ithaka always in your mind. 
Arriving there is what you are destined for. 
But do not hurry the journey at all. 
Better if it lasts for years, 
so you are old by the time you reach the island, 
wealthy with all you have gained on the way, 
not expecting Ithaka to make you rich. 
  
Ithaka gave you the marvellous journey. 
Without her you would not have set out. 
She has nothing left to give you now. 
  
And if you find her poor, Ithaka won’t have fooled you. 
Wise as you will have become, so full of experience, 
you will have understood by then what these Ithakas mean.
©C.P. Cavafy 
Translated by Edmund Keeley and Philip Sherrard
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Introduction
Type 2 diabetes (T2D) is a serious chronic disease causing considerable burden 
on patients as well as health care systems. The increasing prevalence of T2D 
warrants major efforts regarding the development of preventive strategies targeting 
populations at high risk. Family history is considered an important risk factor; the 
chance of developing T2D is two-to-five times higher for people with affected 
relatives. Family history information can be used to detect persons at risk for T2D, 
but also to raise awareness about increased susceptibility and motivate individuals to 
engage in risk-reducing behaviours.
A central question is how to reach persons with a family history of T2D and 
inform them about preventive options. Currently, public health initiatives and 
health care professionals make efforts to promote health-protective behaviour in 
populations at high risk developing T2D. A potential additional targeting strategy 
might be to ask patients to pass on risk and preventive information in their family. 
To promote and facilitate family communication about increased susceptibility to 
diabetes, however, insight is needed in the complex process family risk disclosure.
The main objective of this thesis is to provide insight in the current and potential 
use of communication about familial risk of T2D to promote health-protective 
behaviour in families where T2D is (highly) prevalent. In six sub-studies, we set out to 
explore this question from three perspectives: 1) online public health communications, 
the point of view of 2) patients with T2D, and 3) health care professionals.
Diabetes Mellitus
Diabetes mellitus is a potentially life-threatening disorder characterised by chronically 
elevated blood glucose levels (hyperglycaemia). In order to achieve and maintain good 
glycaemic control, adherence to insulin or oral medication treatment and a healthy 
lifestyle (physical exercise, healthy nutrition, smoking cessation and weight loss if 
necessary) is essential. Consequently, diabetes treatment requires a high degree of 
self-management by the patient, necessary to prevent diabetes-related complications, 
cardiovascular morbidity and mortality (American Diabetes Association, 2011; Nathan, 
1993). This personal responsibility in diabetes care, as well as physical impediments, 
constitute high (emotional) burden in patients (Maes et al., 1996; Roglic et al., 2005).
Two main types of diabetes can be distinguished. Type 1 diabetes (also known 
as ‘insulin-dependent’, or ‘juvenile-onset’ diabetes) results from an autoimmune 
mediated destruction of insulin-producing beta cells in the pancreas and often is 
diagnosed early in life (American Diabetes Association, 2007). Type 2 diabetes (or 
‘non-insulin-dependent’, ‘adult-onset’ diabetes) results from a decreased ability to 
transduce the insulin signal. Type 2 diabetes, to which this thesis is limited, is mostly 
diagnosed after the age of 40, usually has a gradual onset and accounts for 90-95% of 
all cases of diabetes (American Diabetes Association, 2007). 
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The diabetes epidemic
Nowadays, diabetes is affecting about 366 million people worldwide and is expected 
to rise to 552 million by 2030 (Herman & Zimmet, 2012; Whiting et al., 2011). 
Specifically in (newly) industrialised countries with high carbohydrate diets and 
sedentary lifestyle, T2D prevalence is rapidly increasing, with escalating societal and 
economic costs as a consequence (American Diabetes Association, 2008; Johnson 
et al., 2006; Williams et al., 2002; Zimmet et al., 2001). In the Netherlands, over 
800,000 people suffer from diabetes and it has been predicted that in 2025 around 
1.3 million people (8% of the population) will be diagnosed (Baan et al., 2009). 
Risk factors and the inheritable character of type 2 diabetes
T2D is best described as a multi factorial disease, which means disease onset is 
triggered by the interaction of multiple genes and environmental factors (Lyssenko 
et al., 2008b; Rathmann et al., 2011). Risk factors include increasing age, lifestyle-
related factors as obesity, unhealthy diet and physical inactivity, insulin resistance, 
family history and ethnicity (American Diabetes Association, 2007). Epidemiological 
research convincingly demonstrates that T2D is highly prevalent in some families 
and a positive family history predicts the development of T2D, even after adjustment 
for common risk factors (Arslanian et al., 2005; Hemminki et al., 2010; Meigs et al., 
2000). The chance of developing diabetes is two-to-five times higher for people with 
a family history of the disease (Annis et al., 2005; Valdez et al., 2007). Twin studies 
have been used to assess the extent to which familial aggregation of disease can be 
accounted for by inherited genetic factors (Barroso, 2005). Indeed, the concordance 
rates for impaired glucose tolerance and T2D are consistently higher in monozygotic 
than in dizygotic twin pairs (Kaprio et al., 1992; Poulsen et al., 1999). With the 
introduction of Genome Wide Association Studies, knowledge about diabetes 
susceptibility genes has been accumulating in an impressive manner. Currently, nearly 
40 gene variants have been found to raise or lower the risk of T2D (Frayling et al., 
2007; McCarthy & Zeggini, 2009; Saxena et al., 2012; Voight et al., 2010). 
Still, no genes have yet been identified with moderate or major effect on the 
disease, so DNA testing for susceptibility genes in clinical practice is not yet warranted 
(Herder & Roden, 2010). Thus, although the sequencing of the human genome has 
provided tools to gain a better understanding of the role of genes in the development 
of disease, the distinction between genetic and environmental factors is not easily 
made. Social inheritance, due to certain lifestyles in families, may also result in familial 
clustering (van ‘t Riet et al., 2010). Studies concluded that familial risk of T2D is the 
result of shared environmental, cultural and behavioural factors and multiple (hitherto 
unknown) genes (Lyssenko et al., 2008b; Meigs et al., 2008; Vassy et al., 2011). An 
overview of increased risk based on family history is presented in Box 1.
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Other evidence of genetic predisposition may rise from comparing groups 
with different ethnic backgrounds. For instance, in urbanised regions throughout 
the world, people from South-Asian descent are known to be at highly increased 
risk developing T2D (Gupta et al., 2011; Jenum et al., 2005; Lee et al., 2011; 
Ramachandran et al., 2010; Unwin et al., 2009). Recently, susceptibility genes have 
been identified in South-Asian populations (Kooner et al., 2011; Tsai et al., 2010; 
Yamauchi et al., 2010). 
In the Netherlands, most South-Asian inhabitants are immigrants from Surinam, 
a former Dutch colony in South-America. This group has a Hindustani cultural 
background and a six-to-ten time higher T2D prevalence than the Dutch host 
population (Middelkoop et al., 1999) (see Box 2). Primary prevention targeted at 
this population is of urgent priority, since patients with South-Asian ancestry suffer 
disproportionately from the disease considering severe complications, high morbidity 
and mortality rates (Bathula et al., 2010; Gholap et al., 2011).
Box 1. Increased diabetes risk based on family history
Family history Adjusted# OR 95% CI Study
Parents and/or siblings 3.95 3.25-4.79 Annis et al., 
One relative 3.05 2.44-3.82 2005
Two relatives 5.14 3.81-6.91
Three or more relatives 14.83 10.95-20.08
One parent 3.04 2.34-3.94
Both parents 6.95 4.69-10.29
At least one sibling 3.52 2.94-4.21
Moderate familial risk1 2.3 - Valdez et al., 
High familial risk2 5.5 - 2007
Maternal diabetes 2.7 2.0-3.7 Meigs et al., 
Paternal diabetes 1.7 1.2-2.4 2000
Bilineal diabetes 5.2 2.6-10.5
Maternal diabetes and an age of onset <50 years 9.7 4.3-22.0
Concordance rates range from
Dizygotic twin pairs 0.10 to 0.43 Barroso, 2005
Monozygotic twin pairs 0.20 to 0.91
# Adjusted for relevant risk factors as gender, age, race/ethnicity, Body Mass Index
1 One first-degree and one second-degree relative, or one first-degree relative, or two second-degree 
relatives from the same maternal or paternal line
2 Two first-degree relatives or one first-degree and two second-degree relatives
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Type 2 diabetes prevention
Diabetes prevention programmes have demonstrated that lifestyle modifications 
(healthy diet, increased physical activity) or pharmacological interventions can 
significantly decrease the incidence of T2D (Gillies et al., 2007; Kinmonth et al., 
2008; Knowler et al., 2009; Lindstrom et al., 2006; Saaristo et al., 2010). Prevention 
programmes appeared to be effective in persons at risk due to family history 
(Barwell et al., 2008; Brekke et al., 2005; Uusitupa et al., 2011; Williams et al., 2004; 
Yamaoka & Tango, 2005), as well as in persons with South-Asian ethnic background 
(Hsu et al., 2012; Pan et al., 1997; Ramachandran et al., 2006; Viswanathan et al., 
1997; Wing et al., 1998). Now, scientific proof that people may delay or prevent 
the onset of T2D needs to be translated into understandable messages that appeal 
individuals at high risk and include concrete healthy lifestyle recommendations. 
Health care professionals are challenged to find new tools and strategies to detect, 
inform and particularly motivate individuals at high risk.
Public health initiatives
Globally, clinical and public health initiatives are generated to assist in reducing 
the burden of diabetes in the population. For example, the International Diabetes 
Federation (IDF) aims at increasing public awareness about diabetes and its 
complications. In their ‘Global strategic plan to raise awareness of diabetes’, the IDF 
defined target audiences, developed specific communication messages and listed 
strategies that are applicable at local, national, regional or international level 
(International Diabetes Federation, 2003). Through the worldwide network of the 
IDF, national diabetes organizations (member associations) are stimulated to inform 
Box 2. Diabetes prevalence in the Netherlands; populations of Dutch and Surinamese South-Asian origin
% Men % Women % Total Study
Dutch host population
> 20 years1
35-74 years3
40-75 years2 
18-70 years1
4.0
1.0
5.1
-
3.6
5.0
4.5
- 
3.8
3.0
4.8
6.0
Weijers, et al., 1998
Dijkshoorn, et al., 2003
Kriegsman, et al., 2003
Ujcic-Voortman et al., 2009
Surinamese-Hindustan population 
(originally from South-Asian) 3
31-49 years
50-59 years
> 60 years
 
11.8
31.1
39.8
 
9.2
29.4
41.5
 
6.4
27.7
37.1
Middelkoop, et al., 1999
1 Diabetes diagnosed after physical examination (Ujcic-Voortman et al., 2009; Weijers et al., 1998)
2 Diabetes diagnosed by general practitioners (Kriegsman et al., 2003) 
3 Self reported diabetes (Dijkshoorn et al., 2003; Middelkoop et al., 1999)
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groups at high risk about diabetes risk factors and preventive options. Interestingly, 
amongst key players involved in diabetes, such as health care decision makers and 
medical professionals, the IDF defined people with diabetes as target audience to 
spread risk and preventive messages in their families.
In the Netherlands, the national government has defined highly ambitious goals 
in the Prevention Memo 2006, aiming at reducing the incidence of diabetes and its 
complications (Dutch Ministry of Health, 2006). Following this, the Dutch Diabetes 
Federation (Nederlandse Diabetes Federatie; NDF) formulated a National Diabetes 
Action Programme, (Nationaal Actieplan Diabetes; NAD) which will operate until 
2013 (Dutch Diabetes Federation, 2009). The NDF launched a campaign to inform 
the public about risk factors for T2D and preventive options using diverse mass 
media channels, including an informative website. In this campaign, specific groups 
at high risk were targeted, including ethnic minority groups and individuals with 
a family history. On the website, a special portal for professionals was accessible, 
providing audiovisual and written information, including a validated diabetes risk 
test in different languages (Alssema et al., 2008).
In addition, inspired by the grant application of our research project, the 
Dutch Diabetes Foundation chose ‘diabetes and the family’ as central theme in 
their mass media campaigns from 2007-2010. In consecutive years, the aim was to 
raise awareness of familial susceptibility to T2D and preventive options, to urge 
patients to discuss diabetes risk in their family and to bring the ‘National Diabetes 
Inheritance Test’ to the attention of the public. 
The role of medical professionals regarding diabetes 
prevention in high-risk families
In most countries, the use of opportunistic targeted-screening in patients at risk 
for diabetes is recommended (American Diabetes Association, 2011). The Dutch 
College of General Practitioners (Nederlands Huisartsen Genootschap; NHG) 
adopted this recommendation: the Practice Guideline for diabetes treatment 
describes that three-yearly testing to detect (pre)diabetes and assess risk for future 
T2D in asymptomatic people should be considered in adults aged >45 years with 
one or more risk factors (BMI ≥27 kg/m2, first-degree relative with diabetes, 
being from Moroccan or Turkish descent, having a history of gestational diabetes, 
having hypertension, Impaired Fasting Glucose, Impaired Glucose Tolerance, or 
cardiovascular disease). In addition, screening is recommended above the age of 35 
years in Surinamese people with South-Asian ancestry (Bouma et al., 2006). 
Although primary care professionals generally recognize family history as an 
important element in the risk stratification process, family history information seems to 
be under-used in routine practice (Berg et al., 2009). Research has indicated that having 
a family history seems to be positively associated with risk awareness and risk-reducing 
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behaviours in relatives of patients with T2D (Acheson et al., 2010; Baptiste-Roberts 
et al., 2007; Dorman et al., 2012; Hariri et al., 2006), suggesting it could be utilized to 
motivate relatives to engage in risk-reducing behaviours (Claassen et al., 2010a). Indeed, 
targeted diabetes education seemed to increase the recognition of diabetes risk, screening 
possibilities, perceived personal control and the need of healthy behaviour in persons 
with a family history of T2D (Chang et al., 2011; Pierce et al., 2000; Pijl et al., 2009b; 
Qureshi & Kai, 2008; Ruffin et al., 2011; Whitford et al., 2009a; Zlot et al., 2009). Yet, 
directly targeting and informing people about increased familial susceptibility to T2D is 
not current in clinical practice (Heideman et al., 2011a). Studies indicated that physicians 
informed fewer than half of patients with a positive family history about familial risk and 
the importance of preventive behaviour (Chang et al., 2011; Qureshi & Kai, 2008). 
The patient as ‘messenger’ in the family
For health care professionals it is difficult to reach individuals with a family history 
of diabetes. Opportunities of communication with healthy relatives of T2D patients 
are limited, as they do not visit their physician regularly. Directly targeting persons 
with a family history also seems complicated, as the extent of family history collected 
and systematically registered varies widely (Berg et al., 2009; Wilson et al., 2009). 
Therefore, an approach that might be worthwhile to explore is the patient-mediated 
method of cascading, as is used in screening for familial hypercholesterolemia 
(Hallowell et al., 2011). This means that healthy relatives are reached via the index 
patient, who informs them about increased familial susceptibility to the disease and 
preventive options. Patients diagnosed with familial hypercholesterolemia seem to 
prefer a patient-mediated approach more than a direct targeting approach, as they 
consider it less threatening for relatives (Hallowell et al., 2011).
Research has already indicated that patients with T2D seem willing to disseminate 
risk messages in their family (Bonomo et al., 2005; Gnanalingham & Manns, 
1997; Nishigaki et al., 2009; Whitford et al., 2009b). Offspring appears receptive 
to be informed about reducing their diabetes risk via the family system (Esch et al., 
2009; Pierce et al., 2000; Whitford et al., 2009a). However, clearly emerging from 
research in the field of genetic screening is the complexity of the process of family 
risk disclose (Forrest et al., 2003; Wilson et al., 2004). Explorative studies already 
found that pre-existing personal and familial characteristics of patients with T2D, 
as well as their perceptions of family risk, knowledge about diabetes risk factors, 
outcome expectancies, self-efficacy and worries appeared to be predictors of their 
intentions to disseminate diabetes risk messages in their family (Bonomo et al., 2005; 
Gnanalingham & Manns, 1997; Nishigaki et al., 2009; Whitford et al., 2009b). 
Further understanding is needed to facilitate the use of a patient-mediated 
approach in diabetes prevention. As patients learn ways of being ill, how to cope 
with their illness and how to communicate about health problems within a context 
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of societal, familial and cultural rules (Baumann, 2003; Kleinman et al., 1978), 
variation in the usability of a family-oriented approach across patients, families and 
ethnic boundaries may be expected. Multigenerational legacy, the emotional impact 
of witnessing diabetes in the family and features of the course of the disease, shape 
relatives’ health beliefs and understanding of familial risk (Scollan-Koliopoulos et al., 
2005; Walter & Emery, 2005). It remains unknown, however, whether patients’ 
beliefs about, for instance, the cause and controllability of their own disease influence 
ideas about their relatives’ vulnerability to diabetes. Based on the mental contents 
underlying a person’s own health risk appraisal (Cameron, 2008; Kaptein et al., 2007; 
Leventhal et al., 2003), one may expect that the experience of patients with having 
diabetes will be important in the conceptualising of perceptions of susceptibility, 
preventability and controllability of diabetes in relatives. 
In addition, as was mentioned, ethnic variability may be expected. The question 
is whether a family-oriented intervention would be feasible approaching high-risk 
groups in the Netherlands, in particular the Surinamese South-Asian population 
with extremely high diabetes prevalence (Middelkoop et al., 1999). It is known that 
health-care delivery in South-Asian populations is challenging (Hawthorne et al., 
2008; Khunti et al., 2008). On the other hand, given the strong familial aggregation 
of diabetes in South-Asian families (Viswanathan et al., 1996), a family-oriented 
prevention strategy would seem legitimate (Ramachandran et al., 2006). 
Patients’ response to health threats in relatives; an explanatory 
model
In our study, we applied the Common-Sense Model (CSM) of self-regulation of 
health and illness (Cameron, 2003; Leventhal et al., 2003) for further examination 
of the decisional process of patients with T2D whether or not to inform relatives 
about increased familial diabetes risk. The CSM delineates that patients create their 
own ‘models’ or representations of their illness: from direct personal experiences, 
information from significant others as parents and doctors, social and mass medial 
communication, a person develops ideas and expectations about illness and health-
threatening conditions (Leventhal et al., 1997; Weinman & Petrie, 1997). Research 
convincingly demonstrated that a person’s illness representations can be ordered 
into logical themes or dimensions: illness identity, timeline beliefs, consequences, 
controllability, emotional representation, illness coherence and causal beliefs 
(Hagger & Orbell, 2003; Moss-Morris et al., 2002).
Research in which the CSM framework is used has mainly focused on illness 
representations of patients and their influence on coping, recovery and adaptation 
to the illness (Hagger & Orbell, 2003). However, recently, the concept of illness 
representations has been investigated in relation to risk perceptions, disease-related 
worries and preventive behaviour in individuals at increased risk developing a disease 
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(e.g., (Cameron, 2008; Claassen et al., 2010b; Kaptein et al., 2007; van Oostrom 
et al., 2007). In line with that, we may assume that the experience of patients with 
having diabetes also may underpin their perceptions of diabetes threat in relatives 
(see Figure 1, association A).
Subsequently, the CSM proposes that illness representations guide risk-related 
cognitions about the illness threat (e.g., risk judgements, control beliefs) and 
emotional appraisal (e.g., distress, anxiety, worries) which, in turn, will give rise to 
coping procedures for controlling health threats (Cameron, 2003; Leventhal et al., 
2003). These parallel systems of cognitive and emotional information processing may 
exert distinctive influences on protective health behaviours in different situations 
(Cameron & Reeve, 2006).
Research, particularly carried out in the field of (breast)cancer susceptibility, has 
reported considerable variability in the effect of perceived risk, worries and control 
beliefs on cancer protective behaviours (Cameron & Reeve, 2006; Consedine 
et al., 2004). Some study findings suggest that worries and fear often influence 
behaviours independently of the influence of risk beliefs (McCaul et al., 1996; 
Moser et al., 2007). Others describe situations in which worry and fear predict 
behavioural outcome, whereas risk judgments do not (Cameron & Diefenbach, 
2001; Diefenbach et al., 1999). 
In the only diabetes-related study in which worries were measured (Whitford 
et al., 2009b), patients’ concern was found an important cue to inform relatives 
about increased diabetes risk. At present, little is known about the interplay 
Figure 1. The Common-Sense Model of the self-regulation of health threats (Cameron, 2003; Leventhal 
et al., 2003) adjusted for the decisional process of patients with type 2 diabetes whether or not to inform 
relatives about increased familial diabetes risk and preventive options.
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between cognitive risk appraisal (e.g., risk perceptions, perceived illness control) and 
emotional evaluation (e.g., distress, anxiety, worries) in patients’ decisional process of 
familial diabetes risk disclosure (see Figure 1, association B). 
Research questions
The studies in this thesis aim to explore current and potential use of communication 
about familial risk of T2D to promote health-protective behaviour in families where 
T2D is (highly) prevalent from three perspectives.
Public health communication 
To start, as consciousness and interest in familial susceptibility to T2D are 
considered significant factors in the process of family risk disclosure, the public 
availability of and need for information about diabetes, inheritance and prevention 
will be explored.
1.  Is information about familial susceptibility to diabetes and preventive options 
publicly available and does the public call for this information?
  a.  What information about diabetes and inheritance do renowned diabetes 
organizations provide on the Internet?
  b. What information do people need about the role of inheritance in diabetes?
Patients with type 2 diabetes
We choose the patient as focus of interest in our studies. In addition to what is known 
from earlier studies (Nishigaki et al., 2009; Whitford et al., 2009b), facilitating and 
impeding factors of the disclosure of familial diabetes risk by patients with T2D will 
be explored within the framework of the Common-Sense Model (Cameron, 2003; 
Leventhal et al., 2003). Subsequently, the possibility of a patient-mediated targeting 
strategy in diabetes prevention according to Dutch patients with T2D, of which a 
considerable amount is from Surinamese South-Asian descent, will be investigated.
2.  What factors influence intentions of patients to disseminate information about 
diabetes risk and preventive options within the family?
  a.  How do cognitive, emotional and familial aspects influence the decisional 
process of patients whether or not to disseminate diabetes risk- and preventive 
information in their family?
  b.  To what extent are personal illness representations of patients related to their 
perceptions of diabetes threat in family members?
3.  Is it possible to use family communication as a strategy in Dutch diabetes 
prevention, specifically targeting families at high risk with Surinamese South-
Asian ancestry?
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Health care professionals
Practice implications will be considered by reflecting on the insights from above 
mentioned studies with (diabetes) health professionals within the perspective of 
current and future use of family history and family communication as additional 
strategy in diabetes prevention.
4.  What are Dutch health care professionals’ attitudes and practices regarding the 
utilisation of family history in diabetes prevention?
Aim of the study project
The study project that is described in this thesis was financed by the Dutch Diabetes 
Foundation (Diabetes Fonds) as part of their research programme entitled ‘The 
patient’s voice’ (Stem van de Patiënt). This programme emphasizes the desire that 
the projects would anticipate on the wishes and needs of people with diabetes and 
would lead to results that were practically useful to patients and their environment. 
In our project, we conducted three qualitative and three quantitative studies. 
Findings may provide useful insights contributing to the design of public and clinical 
communications and patient education programmes that utilize family history and 
family communication to promote health-protective behaviour in families where 
T2D is (highly) prevalent. 
Outline of this thesis
The chapters of this thesis are based on papers that have been published or submitted 
for publication. All sub-studies presented are explorative and observational in nature. 
In two introductory, qualitative studies we evaluated the public availability of and 
need for information about diabetes, inheritance and prevention. In Chapter 2, 
an international comparison of online information about diabetes and inheritance 
provided by renowned diabetes organizations is presented. The study described in 
Chapter 3 aimed at exploring the need for (additional and/or specific) information 
about the role of inheritance in diabetes of visitors of the website of the National 
Genetic Research and Information Centre (‘Erfocentrum’ in Dutch).
To address the second and third research objectives, a cross-sectional, 
observational study was conducted among 546 patients diagnosed with T2D, 
receiving treatment in primary- or secondary care. In Chapter 4 we aim to get 
insight into the complexity of the decisional process of patients whether or not 
to discuss familial susceptibility to T2D in their family. Cognitive, emotional and 
familial aspects are being explored and further insight is obtained regarding the 
interplay between the family risk perceptions of patients, worries and control beliefs 
regarding diabetes prevention, and their intentions to inform relatives about diabetes 
risk and preventive possibilities. Subsequently, Chapter 5 describes to what extent 
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personal illness representations of patients are related to their family risk perceptions, 
worries about relatives developing T2D, and beliefs with regard to the possibilities of 
diabetes prevention. In both Chapter 4 and 5, the Common-Sense Model of self-
regulation of health and illness (Cameron, 2003; Leventhal et al., 2003) was used as 
theoretical framework. The study in Chapter 6 investigates the possibility of utilising 
family communication as a diabetes prevention strategy, specifically targeting families 
at high risk with Surinamese South-Asian ancestry in the Netherlands.
Next, to reflect on the findings as described in previous chapters, interviews were 
conducted with medical professionals in primary- and secondary care. Chapter 7 
describes the ideas and opinions of health care providers in primary and secondary 
care on current or future uptake of family history and family communication in 
diabetes prevention. The general discussion, in Chapter 8, summarizes and reflects on 
the main findings. Methodological considerations are addressed as well as practice 
implications and further research in this field.
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provide on the Internet?
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Abstract
Aims The worldwide epidemic of type 2 diabetes necessitates preventive actions. 
Providing information to high-risk populations is key. In an international 
comparison of websites, we aimed to investigate the presence and quality of 
information provided by diabetes organizations on inheritance of type 2 diabetes and 
the benefits of a healthy lifestyle targeted at those with a family history or belonging 
to a specific ethnic population.
Methods All websites included in the International Diabetes Federation member 
list in English, German, French, Dutch, Spanish, Portuguese, Swedish, Norwegian, 
Finnish, Danish, and Japanese were included for assessment. Using qualitative content 
analysis, we reviewed 34 websites that provided health-related information on diabetes.
Results Most websites mention family history as a risk factor. However, an explanation 
of the interaction of lifestyle factors and increased genetic susceptibility is lacking. 
Ethnicity is mentioned in only half of the sites describing risk factors. Although 
most websites do provide information on the importance of a healthy lifestyle, 
they do not address specific high-risk groups. Only two websites encourage type 2 
diabetic patients to inform family members of the familial character of diabetes.
Conclusions Information on inheritance of type 2 diabetes and prevention 
specifically targeted at high-risk groups on the Internet by diabetes organizations 
is often of poor quality or indeed is lacking. Efforts should be made to disseminate 
information on heredity of type 2 diabetes and preventive options to the general 
public and high-risk populations.
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Introduction
With the rapidly increasing number of type 2 diabetic patients worldwide (Narayan 
et al., 2003; Steinbrook, 2006; Zimmet et al., 2005), it is necessary to take preventive 
actions (Sherwin et al., 2004). In addition to the known risk factors for type 2 diabetes 
(T2D), such as older age, obesity and lack of physical activity (American Diabetes 
Association, 2003, American Diabetes Association, 2004), evidence has been found for 
an ethnic susceptibility (Abate & Chandalia, 2003; Hsu et al., 2012; Jafar et al., 2003; 
Jenum et al., 2005) and genetic factors in the pathogenesis of T2D (Busch & Hegele, 
2001; Froguel & Vaxillaire, 2003; Grant et al., 2006; Klupa et al., 2000; McCarthy, 
2003; Reynisdottir et al., 2003). Accordingly, screening for a family history of T2D is 
an effective method to detect people at increased risk of developing diabetes (Annis 
et al., 2005; Arslanian et al., 2005; Harrison et al., 2003; Pierce et al., 1995).
Patients, as well as family members, seem to be aware of ‘some’ increased risk, but 
generally underestimate the actual risk percentage and apparently have little knowledge 
of primary prevention (Adriaanse et al., 2003; Farmer et al., 1999; Forsyth & Goetsch, 
1997; Gnanalingham & Manns, 1997; Pierce et al., 2001; Pierce et al., 1999). Scientific 
proof that people (especially those at increased risk) may delay or prevent the onset of 
T2D (Curtis & Wilson, 2005; Davies et al., 2004; Knowler et al., 2002; Sherwin et al., 
2004; Tuomilehto et al., 2001) needs to be translated into an understandable message 
which includes concrete healthy lifestyle recommendations. In this context, primary 
prevention campaigns should aim at providing understandable information regarding 
the interplay of genetic, environmental and behavioural factors in the aetiology of T2D 
(Newell, 2004; Pozzilli, 2005). The World Wide Web may offer a unique opportunity 
to disseminate this information on a large scale (Berland et al., 2001; Eysenbach et al., 
2002; Murray et al., 2003; Thakurdesai et al., 2004).
In this study, we set out to explore what information on inheritance, T2D and 
primary prevention is provided on the Internet by renowned diabetes organizations 
[i.e. associated International Diabetes Federation (IDF) members], whether this 
information is targeted at high-risk groups based on family history and/or ethnicity, 
and to what extent type 2 diabetic patients are urged to notify relatives on their 
increased susceptibility.
Research design and method 
Numerous websites offer information on T2D and the quality is known to vary 
widely (Gimenez-Perez et al., 2005; Seidman et al., 2003b; Thakurdesai et al., 2004). 
In this study, we decided to assess websites of renowned, national diabetes patient 
organizations all over the world. The sampling frame consisted of all associated 
member organizations of the IDF (n=182) with a URL [uniform resource locators 
(global address of resources on the World Wide Web)] available on the IDF website 
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(http://www.idf.org) in September 2005 (n=67). We included three more URLs of 
associated IDF member organizations (Spain, USA and Guyana), because we knew 
these organizations did have a website although they were not mentioned in the 
IDF list. Four websites of non-IDF member organizations were added in order to 
obtain an overview of diabetes information in those specific language regions (see 
‘Data collection’, step 4). In addition, the websites of the IDF and the World Health 
Organization (WHO) were added to gain insight into information provided by 
worldwide health organizations. The final group consisted of 76 websites (see Table 1). 
Inclusion criteria
All websites from the sampling frame in English, German, French, Dutch, Spanish, 
Portuguese, Swedish, Norwegian, Finnish, Danish, and Japanese that provide health 
information on T2D were selected. 
The language criterion was practical, as the researchers were competent reading 
these languages or knew colleagues who could. Eighteen websites had to be excluded. 
Three URLs led to a dead link, meaning the websites not being operational. After a 
first analysis, 21 websites appeared not to give health information about T2D. A total 
of 34 websites were included for content analysis in further detail (see Table 1).
Data collection
Changes in the content of websites necessitate rapid collection of data. Following 
McMillan’s recommendation to use month’s timeframe (McMillan, 2000), all 
websites were analysed in September 2005. The context unit for coding included 
all pages on a website, as well as links leading to attached documents, information 
Table 1. Sampling frame and excluded websites 
Regions
Africa
Eastern 
Mediterranean  
& Middle East Europe
North 
America
South and  
Central 
America
South  
East 
Asia 
Western 
Pacific
World 
wide Total
Total URL  
sampling frame
3 1 40 7 13 1 9 2 76
URLs not 
operational or 
excluded by 
language
0 -1 -16 0 -1 0 -3 0 -21
URLs not providing 
health information
-1 0 -8 -2 -6 -1 -3 0 -21
Total URLs analysed 2 0 16 5 6 0 3 2 34
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leaflets, journals, articles, or magazines published by the diabetes organization. 
Data were collected in four steps: (i) starting at the homepage (defined as the 
first/introduction page), we searched for a direct navigation button possibly leading 
to information about inheritance and primary prevention of T2D. This could be a 
button such as ‘what is diabetes?’, ‘are you at risk?’ or ‘how to prevent diabetes?’; (ii) 
next, we searched for information throughout the whole website, including the links 
mentioned above; (iii) if an internal search engine was available, we searched the 
site using the keywords: ‘genetic’, ‘inheritance’, ‘hereditary’, and ‘prevention’ (translated 
in the language of the website); (iv) when the first three steps did not provide any 
information, we searched for external links to websites providing health-related 
diabetes information. In four cases, we added the URLs of these websites (referenced 
by the German-, French-, Spanish-, and Japanese-associated IDF members) to the 
sample frame. The added websites were reassessed following the steps above.
Assessment of websites
The websites were analysed using a standardized assessment form designed for 
this study. The content analysis was based on four questions, which resemble the 
four communication messages for target audiences developed by the IDF to raise 
awareness of diabetes worldwide (International Diabetes Federation, 2003). (i) Is 
information on T2D and inheritance provided and, if yes, is inheritance only briefly 
mentioned or explained in more detail?; (ii) is family history of T2D mentioned 
as a risk factor and are specific ethnic populations indicated as high-risk groups?; 
(iii) is preventive information provided and, if yes, to what degree does it refer to 
risk information or target audiences and, secondly, is a translation into concrete 
behavioural recommendations made?; (iv) are patients urged to inform relatives 
about their increased risk of developing T2D?
Based on the findings of a preliminary study, coding categories were designed 
regarding the accuracy and comprehensiveness of the information provided. 
In addition, coding categories were formulated concerning the search strategy. 
Information easily found by using a direct link or navigation button on the 
homepage, e.g., ‘what is diabetes’, ‘who is at risk’, or ‘how to prevent diabetes’, and a 
direct reference or link to these sections, was categorized as ‘direct link’. Information 
difficult to locate, found after intensive search, or by using the internal search engine, 
was categorized as ‘no direct link’. 
All reviewers were familiar with diabetes and/or genetics from a professional point 
of view. They received the exact URL and the standardized assessment form, including 
a detailed coding scheme and an explanation of the steps that should be taken. 
Websites in English, German, and Dutch were analysed twice by one author (SvE). 
Native speakers assessed sites in Swedish, Norwegian, Finnish, Danish, and Japanese 
once. Websites in French, Spanish and Portuguese were analysed by native speakers 
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once, and re-analysed by one author with knowledge of these languages (SvE). All 
re-analyses took place within 2 weeks. Reviewers in native languages were instructed 
to search the website until no additional information could be found, following 
the steps described in ‘Data collection’. A time restriction of 1 h per website was 
indicated, but no reviewer mentioned a shortage of time. In four cases, the first author 
contacted the reviewers in native languages for clarification of their assessment.
As the World Wide Web is a fast-moving medium, every relevant text fragment 
was copied so discrepancies as a result of eventual changes in content could be checked 
with the copies in the archive (Koehler, 1999). Data were entered in SPSS 11.0 (SAS 
Institute, Cary, NC, USA), frequencies and cross tabulations were computed.
Results
Of 34 websites retrieved, 30 (88%) provided some information on diabetes and 
inheritance and four websites (12%) did not. Three websites (9%) mentioned family 
history in a list of risk factors, without further explanation or comments on genetics 
or inheritance. Sixteen websites (47%) provided brief information (in one or two 
sentences), such as ‘type 2 diabetes is likely to have a genetic basis’, ‘heredity plays a role 
in diabetes’, or ‘type 2 diabetes tends to run in families’. Five websites (15%) provided 
basic information explaining the interaction of environmental factors and genes 
in the development of T2D, for instance ‘A genetic predisposition, being overweight 
and a lack of exercise contribute to the onset of type 2 diabetes. Several genes are linked to 
type 2 diabetes. Scientists believe that the combination of several genes causes the disease. 
The challenge is to understand and identify the mechanisms at work and all the possible 
combinations that trigger type 2 diabetes’. Six websites (18%) gave detailed information, 
including risk percentages, depending on the relation of the affected family member.
On 19 websites (56%), this information was easily found via a direct link; on 
eight websites (24%), information was difficult to locate (see Table 2).
Of the 30 websites, which provided some information on inheritance, most 
(n=28; 82%) translated this information in ‘family history’ as a risk factor. Ethnic 
background as a risk factor was mentioned in half of the cases (n=17). In eight 
of those 17 websites, this information was not specific (mentioning only ‘certain 
ethnic groups’, ‘non-Caucasian’, or ‘some groups of immigrants’) or indicated high-risk 
groups of little relevance to that specific region (e.g., ‘Indians living in Asia 
and Afro-Americans’ mentioned in Luxembourg, and ‘Asia, Africa and the Pacific Ocean 
area, Pima Indians in USA’ mentioned in Sweden; see Table 3).
Ten websites (29%) offered a risk test, consisting of body mass index calculation 
and questions to be answered by yes/no, on the basis of a personalized risk profile for 
T2D is calculated. All risk tests included family history. Interestingly, only three risk 
tests (Diabetes UK, Canadian Diabetes Association, and Diabetes New Zealand) 
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asked about ethnicity (see Table 3). As to informing family members about their 
risk of developing diabetes, only two websites (Canadian Diabetes Association and 
Diabetes New Zealand; 6%) made patients aware of the importance of informing 
family members about their increased susceptibility, but there were no specific 
guidelines provided on what information should be conveyed, how and to whom (see 
Table 3). Fourteen websites (42%) provided a discussion forum. On only the French 
and the Irish websites was inheritance a topic people discussed. 
We found seven websites (21%) that did not provide any information on prevention 
of T2D. Twelve websites (35%) provided brief information on primary prevention 
(for example, by stating ‘a healthy lifestyle can prevent type 2 diabetes’). On seven of these 
websites (21%), information was found easily using direct links; on five websites (15%), 
no direct links were provided. Fifteen websites (44%) did translate preventive information 
into concrete recommendations for behaviour change, mostly found via direct links 
(n=11; 32%). In four cases (12%), a more intensive search was required (see Table 4).
Table 2. Websites providing information on type 2 diabetes and inheritance
 Assessment of information on inheritance
Total 
(%)
Accessibility 
of information
No 
information 
on inheritance 
(%)
Family history 
only mentioned 
in list of risk 
factors  
(%)
Brief 
information 
on inheritance 
(%)
Explaining 
genes and 
environment 
(%)
Detailed 
information 
with risk 
percentages 
(%)
No information 4 (11.8) 3 (8.8) - - - 7 (20.6)
Information provided by 
A direct link - - 10 (29.4) 3 (8.8) 6 (17.6) 19 (55.9)
No direct link - - 6 (17.6) 2 (5.9) - 8 (23.5)
Total (%) 4 (11.8) 3 (8.8) 16 (47.1) 5 (14.7) 6 (17.6) 34 (100)
Table 3. Websites providing information regarding risk factors and addressing target audiences 
Websites providing information regarding: n (% of total)
Family history mentioned as risk factor 28 (82.4)
Ethnicity mentioned as risk factor
Specified and relevant for region
Not specified
9 (26.5)
8 (23.5)
A Risk test
Including family history 
Including family history and ethnicity
7 (20.6)
3 (8.8)
Urging patients to inform relatives on increased susceptibility 2 (5.9)
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Information on primary prevention varied as to the degree to which it referred 
to risk information (described elsewhere) or target audiences. Eight websites (24%) 
provided information on primary prevention, but no reference was made to risk 
factors or high-risk groups. In 13 cases (38%), risk- and preventive information 
were provided in succession on the same page, or there was a direct link, but no 
explicit reference was made. Six websites (18%) directly addressed preventive 
information at high-risk groups and urged them to take action, for example ‘you 
have to take extra care and consult a physician, when type 2 diabetes runs in the family’ 
(see Table 4).
Discussion
This is, to our knowledge, the first review of information on inheritance, diabetes and 
primary prevention provided by diabetes associations on the Internet. Although most 
websites do provide some information on the familial character of diabetes, ethnicity 
as a risk factor is given little mention. In two-thirds of the websites examined, 
information on inheritance is missing or very brief; in almost 25% of the websites, 
information on inheritance is hard to find. With the emerging evidence regarding 
genetics of diabetes, it would seem important to explain the multifactorial aetiology 
to both patients and relatives (Newell, 2004; Pozzilli, 2005). Translating this complex 
interaction in a clear way is a challenge, particularly as Ponder et al. (1996) have 
indicated that older as well as younger people appear to have difficulty understanding 
the concept of ‘genetics’ in relation with diabetes.
Table 4. Websites providing information on primary prevention
Combination risk and preventive information
Total 
(%) 
Assessment of 
preventive information 
and accessibility
No 
information 
on primary 
prevention 
(%)
No reference 
between 
preventive and 
risk information 
(%)
Risk and preventive 
information 
presented at same 
page  
(%)
Preventive 
information 
directly addressing 
high-risk groups 
(%)
No information 7 (20.6) - - -  7 (20.6)
Briefly mentioned
Direct link
No direct link
-
-
 4 (11.8) 
3 (8.8) 
2 (5.9) 
2 (5.9) 
 
1 (2.9) 
-
7 (20.6) 
5 (14.7) 
Mentioned and translated 
into concrete behaviour
Direct link
No direct link
 
-
-
 
-
1 (2.9)
 
7 (20.6) 
2 (5.9)
 
4 (11.8) 
1 (2.9)
 
11 (32.4)
4 (11.8)
Total (%) 7 (20.6) 8 (23.5) 13 (38.3) 6 (17.6) 34 (100)
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We found that only 44% of the websites provide preventive information including 
healthy lifestyle recommendations. In addition, only a few websites (18%) target 
their information directly to relatives of type 2 diabetic patients and/or certain ethnic 
populations. This would imply that, in most of the cases, people have to combine 
risk information (‘do I belong to a high-risk group?’) and preventive information (‘is 
this preventive information especially relevant for me?’) themselves. Generally, our 
findings suggest that a few websites provide high qualitative information on both 
inheritance, as well as primary prevention. Websites offering detailed information on 
inheritance more often provide extensive preventive information along with concrete 
behaviour change recommendations.
Despite the IDF recommendation (International Diabetes Federation, 2003), only 
two websites took up the challenge of stimulating patients to inform relatives about their 
increased susceptibility. Clearly, the issue of raising awareness among family members 
deserves more attention. The fact that inheritance was found to be a topic on only two 
discussion panels may be explained by a lack of knowledge about or interest in inheritance. 
Although we did not assess website information on readability in this study, we 
are concerned with the fact adults with low literacy face problems searching health 
information on the Internet. Most health websites require at least a high-school 
reading proficiency (Birru et al., 2004). Indeed, evidence suggests that mainly 
younger, Caucasian people, with higher education, higher income, and who live in 
metropolitan areas seem to benefit from information provided on the Internet (Fogel, 
2003; United States General Accounting Office, 2001). Online health information 
providers therefore need to ensure that their written material is pitched at a level 
appropriate to the intended lay audience (Boulos, 2005). Health education providers 
should also consider other means of primary prevention strategies and delivering 
health information in addition to the Internet. 
We are aware of some limitations of our methodology. First, the selection of 
websites was limited by choice of languages, as a result of which Eastern European 
countries, including Russia, are missing. Asia, Eastern Mediterranean, and Africa are 
underrepresented. According to the IDF list, 37% of all associated members (n=182) 
do have a website. In reality, 61% of the European member organizations administer 
a website; 42% in Western Pacific; 36% in South and Central America; 23% in North 
America; 17% in South East Asia; 14% in Africa; and 7% in Eastern Mediterranean 
and Middle Eastern countries (n=1; however, that one is not operational). Further 
efforts should be made to stimulate web-based projects in these regions.
Another limitation may be the bias involved in coding websites of varying 
lengths. Some websites were reasonably large and/or complex and thus difficult to 
access. We cannot exclude the possibility that a continued search (particularly in 
linked documents) could have resulted in some additional information we did not 
retrieve. However, we doubt that people searching the Internet for information on 
inheritance and diabetes would actually find this information.
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Our review of international websites suggests there is an urgent need to further 
improve the information provided on the Internet with regard to inheritance and 
prevention in T2D. One way of achieving this would be through the development 
of guidelines on the quality and content of diabetes-related websites (Seidman et al., 
2003a, 2003b). 
We experienced the Internet as a fast-changing medium. When preparing this 
study in March 2005, several websites were assessed in a pilot study. By September 
2005, a substantial number of websites had updated and improved their information 
on inheritance and primary prevention. However, this information should be accessed 
preferably through a direct button on the homepage/first page of the website. For 
most websites, this will probably require an architectural adjustment of the website. 
Given the importance of the topic, this would seem an effort worthwhile.
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Abstract 
Background Diabetes Mellitus is a global health problem. Scientific knowledge 
on the genetics of diabetes is expanding and is more and more utilised in clinical 
practice and primary prevention strategies. Health consumers have become 
increasingly interested in genetic information. In the Netherlands, the National 
Genetic Research and Information Centre provides online information about the 
genetics of diabetes and thereby offers website visitors the opportunity to ask a 
question per email. The current study aims at exploring people’s need of (additional) 
information about the role of inheritance in diabetes. Results may help to tailor 
existing clinical and public (online) genetic information to the needs of an increasing 
population at risk for diabetes.
Methods A database with emailed questions about diabetes and inheritance (n=172) 
is used in a secondary content analysis. Questions are posted in 2005-2009 via a 
website providing information about more than 600 inheritable disorders, including 
all diabetes subtypes. Queries submitted were classified by contents as well as 
persons’ demographic profiles.
Results Questions were received by diabetes patients (49%), relatives (30%) 
and partners (21%). Questioners were relatively young (54.8% <30 years) and 
predominantly female (83%). Most queries related to type 1 diabetes and concerned 
topics related to (future) pregnancy and family planning. Questioners mainly asked 
for risk estimation, but also clarifying information (about genetics of diabetes in 
general) and advice (mostly related to family planning) was requested. Preventive 
advice to reduce own diabetes risk was hardly sought. 
Conclusions Genetic information on diabetes provided by professionals or public 
health initiatives should address patients, as well as relatives and partners. In particular, 
women are receptive to genetic information; they worry about the diabetes related 
health of (future) offspring. It seems important that information on the contribution of 
genetics to type 1 diabetes is more readily available. Considering the high prevalence 
of type 2 diabetes with strong evidence for a genetic predisposition, more effort seems 
needed to promote awareness around familial clustering and primary prevention.
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Background 
Diabetes Mellitus (a group of disorders characterised by abnormal high blood glucose 
levels) is a growing health problem (Unwin et al., 2009). In the last decade, scientific 
knowledge on the genetics of diabetes is expanding and has resulted in clinical 
application of genetic testing in the case of Maturity-Onset Diabetes of the Young 
(MODY) and Maternally Inherited Diabetes and Deafness (MIDD) (Pearson, 
2008). The understanding of genetic variation predisposing to type 1 diabetes (T1D) 
(Erlich et al., 2008), Latent Autoimmune Diabetes in Adults (LADA) (Hosszufalusi 
et al., 2003)), type 2 diabetes (T2D) (Frayling, 2007)), and gestational diabetes (GD) 
(Robitaille & Grant, 2008)) is evolving. In the case of T2D and GD, family history 
is used as a marker for genetic susceptibility and a potential risk stratification tool in 
preventive activities (Claassen et al., 2010a; Hariri et al., 2006; Harrison et al., 2003).
Health consumers have become increasingly interested in genetic information 
(Dutta et al., 2010; Taylor et al., 2001). This increasing interest is coupled with a 
growing trend in consumer uses of the Internet for health-related purposes. Statistics 
reveal that eight in ten American internet users (approximately 113 million adults) 
searched online for health information in 2006 (Fox, 2006). In the Netherlands, 
about 93% of the population has access to Internet. Of all inhabitants using the 
Internet, 54% looked for information about health and medicines at least once in 
three months in 2009 (Netherland’s National Statistics Agency, 2009). 
While consumers recognize great potential in the Internet for health 
communication on human genetics (Bernhardt et al., 2002), health professionals 
and genetic experts acknowledge that the translation of genomic information will be 
a challenge (McBride et al., 2010). Information has to be adjusted to the (genetic) 
literacy levels of target audiences (Lea et al., 2010) and has to serve the public’s 
genetic information needs (Scheuner et al., 2008). Since the growing popularity 
of Internet use, indeed there are a lot of studies evaluating genetic web content 
(van Esch et al., 2006; Shepperd et al., 2006), readability (Boulos, 2005), and effect 
on behavioural outcomes (Dutta et al., 2010). In addition, the current study was 
designed to get insight into the public’s interest, perceptions and information need 
about the genetics of diabetes. 
In the Netherlands, the National Genetic Research and Information Centre provides 
online information about the genetics of diabetes (all subtypes). Thereby, the Centre offers 
website visitors the opportunity to ask a question per email. We used this database with 
emailed questions to gain insight into people’s need of (additional) information about the 
role of inheritance in diabetes. After all, depending on whether or not visitors read the 
provided information, the emailed questions reflect their information needs, unaddressed 
issues, areas of uncertainty or difficult to understand concepts. 
Our research interest is in developing a profile of questioners, as well as the 
discovery of themes and tendencies in the emailed questions. Findings from this 
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study will contribute to better understanding of specific information needs of online 
consumers about genetics and diabetes. The results may help to tailor existing clinical 
and public (online) health information to the needs of an increasing population at 
risk for diabetes (Collins et al., 2003; Khoury, 2003).
Methods
Data source
The National Genetic Research and Information Centre in the Netherlands provides 
online information about more than 600 inheritable disorders, including all diabetes 
subtypes (http://www.erfelijkheid.nl/zena/diabe.php). Web statistics indicate that 
the general number of website visitors is reaching 2,2 million per year. Almost 9,000 
visitors searched specifically for information on ‘diabetes and inheritance’ in 2009. 
For each diabetes subtype, information about the pathophysiology, diagnosis, 
treatment, prevalence, and genetics is provided. Multifactorial-, monogenetic-, or 
mitochondrial inheritance is explained, and risk estimations are given for first- 
and second-degree relatives of T1D, T2D, and MIDD patients. Links to other 
informative websites are given. Apart from reading the information on the website, 
visitors are offered the possibility to submit a question per e-mail. Three staff 
members, who are all educated in genetics and inheritance, answer the questions 
within three days. This helpdesk team refers to professionals in the field (e.g., clinical 
genetic centres, diabetes specialists or general practitioners) in case they are unable to 
answer the question. When posting a question on the website, visitors are invited to 
disclose information (optional) about their gender, age, and whether their interest is 
personal or professional, for the purpose of evaluation.
Since January 2005, the National Genetic Research and Information Centre has 
systematically registered personal queries from website visitors. This database with 
emailed questions is designed for administrative purposes, as well as monitoring 
the quality of the web content. For the current study, the Centre handed over data 
concerning ‘diabetes and inheritance’ to the researchers and consented with the 
research objectives and methods. In view of the observational and non-invasive 
nature, this study is not subject to the Dutch Medical Research Involving Human 
Subjects Act. The researchers followed the rules defined in the Dutch Code of 
Conduct for Medical Research, in which a specific code for adequate secondary use 
of data is defined.
Study sample 
Data were derived from a sample of 265 e-mailed questions related to diabetes and 
inheritance (administered between January 2005 and November 2009). The National 
Genetic Research and Information Centre assigned an identification number (#) to each 
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email. The researchers received the emails without name and email address, to protect 
confidentiality of participants. A list with identification numbers and corresponding 
information about questioners’ gender, age, and personal versus professional interest 
was enclosed.
It is not possible to ask informed consent of participants in secondary analyses, and 
we therefore excluded all questioners (n=11) that opted not to provide any personal 
information. In addition, two exclusion criteria were applied. Fifty-eight e-mails did 
not relate to genetics and inheritance, but concerned diabetes (treatment) in general. 
Secondly, in this study we were primarily interested in (additional) information 
needs of ‘private’ health consumers, aiming at tailoring (online) information about 
diabetes and genetics. Thirty-eight questions were asked by students and health care 
professionals, and therefore were excluded from the sample. From the 158 e-mails left, 
fourteen contained two questions. In total, 172 queries were included in this study.
Data analysis
In this study, we used secondary content analysis. The advantage associated 
with secondary data analysis is its convenience and cost-effectiveness (Szabo & 
Strang, 1997). We adopted an iterative and inductive approach which is argued 
to be applicable in computer-mediated convenience samples (Herring, 2010). 
Two researchers (SvE and research assistant) double-coded all email questions 
using qualitative data indexing software (Kwalitan 5.0 (Peters & Wester, 1994)). 
Emerging themes and tendencies were identified and categorised; ambiguities were 
resolved and categories were reduced to major themes in discussion with two senior 
researchers and re-reading the emails (Miles & Huberman, 1994).
After qualitative classification, data were quantified in order to develop 
participants’ profile (by age, gender and family status) and observe the distribution 
of coding labels within the emerged categories (‘type of diabetes inquired’, ‘topics 
inquired’, ‘expressed worries’, and ‘type of information requested’). Illustrative quotes 
are presented as summaries of the questions’ quintessence, paraphrasing the original 
Dutch formulation as much as possible (however, sometimes with minor alteration to 
respect subjects’ confidentiality). Participants’ identification number (#), gender, age 
in years, and family status are included after each quote to help the reader identify 
the backgrounds of its source.
Results
Questioners’ profile and type of diabetes inquired
As shown in Table 1, it appeared that most people asking questions via the website 
were relatively young; sixty-eight persons (54.8%) were <30 years. Mainly women 
inquired the role of inheritance in diabetes (n=131; 82.7%). Nearly half of the 
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questions were asked by diabetes patients (n=77; 48.9%); almost one third by relatives 
(n=47; 29.6%) and the remaining by partners of diabetes patients (n=34; 21.5%).
Most questions concerned T1D (n=59; 37.3%). Relatively few questions referred 
to T2D (n=15; 9.5%) and GD (n=13; 8.2%). Thirteen participants inquired about 
T1D as well as T2D (8.2%), since they seemed confused about the presence of both 
diabetes subtypes in their family. A T1D patient for example asked: “I am pregnant. 
Both my parents have type 2 diabetes. Is my baby at increased risk for type 1 or type 
2 diabetes?” [#3129 Female, 27y, Patient]. Other types of diabetes, such as MODY, 
MIDD or LADA, were rarely inquired (n=8; 5.0%).
Notably, in forty-four questions (27.9%) the type of diabetes was not specified, 
for example: “Has diabetes in men consequences for offspring?” [#2097 Female, 31y, 
Partner], or “I have diabetes. My partner’s father and grandfather also have diabetes. 
We are thinking about having children. Is diabetes inheritable and if yes, what is the 
diabetes risk of our children?” [#2088 Female, 18y, Patient]. Additionally, slightly 
more than half of the questions (n=86; 54.6%) did not contain well-defined family 
information, for instance: “Five persons in my family have diabetes. Does this have to 
do with inheritance?” [#3104 Female, 65y, Relative].
Table 1. Questioners’ profile, type of diabetes inquired and information  provided about family history (n=158)
Questioners’ and questions’ characteristics N (%)
Age in years
< 20
21-30
31-40
> 41
19 (12.1)
67 (42.7)
40 (25.0)
32 (20.2)
Gender 
Female
Male
131 (82.7)
27 (17.3)
Family status
Patient
Relative
Partner
77 (48.9)
47 (29.6)
34 (21.5)
Type of diabetes inquired
Type 1 diabetes
Type 2 diabetes
Type 1 and type 2 diabetes
Gestational diabetes 
MODY/MIDD/LADA
Diabetes insipidus*
Diabetes type not specified
59 (37.3)
15 (9.5)
13 (8.2)
13 (8.2)
8 (5.0)
6 (3.8)
44 (27.9)
Question lacks well-defined information about family history 86 (54.6)
* Although the name is rather similar, diabetes insipidus is a different clinical entity (left out of the scope of this paper).
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Topics that people inquire about
Table 2 displays the topics of interest. Eighty-four participants (48.8%) inquired 
about genetics and inheritance in relation to reproduction. More than half of these 
questions specifically referred to a (future) pregnancy. 
Evidently, the period of pregnancy brings up worries about consequences for the 
questioners’ health as well as the health of the foetus, for instance: “I am 13 weeks 
pregnant and have type 1 diabetes. My blood glucose levels are very unstable. I am 
worried about my health and possible consequences for my baby.” [#5012 Female, 
30y, Patient], or in case of GD: “I have gestational diabetes. What are the risks for 
the baby during pregnancy and what is the risk for the child later in life?” [#0014 
Female, 26y, Patient]. Even regarding to late onset T2D people seem to be worried: “I 
am six weeks pregnant. My husband is a type 2 diabetes patient. Is there a risk for my 
child?” [#1048 Female, 31y, Partner]. The preconception phase was mostly inquired 
by T1D patients: “I have so many questions. I have type 1 diabetes and want to get 
pregnant. Is that possible? What are the risks for me, the pregnancy and the baby?” 
[#3131 Female, 36y, Patient]. Besides pregnancy, ‘family planning’ was often explicitly 
mentioned as a reason for asking the question. A few questioners were in serious 
doubt about having offspring, because of the (sometimes high) prevalence of diabetes 
in their family. As one patient stated: “Three persons in my family, including myself, 
have type 1 diabetes. A fourth family member is diagnosed with LADA. What is the 
chance my future children will develop diabetes? I don’t know whether I want to have 
children, if they would be at really high risk.” [#5055 Female, 24y, Patient]. 
More than one third of the e-mails (n=64; 37.2%) concerned the genetics of 
diabetes ‘in general’. Most questioners inquired about the role of inheritance in their 
Table 2. Topics that people inquire about, expressed worries, and type of information requested
N (%)
Topics inquired
Genetics and inheritance in relation to reproduction 
Genetics and inheritance in general
(New) technologies: genetic testing, gene therapy
84 (48.8)
64 (37.2)
24 (14.0)
Expressed worries
Worries about offspring’s diabetes risk
Worries about own diabetes (risk)
Not explicitly mentioned
78 (45.3)
58 (33.7)
36 (20.9)
Type of information requested
Risk estimation
Asking for an explanation/clarification/verification
Looking for advice
Asking (specified) information 
69 (40.1)
42 (24.4)
38 (22.1)
23 (13.4)
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family, for instance: “Two of my kids have type 1 diabetes. Both my parents have 
type 2 diabetes. Since type 2 diabetes is not inheritable, why do my children have type 
1 diabetes?” [#1025 Female, 28y, Relative]. Some people are specifically interested 
in genes: “I have type 1 diabetes, celiac disease and epilepsy. Which gene defects are 
causing these diseases? Are these genes related?” [#1018 Male, 30y, Patient]. 
A small amount of e-mails (n=24; 14.0%) concerned queries about (new) 
technologies such as genetic testing, genetic therapy and progresses in the scientific 
field, for example: “Which medical centre in the Netherlands performs genetic 
tests for MODY? Which qualifications for testing are required?” [#3105 Male, 35y, 
Patient]. A questioner with high expectations asked: “I have type 2 diabetes. When 
will gene therapy be available?” [#1039 Male, 28y, Patient].
Expressed worries
It appeared that almost half of the queries received (n=78; 45.3%) were related to 
worries about (future) offspring’s diabetes risk. One third (n=58; 33.7%) referred 
to the questioner’s own diabetes related health or diabetes risk. Noteworthy, some 
people inquiring offspring’s diabetes risk seem not worried or even aware of their own 
possibly increased diabetes risk, for instance: “My partner has type 1 diabetes. My 
father, and possibly my mother-in-law, had type 2 diabetes. What is the chance my 
child will develop type 1 diabetes?” [#4027 Female, 36y, Partner]. Or: “My uncle has 
diabetes. Is it possible this disease is inheritable for my future child?” [#1040 Female, 
25y, Relative]. Not all questioners did explicitly express worries in their e-mail.
Type of information requested
Table 2 summarizes the type of information that website visitors requested. Most 
e-mail questions (n=69; 40.1%) pertained a request for (personalised) risk information. 
On the website, risk estimations for first- and second-degree relatives of T1D, T2D, 
and MIDD patients are described. In theory, questions as: “My partner has type 1 
diabetes. What is the risk my future child will develop diabetes?” [#0106 Female, 29y, 
Partner] could be answered by reading this information. Evidently, in families with 
complex family history (different types of diabetes and/or diabetes running through 
several generations), the provided risk information might be difficult to apply. For 
instance, “A relative of mine has type 1 diabetes. In my wife’s family type 1 as well 
as type 2 diabetes is prevalent. Is it possible to estimate whether my children are at 
increased risk for type 1 or type 2 diabetes?” [#3154 Male, 28y, Relative].
In almost one quarter of the e-mails (n=42; 24.4%), the questioner requested an 
explanation, clarification or verification. For example, people inquired about the (genetic) 
co-occurrence of different types of diabetes in their family: “Are gestational diabetes and 
diabetes insipidus genetically related?” [#3134 Female, 46y, Relative]. Some wanted to 
verify or validate information or ideas: “I have type 1 diabetes. My father, my aunt and 
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grandmother also have type 1 diabetes. I was told it’s a coincidence. Is that true?” [#2079 
Female, 25y, Patient], or “I have type 1 diabetes. Several family members have type 2 
diabetes. Is it possible I inherited my diabetes?” [#2066 Female, 16y, Patient].
Thirty-eight participants (22.1%) expressed a wish to obtain preventive and/
or therapeutic advice, with regard to either one’s own health or the diabetes related 
health of offspring. For example, “We are thinking about a pregnancy. My partner has 
type 1 diabetes. In my family, some relatives have type 2 diabetes. What precautionary 
measures do we have to take to get a healthy baby?” [#1016 Female, 29y, Partner]. 
Preventive advice to reduce own T2D risk was hardly sought. As regards, only three 
questioners referred to the multifactorial aetiology of T2D: “My father has type 2 
diabetes. How can we prevent developing diabetes?” [#0012 Female, 40y, Relative].
Finally, in some e-mails (n=23; 13.4%) people included a clear request for specific 
information, as a MODY patient stated: “I am looking for information. My son and 
I are diagnosed with MODY, caused by a heterozygote mutation.” [#3138 Female, 
30y, Patient]. Or a patient was interested in scientific progresses: “How far are 
developments in the field of stem cell transplantation or other possible solutions to 
cure type 1 diabetes?” [#5016 Male, 41y, Patient].
Information need
To get a clearer view of questioners’ information needs, we combined the topics 
they inquired about with the type of information they requested. It appeared that 
questioners inquiring about genetics in relation to reproduction most of the time 
were in need of risk information (n=40; 47.7%) or advice (n=30; 35.8%). The majority 
of queries concerning genetics and inheritance of diabetes in general also contained 
a need for risk information (n=28; 43.8%) and in almost an equal number of cases a 
request for explanation or verification (n=26; 40.6%). People submitting an e-mail 
about (new) technologies in the genetic field mostly demanded specified information 
(n=14; 58.3%) (see Table 3).
Table 3. Topics inquired about related to the type of information requested*
Type of information 
requested
Topics inquired about
Reproduction  
(n=84)
Genetics in general  
(n=64)
(New) technologies  
(n=24)
Risk estimation 47.7 43.8 4.2
Explanation/ verification 15.5 40.6 12.5
Advice 35.8 3.1 25.0
(Specific) information 0.0 12.5 58.3
* Data are percentages
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Discussion
Based on e-mails received by the Dutch National Genetic Research and Information 
Centre, it appears that people in need of (additional) online information about 
diabetes and inheritance are relatively young and predominantly female. This is 
in line with previous research indicating that younger Internet users and women 
are most likely to search for online genetic information (Bernhardt et al., 2004; 
Eriksson-Backa, 2003). Yet, the online population is expanding and becoming 
more representative in terms of race, age, income, and educational attainment 
(Fox & Rainie, 2000; Ybarra & Suman, 2008). Interestingly our data suggest that 
besides patients with diabetes, relatives and partners seem interested in the topic 
of inheritance. This is in contrast to earlier reports in the field of oncology where 
partners and relatives are described as potential ‘blockers’ of genetic information in 
families (Koehly et al., 2009). This difference at least may be partly related to the 
disease at stake and warrants further investigation.
Although only accounting for 5-10% of the overall prevalence of diabetes, most 
questions concerned T1D. Apparently, T1D is assumed to be genetic, probably 
because of its juvenile onset. More interest could be expected regarding the genetic 
subtypes of diabetes, MODY and MIDD, although they are rare and treated in 
specialty clinics where genetic information may be readily available (Pearson, 
2008). Considering the high prevalence of T2D (~90% of all diagnosed cases) and 
GD (2-5% of all pregnancies, with higher prevalence in some ethnic/racial groups 
(Hunt & Schuller, 2007)), the role of heredity in these subtypes appears to be under 
appreciated. Possibly, the information need is low due to underestimation of the 
seriousness of the condition (Lamont et al., 2002) or limited awareness about the 
role of genetics and shared environment in the aetiology (Adriaanse et al., 2003; 
Kemple et al., 2005). Recent trends indicating a growing awareness of family risk and 
worries about the development of T2D in offspring (Whitford et al., 2009a, , 2009b) 
is not reflected in our results yet. Possibly, people found genetic information about 
T2D, GD or MODY/MIDD/LADA subtypes on other websites than the one we 
studied. Research however reveals that most online health information seekers start 
their session at a search engine (Fox, 2006) and using Google, the first (and almost 
only) hit when searching for ‘diabetes and inheritance’ in Dutch refers to the website 
of the National Genetic Research and Information Centre. Moreover, we found earlier 
that information on diabetes and inheritance provided by websites of renowned 
diabetes organizations is generally poor or lacking (van Esch et al., 2006).
Finally, data reveal that the majority of queries concern topics related to (future) 
pregnancy and family planning. This finding is in line with the relatively young age of 
questioners and overrepresentation of women in our study. It is known that the phase 
of reproduction generates an active search for genetic information (Eriksson-Backa, 
2003; Larsson, 2009). Women have been found to search for genetic information, 
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because they worry about the health of their (future) offspring (d’Agincourt-
Canning, 2001). These results resemble our finding that in most queries worries 
about the diabetes related health of (future) offspring were expressed.
Strengths and limitations
A strength of this study is that data were collected from a registry of people’s search 
for information in a ‘natural’ setting as opposed to exploring beliefs and knowledge 
on genetics in a (high-risk) clinical setting or in general public using questionnaires 
(Morren et al., 2007). We were able to explore questions based on individual 
perceptions and interests, described in people’s own words.
However by utilising secondary data analysis, we were unable to further expand 
our understanding by posing additional questions for example related to the amount 
of visitors actually reading the information provided on the website, the degree of 
understanding, and perceived utility of the expert answers received (Szabo & Strang, 
1997). On the other hand, it appeared that the available 172 queries generated a 
study sample that was rich enough to emerge categories reflecting interesting themes 
and tendencies to describe.
We are aware that people submitting e-mail questions via the Internet may 
represent a selective group (in our study: young, predominantly female Internet users) 
and we cannot exclude selection bias. In addition, the study’s generalizability is limited 
due to its reliance on questions gathered by only one web based supplier of genetic 
information. It would be interesting to expand our study using other interactive 
websites and other countries to provide insight in other settings and cultures.
Practical implications
In earlier research, it appeared that physicians are the preferred first source of health 
information for 50% of Americans. Yet only 11% report their physician as the first 
line of inquiry, as compared with 49% who report that the Internet is their first source 
(Hesse et al., 2005). Consequently, the delivery of genetic information on diabetes is 
important in clinical practice as well as in (web based) public health initiatives. 
Diabetes professionals might adjust their information after discussing clients’ 
information needs, family situation and risk perceptions. It is important to notice 
that some recipients will be in need of personalised risk information, while others 
prefer clarifying information or advice. Public health initiatives, including web-based 
strategies, can add to the health education of people about genetic backgrounds 
of common diseases, and provide general risk information as well as preventive 
messages. In addition, information on scientific progress and new technologies in the 
field of genetics may fulfil the need of a small, but highly interested public.
In addition of public information, individuals may wish to receive personalised 
(risk) information or advice. Utilising an email approach often requires more detailed 
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information from the person than currently provided. As an alternative, clinicians 
and public health providers could compile a list of frequently asked questions (and 
answers) about diabetes and inheritance and incorporate it into (web based) diabetes 
family education.
Conclusion
Utilising genetic information requires a well-considered strategy. Our study suggests that 
patients, in particular women, but also relatives and partners, are in need of information on 
the genetics of diabetes. Preventive advice to reduce own diabetes risk was hardly sought. 
Considering the high prevalence of T2D and GD, more effort seems needed to explain 
the multifactorial aetiology (and with it, the risk of familial clustering). Opportunities 
to delay or prevent T2D and GD onset by adopting a healthy lifestyle (Horton, 1991; 
Kinmonth et al., 2008) should be emphasized. To optimise health behaviour, these efforts 
should take public perceptions about inherited predisposition and primary prevention into 
account (Pijl et al., 2009a; Senior et al., 1999). Findings from this study underscore the 
importance of further exploring the genetic information needs of people with diabetes of 
all types. At least it seems important that information on the contribution of genetics to 
T1D is more readily available.
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Abstract
Aims Patients with type 2 diabetes may play a role as intermediary between medical 
professionals and at-risk relatives to promote diabetes prevention in their family. 
This study aimed to further our understanding of factors that influence the decisional 
process of familial risk disclosure in patients with diabetes.
Methods In a cross-sectional study, patients with type 2 diabetes (n=546) filled in 
a questionnaire assessing family risk perception, worry, personal beliefs regarding 
diabetes prevention, diabetes-related family communication, intention and perceived 
ability to inform relatives about familial risk of diabetes. Data were analysed using 
hierarchical logistic regression and multiple mediation analyses.
Results Sixty percent of the patients were willing to inform their relatives about 
familial diabetes risk; 61% reported high family risk perception and 41% had positive 
control beliefs with regard to preventive options in relatives. A majority (69%) 
did not express serious concern about relatives developing diabetes. Worry about 
relatives, knowing what to tell, whom to notify, and communication about diabetes 
in general appeared to facilitate family risk disclosure. Unexpectedly, high family 
risk perception in itself did not significantly increase patients’ intentions to inform 
relatives; rather, risk perception appeared to exert an indirect effect through worry 
and beliefs about diabetes prevention. 
Conclusions Worry in patients with diabetes appears to be a key factor in the 
process of family risk disclosure. When professionals guide their patients in this 
process, they should not only provide risk information, but also address worry and 
emphasize opportunities for diabetes prevention.
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Introduction
Diabetes prevention programmes convincingly demonstrated that lifestyle 
modifications or pharmacological interventions can significantly decrease the 
incidence of type 2 diabetes (T2D) in high-risk populations (Yamaoka & Tango, 
2005). Therefore, health care professionals are challenged to find new strategies 
to detect and motivate individuals at high risk. Family history is recognized as an 
important stratification tool (Lyssenko et al., 2008b), and having a family history 
of diabetes seems to be positively associated with risk awareness and risk-reducing 
behaviours in relatives of patients with T2D (Baptiste-Roberts et al., 2007; Chang 
et al., 2011). Yet, lifestyle interventions specifically aiming at prevention of T2D in 
people with a family history seem to be scarce (Heideman et al., 2011a). 
Utilizing patients as messengers in the family, as, for example, in cascade 
screening (Herman et al., 2009), could be an effective strategy to reach healthy 
individuals with a family history of diabetes. Research has already indicated 
that adult offspring of patients with diabetes generally seems receptive to being 
informed via the family system about reducing their diabetes risk (van Esch et al., 
2009; Pierce et al., 2000; Whitford et al., 2009a). The majority of patients (ranging 
from 55 to 100%) recognize the necessity of disseminating risk and preventive 
messages in their family (van Esch et al., 2012b; Gnanalingham & Manns, 1997; 
Nishigaki et al., 2009; Whitford et al., 2009b). However, the number of participants 
that actually inform their relatives appears to be lower (ranging from 49 to 65%) 
(Gnanalingham & Manns, 1997; Nishigaki et al., 2009; Nishigaki et al., 2011; 
Whitford et al., 2009b). At this point, the question is: what health care professionals 
can do to guide patients in the process of family risk disclosure?
Earlier studies found that pre-existing personal and familial characteristics, as well as 
family risk perception, knowledge about diabetes risk factors, outcome expectancies and 
self-efficacy, appeared to be predictors of patients’ intentions to disseminate risk messages 
in their family (Gnanalingham & Manns, 1997; Nishigaki et al., 2009; Whitford et 
al., 2009b). Generally, risk perception is recognized as a key motivator of risk-reducing 
behaviours (Weinstein, 1993). However, it has been observed that aspects other than 
perceived risk need to be explored to help target efforts in the primary prevention of 
diabetes (Hivert et al., 2009). In the only study in which worries were measured (Whitford 
et al., 2009b), patients’ concerns about relatives were found an important cue to action. 
Research carried out in the area of cancer control behaviours has reported considerable 
variability in the observed relationships of perceived risk, worry and control beliefs with 
cancer protective behaviours (Cameron & Reeve, 2006; Consedine et al., 2004). These 
interrelationships remain unexplored in the field of familial diabetes risk disclosure.
Therefore, in the current study, we first explored the influence of patients’ family 
risk perceptions, worry, personal beliefs about diabetes prevention, self-efficacy and 
diabetes-related family communication on their willingness to inform relatives. 
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Next, based on the Common-Sense Model of self-regulation of health and illness 
(Cameron, 2003; Leventhal et al., 2003), we set out to gain further understanding of 
how reasoned cognitions (i.e. family risk perception and control beliefs about diabetes 
prevention) and emotional appraisal (i.e. worry about relatives developing diabetes) 
are interrelated and associated with patients’ intentions to discuss familial diabetes 
risk. In addition to the importance of understanding the underlying mechanisms 
by which psychosocial factors influence health protective behaviours, findings may 
facilitate the development of targeted family-based diabetes prevention programmes.
Patients and Methods
Data were collected within the context of a larger cross-sectional study on family 
history and T2D, which was conducted in the Netherlands in 2007. Registered 
patients with T2D (aged >18 years) in four primary care practices and the diabetes 
outpatient clinics of the VU University Medical Center and the Haaglanden Medical 
Center were invited by their physician to participate in the study (n=1312). Patients 
who were not eligible because of severe medical and/or emotional burden were 
excluded by the physicians beforehand. All participants gave informed consent and 
the VU University Medical Center Ethics Committee approved the study.
Measures
Self-reported socio-demographics and diabetes-related characteristics were collected, 
including age, gender, domestic situation, education and ethnicity. Participants were 
identified as non-Dutch if at least one parent was born outside the Netherlands 
(definition Statistics Netherland). Family history of T2D in first- and/or second-
degree relatives was assessed, as well as treatment in primary or secondary care, 
diabetes duration, received medical therapy and diabetes complications.
As in disorders with a multifactorial aetiology, the increased risk is not only 
present in first-degree, but also in second-degree relatives (Scheuner et al., 1997; 
Valdez et al., 2007). Family risk perception and worry about relatives was explored 
with regard to offspring as well as other relatives (including siblings, grandchildren, 
aunts/uncles and nieces/nephews). Measurements were based on previous studies 
(Nishigaki et al., 2009; Pierce et al., 1999; Whitford et al., 2009b) (see Table 2 for 
exact wording of questions). Assuming that communication in social settings is often 
not restricted to first-degree relatives, participants (only those with living relatives) 
were asked whether diabetes in general is a topic that is discussed with first-degree as 
well as second-degree relatives. Answers were provided on a four-point Likert scale. 
Control beliefs of patients were assessed by asking ‘do you think there is anything 
your relatives can do to delay or prevent developing diabetes?’ (no/don’t know/yes). 
Statements were provided to enquire about patients’ intentions to inform relatives 
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and perceived self-efficacy (i.e. ‘knowing what to tell’, ‘who to notify’ and ‘how to 
inform relatives’). Response options were agree/disagree/don’t know.
Data analysis
Analyses were performed using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA). 
Chi-square tests and an independent Student’s t-test were calculated in non-response 
analysis. The outcome variable was dichotomized to compare patients who were willing 
to inform relatives (yes=1) with those who were not, or had not yet decided (no/
don’t know=0). Logistic regression analysis (backwards elimination) was conducted to 
identify demographic and diabetes-related variables that were significantly associated 
with the outcome variable. Next, hierarchically grouped subsets of variables were 
entered in the model, controlling for relevant covariates. The probability level for 
statistical significance was set at P≤ 0.05 (two-tailed) for all statistical analyses.
As risk perception is seen as an important cue to action (Leventhal et al., 2003; 
Weinstein, 1993), and a key variable in health-promoting campaigns (O’Neill et 
al., 2009), we set out to explore the possibility of family risk perception exerting an 
indirect effect on patients’ intentions to inform relatives through worry and personal 
beliefs about diabetes prevention. Multiple mediation analysis was performed using 
a SPSS macro, allowing for simultaneous mediation by two variables (i.e. worry and 
control beliefs) and controlling for covariates (Preacher & Hayes, 2008). This procedure 
is recommended over the widely used causal-steps approach, because it has higher 
power while maintaining reasonable control over the Type I error rate (Hayes, 2009). 
The analysis produced traditional direct effects (a, b, c and c’ paths, see Figure 1); 
however, Preacher and Hayes emphasize the direction and size of the indirect effects 
(Preacher & Hayes, 2008). Bootstrapping (a non-parametric re-sampling procedure 
that does not impose the assumption of normality of the sampling distribution) was 
used to examine specific indirect effects of each putative mediator (a1b1 and a2b2 paths) 
and the total indirect effect of the mediators as a set (a1b1+a2b2 path, see Figure 1). 
Results
Of 1312 patients invited, 546 (41.6%) filled in the questionnaire. Table 1 shows the 
background characteristics of the participants. The majority of the study sample (60.3%; 
n=298) expressed their intention to talk about diabetes risk and primary prevention 
in their family. Other participants did not intend to do so (18.2%; n=90) or answered 
‘don’t know’ (21.5%; n=106). Most participants indicated knowing what to tell (76.6%; 
n=379), who to notify (74.4%; n=369) and how to inform their relatives (72.5%; n=358).
Table 2 shows that more than half of the participants (60.9%; n=286) thought it was 
(very) likely that offspring and/or other relatives would develop T2D. However, only 
approximately one third (31.4%; n=142) expressed serious concern about that. Less than 
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Table 1. Socio-demographic and diabetes-related characteristics of responders and non-responders (n=1312).
 
Responders (n=546) Non-responders (n=766)
n % n %
Socio-demographic characteristics
 Mean age ± SD* 63.6 ± 11.7 years 60.1 ± 13.3 years
 Female 274 50.2 390 51.0
 Living with partner and/or offspring 350 66.0 - -
 Low educational achievement† 336 64.4 - -
 Dutch ethnic background‡ 311 57.6 - -
Diabetes-related characteristics
 Treatment in primary care 286 52.4 423 55.2
 Family history in first and/or second-degree relatives 391 71.6 - -
 Diabetes duration < 10 years 356 65.6 - -
 Treatment with oral medication§ 334 61.6 - -
 Reporting diabetes complications¶ 289 54.0 - -
* Statistically significant difference between responders and non-responders; P<0.001.
† No education, primary school and lower vocational/trade education.
‡ Almost one third (29.1%; n=157) had at least one parent with Surinamese South-Asian background; 7.2% had at 
least one parent from another Western country (n=39); 6.1% had non-Western ancestry (n=33).
§ As opposed to insulin treatment.
¶ Self-reported complications included retinopathy, neuropathy and nephropathy and co-morbid 
cardiovascular problems.
half of the participants (41.4%; n=216) had positive beliefs regarding the possibility of 
relatives delaying or preventing diabetes onset. The majority (79.9%; n=388) indicated that 
they discuss their diabetes with first- and/or second-degree relatives ‘sometimes/often’.
Factors that influence patients’ intentions to inform relatives
From all background variables, only higher education (OR 1.8; 95% CI 1.2-2.7) and 
non-Dutch descent (OR 1.7; 95% CI 1.1-2.4) appeared to be related with a more 
a positive intention towards disclosure of family risk. In Table 3, the outcomes of a 
stepwise logistic regression analysis, adjusted for education and ethnicity, are presented. 
No significant relation between family risk perception and patients’ intentions to 
inform relatives was found (OR 1.0; 95% CI 0.6-1.7). However, worry (OR 2.1; 
95% CI 1.1-3.7) and personal control beliefs (OR 1.6; 95% CI 1.0-2.7) appeared to 
be positively associated with the outcome variable. As would be expected, by adding 
diabetes-related family communication to the model, it was learned that patients 
showed greater intention to disseminate risk and preventive information when diabetes 
is regularly discussed with relatives (OR 2.5; 95% CI 1.4-4.4). Yet patients’ worries 
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Table 2. Descriptive statistics with regard to patients’ family risk perceptions, worries about relatives’ health, 
control beliefs regarding diabetes prevention and diabetes-related family communication
n %
Family risk perception§
“I think it is not (very) likely that offspring and other relatives† will develop Type 2 diabetes”
“I think it is (very) likely that offspring and/or other relatives† will develop 
Type 2 diabetes”
184
 
286
39.1
 
60.9
Worry about relatives developing diabetes§
“I have no/little worries about my offspring and other relatives† developing Type 2 
diabetes”
“I have (quite) a lot of worries about my offspring and/or other relatives† developing type 
2 diabetes”
 
310 
142
 
68.6 
31.4
Personal control beliefs regarding diabetes prevention
“Do you think there is anything your relatives can do to delay or prevent developing 
diabetes?”
No 
Don’t know 
Yes
 
86 
224 
216
 
16.3 
42.64 
1.1
Pre-existing family communication about type 2 diabetes‡
“I never/rarely discuss my diabetes with first- and second-degree relatives”
“I sometimes/often discuss my diabetes with first- and/or second-degree relatives”
98
388
20.2
79.9
§ The questions about patients’ family risk perceptions and worries about relatives were combined for 
offspring and other relatives.
† Other relatives include siblings, grandchildren, aunts/uncles and nieces/nephews.
‡ The question about family communication about diabetes was combined for first- and second-degree family 
members.
remained a significant determinant (OR 2.0; 95% CI 1.1-3.8). The final step reveals 
that knowing what to tell (OR 3.2; 95% CI 1.6-6.4), who to notify (OR 2.5; 95% CI 
1.3-4.9) and being worried about relatives’ health (OR 2.4; 95% CI 1.3-4.7) facilitated 
patients’ intention to inform relatives most strongly. Family communication about 
diabetes in general (OR 1.9; 95% CI 1.0-3.6) also remained a predisposing factor.
Exploring putative indirect effects
As higher risk perception appeared not to be significantly associated with the 
intention to inform relatives, the possibility of an indirect association between family 
risk perception and the outcome variable through patients’ worries and personal 
beliefs about diabetes prevention was explored (see Figure 1). Findings indicated that 
increased risk perception led to elevated levels of worry (a1 path; β=0.28, P<0.001), 
which in turn led to greater intention to inform relatives (b1 path; β =0.65, P <0.01). 
A trend was found towards higher risk perception leading to more negative beliefs 
about diabetes prevention (a2 path; β =-0.07, P=0.11). Positive control beliefs 
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increased patients’ intentions to talk with their relatives (b2 path; β =0.33, P<0.05). 
According to the procedure of Preacher and Hayes (Preacher & Hayes, 2008), family 
risk perception exerted a positive indirect effect on the intention to inform relatives 
through worry (a1b1 path; point estimate= 0.19, BCa 95% CI 0.06 to 0.33). Personal 
beliefs in diabetes prevention, however, showed only a trend towards a negative 
indirect effect (a2b2 path; point estimate= -0.02, BCa 95% CI -0.08 to 0.00). The 
relationship between patients’ family risk perceptions and their intentions to inform 
their relatives about T2D risk was positively mediated through worry and control 
beliefs as a set (a1b1+a2b2 path; point estimate= 0.17, BCa 95% CI 0.03 to 0.31). It 
seemed that opposite signed direct effects of worry and control beliefs with family 
risk perception slightly attenuated the total indirect effect.
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Figure 1 Graphic representation of the multiple mediation model (Preacher & Hayes, 2008). Estimates 
are shown of the total (without putative mediators) and direct (with putative mediators) effects of family 
risk perception on patients’ intentions to inform relatives, as well as the indirect effect through worry 
about relatives and personal beliefs about diabetes prevention, while controlling for education and 
ethnicity. The bootstrap method was used, calculating 10000 sample boots. Data were analysed list 
wise, resulting in a sample size of n=386. Direct effects are represented with standardized regression 
coefficients (β) and P-values. Indirect effects are represented by point estimates (boot β) and a Bias 
Corrected and accelerated 95% Confidence Interval (BCa 95% CI).  
Total effect (c path) 
β =0.21; P=0.10 
Direct effect (c’ path) 
β =0.07; P=0.61 
Emotional appraisal 
Worry about relatives 
 
Specific indirect effect 
(a1b1 path)  
Point estimate = 0.19; 
BCa 95% CI 0.06 to 0.33 
 
Reasoned cognition 
Beliefs about diabetes 
prevention 
 
Specific indirect effect 
(a2b2 path)  
Point estimate = -0.02;  
BCa 95% CI -0.08 to 0.00 
 
Direct effect (a1 path) 
β =0.28; P<0.001 
Direct effect (b1 path)  
β =0.65; P<0.01 
 
Reasoned cognition 
Family risk perception 
 
Intention to inform 
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Direct effect (b2 path) 
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Direct effect (a2 path) 
β =-0.07; P=0.11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total indirect effect 
(a1b1+a2b2 path) 
Point estimate = 0.17; 
BCa 95% CI 0.03 to 0.31 
 
Figure 1. Graphic representation of the multiple mediation odel (Preacher & Hayes, 2008). Estimates 
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Discussion
In this study, we explored factors that are associated with the willingness of 
patients with T2D to serve as a health educator in the family. In line with earlier 
studies, more than half of the participants intended to inform their relatives about 
increased diabetes risk (Gnanalingham & Manns, 1997; Nishigaki et al., 2009; 
Whitford et al., 2009b). Worry about relatives’ health, knowing what to tell, whom 
to notify and family communication about diabetes in general appeared to be 
important predisposing factors of family risk disclosure. Interestingly, high family 
risk perception was not significantly associated with patients’ intentions to inform 
relatives. Rather, risk perception appeared to have an indirect effect on the intention 
to talk with relatives through worries about relatives’ health and personal beliefs 
about diabetes prevention, in which worry had the largest specific indirect effect. 
These findings underscore the complexity of patients’ decisional processes to engage 
in actions to protect their family members’ health.
Although our results underline the importance of addressing patients’ worries, 
interventions also need to address risk perceptions. After all, promoting health-
protective behaviour cannot successfully target worries alone, because worries cannot 
be permanently altered without changing risk cognitions that elicit this affective 
response (Cameron, 2003). Education on the possibilities of diabetes prevention 
is clearly needed, given our finding that more than half of the participants did 
not have positive beliefs about preventive options. Patients’ understanding of risk 
factors and primary prevention should be assessed to inform the development and 
implementation of educational programmes. In addition, to optimize acceptance 
of provided risk and preventive information and increase message effects, patient’s 
perceptions of, for instance, the seriousness and controllability of their condition, 
should be taken into account (Rimer & Kreuter, 2006).
Our research was strengthened by the fact that the study population resembled 
the population with T2D in the Netherlands (van Dam et al., 1991). Ethnic 
backgrounds of the participants were mixed, representing minority groups with high 
T2D prevalence (Middelkoop et al., 1999; Weijers et al., 1998). In an earlier study, 
we reported on cultural variation in patients’ risk perceptions, worries and family 
communication (Heideman et al., 2011a). In this study, we adjusted for ethnicity. 
Future (qualitative) research should explore the role of culture in the context 
of family risk disclosure, because it may have implications for the delivery and 
construction of educational messages targeting different high-risk families.
However, potential selection bias because of low response rate warrants 
consideration; those who participated may have stronger family bonding than 
patients who chose not to participate. Secondly, to enable comparison of results with 
earlier research (Nishigaki et al., 2009; Pierce et al., 1999; Whitford et al., 2009b), 
similar one-item questions about family risk perception and worry were used in this 
60
Chapter 4
study. Future studies should use multiple item measures to corroborate the reliability 
and validity of these constructs and our study findings. Finally, it is important to 
notice that causality cannot be proven in a cross-sectional study design. Results of 
the multiple mediation analysis reflect correlations between variables. Causal patterns 
as presented in Figure 1, however, were based on the Common-Sense Model of self-
regulation of health and illness (Cameron, 2003; Leventhal et al., 2003), in which 
risk perception, worry and control beliefs precede (the intention towards) health 
protective behaviour. However, we have to take into account that the Common-
Sense Model is described as a dynamic processing system, in which risk perception, 
emotional responses and behaviour are interrelated and evolve over time. 
In summary, we can conclude that patients with T2D are generally willing to 
inform their relatives, and the intention to do so is partly driven by worry. This 
raises the question how to best utilize patients as messengers and the need for 
education material and support. The results of this study clearly point to the need 
for professionals to provide risk information, but also address worry and emphasize 
opportunities for diabetes prevention.
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Abstract
In the fight against the type 2 diabetes (T2D) epidemic, patients might be asked to 
discuss familial susceptibility to T2D in their family. Illness representations of patients 
(N=546) were assessed to explore their impact on perceived T2D threat in relatives. 
Reporting high T2D burden, emotional impact and perceiving T2D as an inheritable 
disease seemed to increase patients’ family risk perception and worries about relatives’ 
future health. Patients with coherent illness understanding reported positive beliefs 
regarding T2D prevention in relatives. Findings may give direction in how illness 
representations may be used to guide patients in the process of family risk disclosure.
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Introduction
Type 2 diabetes (T2D) is a chronic progressive disorder and an increasing health 
problem in many countries because of explosively rising prevalence (Herman & 
Zimmet, 2012). Increased susceptibility to T2D is associated with hereditary factors 
and unhealthy lifestyle: the chance of developing T2D is two to five times higher for 
people with close relatives diagnosed with the disease (Valdez et al., 2007). Diabetes 
treatment requires a high degree of self-management, which implies healthy eating, 
being active, monitoring of blood glucose and taking medication. These behaviours 
occur largely within the family setting, which make patients a role model in their 
family (Scollan-Koliopoulos et al., 2005). 
In the fight against the diabetes epidemic, it seems worthwhile to explore 
whether patients could play a more active role in the prevention of T2D in their 
family. Professionals could ask patients to inform their relatives about familial 
susceptibility to T2D and preventive options, as in patient-mediated cascade 
screening for familial hypercholesterolemia (Hallowell et al., 2011). Research 
already indicated that adult offspring of patients seems receptive to be informed 
about reducing their T2D risk via the family system (Pierce et al., 2000; Whitford 
et al., 2009a) and the majority of patients recognise the necessity of disseminating 
risk- and preventive messages in the family (van Esch et al., 2012a; Nishigaki et al., 
2009; Whitford et al., 2009b). The question is, however, whether a patient-mediated 
strategy targeting persons with a family history will be applicable in T2D prevention. 
When patients are asked to pass on information about familial susceptibility to 
T2D, it seems important to understand if and to what extent their beliefs about, for 
instance, the cause and controllability of their own disease influence ideas about the 
vulnerability to T2D in their relatives. 
A useful framework for identifying patients’ perceptions about their illness is 
the Common-Sense Model (CSM; Leventhal et al., 2003). The CSM proposes that 
patients create their own models or representations of their illness. These illness 
representations (IRs) guide risk-related cognitions about the illness threat (e.g., risk 
judgements, control beliefs) and emotional appraisal (e.g., distress, anxiety, worry), 
which, in turn, will give rise to coping procedures for controlling health threats 
(Cameron, 2003; Leventhal et al., 2003). Research convincingly demonstrated that 
IRs could be ordered into five logical themes or dimensions: illness identity, timeline 
beliefs, consequences, controllability and causal beliefs (Hagger & Orbell, 2003). 
Understanding IRs of patients with diabetes already has proven to be useful in, 
for instance, managing diabetes outcomes, quality of life and self-care behaviour 
(Mc Sharry et al., 2011; Paschalides et al., 2004; Searle et al., 2007b). Recently, 
studies reinforce the importance of understanding IRs in a social and familial context 
(Quiles Marcos et al., 2009; Searle et al., 2007a; White et al., 2009; August & 
Sorkin, 2011) and there has been a growing interest in IRs of individuals at 
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increased (familial) risk developing a disease (e.g., Cameron, 2008; Claassen et al., 
2010b; Figueiras, 2007; Kaptein et al., 2007). This is the first study, to the best of 
our knowledge, that uses the CSM framework to explore IRs in relation to risk 
estimations and affective appraisal that do not concern a person’s own health, but 
rather involve health risks in close relatives.
In our former study, patients’ perceptions of T2D risk in relatives, their worries 
about relatives developing the disease and their beliefs with regard to the possibility 
of T2D prevention in relatives appeared to be important factors that influenced 
intentions of patients to pass on risk and preventive information in their family (van 
Esch et al., 2012a). In the current study, we set out to explore whether and to what 
extent patients’ IRs are related to these three determinants in family risk disclosure. 
Findings may give direction in how personal beliefs of patients with T2D may be 
used to guide –and potentially improve- the process of disclosure of familial T2D 
risk. Based on the mental contents underlying a person’s own health risk appraisals 
(Cameron, 2008; Kaptein et al., 2007; Shibayama et al., 2011), we hypothesize that 
attributions that may tell something about feelings of little control and perceived 
seriousness and severity of the disease will be associated with perceptions of greater 
T2D risk in relatives. IRs that are indicative for high diabetes burden (e.g., daily 
consequences and emotional representations) seem likely to be associated with 
elevated levels of concern about relatives developing T2D. Beliefs that one can take 
actions to prevent diabetes are assumed to interact with risk estimates and beliefs 
regarding T2D prevention. 
Method
The study used a cross-sectional survey design. Data were collected within the context 
of a larger study on family history and T2D prevention, which was conducted at 
primary and secondary care practices in the Netherlands in the period 2007-2011. The 
VU University Medical Center Ethics Committee granted ethical approval.
Participants
Registered patients with T2D (aged >18 years) in four primary care practices and the 
diabetes outpatient clinics of the VU University Medical Center and the Haaglanden 
Medical Center were invited by their physician to participate in the study (N=1312). 
The physicians excluded patients who were not eligible because of severe medical 
and/or emotional burden beforehand. Eligible patients received a study invitation 
letter from their physician. Once written informed consent was obtained, the 
participants were provided with a self-report questionnaire per mail. 
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Measures
Self-reported socio-demographics included age, gender, domestic situation, 
educational achievement and ethnic background. Patients were identified as 
non-Dutch when at least one parent was born outside the Netherlands (Statistics 
Netherlands; http://www.cbs.nl). Additionally, participants reported on the following 
diabetes-related characteristics: family history of T2D in first-degree and/or second-
degree relatives, diabetes duration, treatment setting (primary versus secondary care), 
medical treatment and presence of diabetes complications.
Illness representations
IRs were assessed using the Dutch version of the Illness Perception Questionnaire 
Revised (IPQ-R) (Moss-Morris et al., 2002), which is retrievable from 
www.uib.no/ipq/. The IPQ-R scales have been tested in a variety of patients, 
including T2D and have been found to have adequate test-retest reliability and 
internal validity (Moss-Morris et al., 2002; Skinner et al., 2003).
The IPQ-R measures participants’ IRs over nine dimensions. The illness identity 
scale provides a list of 14 general symptoms; patients indicated whether they 
experience these symptoms and whether they believe these symptoms are related 
to their diabetes. The timeline subscale measures the perceived duration of the 
illness (acute-chronic; six items) and the extent of illness variability, fluctuations 
and unpredictability (timeline-cyclic; four items). Consequences are measured 
by the perceived impact of T2D on patients’ life (six items). The control subscale 
assesses perceived efficacy in controlling the illness (personal control; six items, 
treatment control; five items). The illness coherence subscale measures the extent 
to which patients have coherent illness understanding (five items) and emotional 
representations refer to perceived emotional states associated with the illness (six 
items). Finally, causal representations were assessed with a list of potential factors 
responsible for diabetes occurrence (i.e. heredity, diet or eating habits, chance or bad 
luck). As items relevant to the causes of the illness are allowed to be inserted into 
the questionnaire, two possible causes (‘lacking exercise’ and ‘fate’) were added to the 
original 18 causes from the IPQ-R (Moss-Morris et al., 2002). Responses were given 
on a 5-point Likert scale ranging from 1 ‘strongly disagree’ to 5 ‘strongly agree’.
Outcome measurements
Based on the CSM framework (Leventhal et al., 2003), cognitive (family risk 
perception and control beliefs regarding T2D prevention) and affective (worries 
about relatives developing T2D) risk appraisals of patients with T2D were used 
as indicators of perceived illness threat in relatives. Patients were asked “How 
likely do you think it is that your child(ren) will get T2D?”. As in disorders with 
a multifactorial aetiology, the increased risk is present in first-degree and second-
degree relatives (Scheuner et al., 1997; Valdez et al., 2007), the same question was 
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asked with regard to other relatives (siblings, grandchildren, aunts/uncles and nieces/
nephews). Answers were provided on a four point Likert scale, ranging from 1=not 
very likely to 4=very likely. Emotional appraisal was measured in a similar way: “Do 
you worry that your child(ren)/other relatives might get T2D?”. Answers ranged 
from 1=not at all to 4=a lot. To measure control beliefs with regard to diabetes 
prevention, patients were asked: “Is there anything your relatives can do to delay or 
prevent developing T2D?”. Response options were no/don’t know/yes.
Data analysis
Analyses were performed using SPSS version 16.0. Chi-square tests and an 
independent Student’s t-test were used in non-response analyses. The probability 
level for statistical significance was set at ≤ 0.05 (two-tailed). Internal consistency 
of the IPQ-R subscales was established by calculating Cronbach’s alpha coefficients. 
The identity scale score was calculated by dividing the sum of yes-rated symptoms 
related to T2D by the number of items provided. Higher scores indicated a stronger 
belief that the experienced symptoms are part of patient’s illness. Means and 
standard deviations were calculated on the other IPQ-R subscales, with higher scores 
denoting greater endorsement of the given construct. One-sample t-tests were used 
to compare mean scores with the neutral value (not disagree/not agree=3). The 20 
items pertaining to the perceived cause of T2D were analysed as separate items and 
not as scale scores, because descriptive information was considered more informative 
than items clustered in subscales. Percentages of endorsement of a causal item 
were computed through dichotomisation (scores 1, 2 and 3 were coded into 0=not 
endorsed, and scores 4 and 5 into 1=endorsed). 
Outcome variables were dichotomized and variables measuring family risk 
perceptions and worries about relatives were combined for offspring and other relatives. 
Outcome categories were successively: “I think it is not (very) likely that offspring and 
other relatives will develop T2D”=0 and “I think it is (very) likely that offspring and/or 
other relatives will develop T2D”=1. “I have no/little worries about offspring and other 
relatives developing T2D”=0 and “I have (quite) a lot of worries about offspring and/or 
other relatives developing T2D”=1. “I don’t think that, or I don’t know whether there is 
anything my relatives can do to delay or prevent T2D onset” =0 and “I do think there is 
something my relatives can do to delay or prevent T2D onset”=1.
Associations between socio-demographic and diabetes-related variables and 
the outcome variables were calculated using multiple logistic regression analyses 
(backward elimination). To assess associations between separate IRs and the outcome 
variables, a series of univariate logistic regression analyses was conducted adjusting 
for relevant covariates (i.e. age and family history for family risk perceptions; age 
and ethnic backgrounds for worries about relatives; educational achievement and 
diabetes complications for beliefs about T2D prevention). Collinearity diagnostics 
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were examined (Stevens, 2009). To control for potentially type I errors due to 
multiple comparisons (i.e. finding a relationship when in fact no relationship exists) a 
conservative significance value of p<0.01 was applied. 
Results
Of 1312 patients invited, 546 (41.6%) filled in the questionnaire. There were no differences 
in gender (χ2(1)=1.036, p=0.312) nor treatment setting (primary versus secondary care) 
(χ2(1)=0.081, p=0.780) between responders and non-responders. Non-responders, 
however, were a little younger than responders (t=-5.044; p<0.001; 95% CI between -2.1 
and -4.9 years). Table 1 shows the background characteristics of the study sample. 
Perceived diabetes threat in relatives
More than half of the patients (60.9%; n=286) thought it was (very) likely that 
offspring and/or other relatives would develop T2D. About one third of all patients 
(31.4%; n=142) expressed serious worries about relatives that might develop T2D. 
Multivariate regression analyses revealed that, generally, patients with a family history 
of T2D perceived higher T2D risk in their relatives and a non-Dutch background 
appeared to predispose for worries about relatives developing T2D. Younger patients 
perceived higher T2D risk in their relatives and expressed more concern about their 
relatives’ health as compared to the older participants (see Table 2).
Less than half of the study sample (41.4%; n=216) had positive beliefs regarding 
possibilities to delay or prevent T2D onset in their relatives. Higher education 
appeared to be associated with more positive control beliefs, whereas patients with 
diabetes-related complications (indicative for severe diabetes burden) were less 
confident that relatives would be able to postpone or prevent T2D onset. Noticeably, 
gender, patients’ domestic situation, T2D duration, medical treatment and treatment 
setting were not related to outcome variables. Multicollinearity between independent 
variables could not be demonstrated. 
Illness representations
Patients reported an average of three illness symptoms (M=3.16; SD=3.08) and related 
one symptom to their diabetes (M=0.99; SD=1.90). Most frequently listed symptoms 
were fatigue (22%; n=121), sore eyes (14%; n=77), and stiff joints (10%; n=52).
The internal consistency of the IPQ-R subscales was acceptable or good (Cronbach’s 
alpha >0.7 or >0.8), except for personal and treatment control it was questionable (α=0.66 
and α=0.58 respectively) (George & Mallery, 2003). In comparison to the neutral 
value of each subscale, patients had strongly held beliefs about the chronicity of their 
disease (timeline-acute/chronic; M=4.00, SD=0.74), effectiveness of controlling T2D 
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Table 1. Participants’ socio-demographic and diabetes-related characteristics  (N=546)
Socio-demographic characteristics n %
Age (mean ± sd) 63.6 ± 11.7
Gender
Male
Female
272
274
49.8
50.2
Domestic situation
Living alone
Cohabitation with partner and/or offspring
180
350
34.0
66.0
Education
Low (no education, primary school, lower vocational/trade education)
High (secondary or tertiary school, bachelor- or master degree)
336
186
64.4
35.6
Ethnic background
Dutch
Surinamese South-Asian
Other (non-)Western countries
311
157
72
57.6
29.1
13.3
Diabetes related characteristics 
Family history of diabetes 
No family history
First-degree or second-degree relatives
First-degree and second-degree relatives
155
189
202
28.4
34.6
37.0
Diabetes duration
< 5 years 
5-10 years
> 10 years
241
115
187
44.4
21.2
34.5
Treatment setting
Primary care
Secondary care
285
261
52.2
47.8
Treatment
Diet and/or tablets
Insulin
334
208
61.6
38.4
Diabetes complicationsϮ
Yes 
No
289
246
54.0
46.0
Ϯ Self-reported complications included retinopathy, neuropathy, and nephropathy and co-morbid 
cardiovascular problems.
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by own behaviour (M=3.60, SD=0.58) and by medical treatment (M=3.67, SD=0.56). 
They reported a rather good understanding of their disease (illness coherence; M=3.48, 
SD=0.73) (all p<.001). Moreover, patients did not perceive their disease as unpredictable 
(timeline-cyclic; M=2.74, SD=0.91), they did not report major consequences (M=2.84, 
SD=0.77) and emotional impact (M=2.49, SD=0.80) (all p<.001). 
Causal attributions seemed to be in accordance with the multifactorial aetiology 
of T2D. The top-ten of most endorsed causes were: heredity (61.3%; n=314), ageing 
(49.4%; n=253), diet or eating habits (44.5%; n=220), stress (40.4%; n=205), lack of 
exercise (37.4%; n=187), chance or bad luck (36.7%; n=182), fate (29.7%; n=148), 
my own behaviour (25.3%; n=125), family problems or worries (22.9%; n=115) and 
altered immunity (21.6%; n=107). 
Illness representations and perceived diabetes threat in 
relatives
Univariate regression analyses revealed that reporting more diabetes symptoms, 
perceiving one’s own diabetes as variable and unpredictable (high scores on timeline-
cyclic), experiencing high emotional burden and attributing T2D to inheritance was 
associated with higher T2D family risk perceptions and more worries about relatives 
developing T2D. In addition, reporting serious daily consequences and attributing 
T2D to fate also seemed to increase patients’ concern about relatives’ health. Patients 
with coherent IRs and patients reporting diabetes symptoms and high levels of 
personal and treatment control expressed positive attitudes towards T2D prevention 
in relatives (see Table 3). 
Causal factors that showed the strongest association with positive beliefs 
regarding T2D prevention in relatives were attribution to diet/eating habits 
and lacking exercise. Attribution to stress/worry and one’s own behaviour also 
were positively associated with control beliefs. Attribution to chance/bad luck 
appeared to be negatively associated with beliefs about T2D prevention in relatives. 
Multicollinearity between independent variables could not be demonstrated. 
Discussion
This study aimed to understand how IRs of patients with T2D are related to 
perceptions of diabetes threat in their relatives. It appeared that perceiving diabetes 
as a serious or unpredictable disease was related to higher family risk perceptions and 
worries about relatives developing T2D. Experiencing serious daily consequences 
and high emotional impact were most strongly associated with elevated levels of 
concern. As hypothesized, patients with coherent IRs and high levels of personal and 
treatment control expressed positive attitudes towards T2D prevention in relatives. 
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Interestingly, older patients seemed to perceive their relatives as less vulnerable to 
T2D and they were less concerned about the fact that relatives could develop T2D. 
Earlier studies suggest that the elderly minimize health risk (Leventhal & Crouch, 
1997). Being of non-Dutch descent was found to be related to (a lot of ) worries 
about relatives’ health, as was reported in earlier research (van Esch et al., 2012b). It 
would be interesting to explore ethnic variability in IRs in relation to patients’ family 
risk appraisal in further detail, as differences in IRs may be assumed between ethnic 
populations (Grewal et al., 2010).
Pertaining to the idea of stimulating family communication about T2D in 
high-risk families, assessment of IRs may help professionals to identify patients 
who are assumed to be most successful as messenger in their family. For instance, 
reporting positive control beliefs was associated with higher education and causal 
attributions that are in accordance with current medical opinions (American 
Diabetes Association, 2007). This may suggest that these patients seem able to 
deliver accurate risk messages in their family. In contrast, patients suffering from 
diabetes complications and attributing their diabetes to chance/bad luck were 
less confident that relatives would be able to postpone or prevent T2D onset. 
Addressing unhelpful beliefs, for instance, with regard to causal attribution and the 
controllability of T2D (onset) seem important targets when guiding patients in the 
process of family. Eliciting the patient’s perspective will optimize the acceptance of 
information that could correct patients’ cognitions (Phillips et al., 2012). 
Strengths of the study include the relatively large study sample (n=546) that 
resembled the population of patients with T2D in the Netherlands with regard 
to socio-demographic and diabetes-related characteristics (van Dam et al., 1991; 
Middelkoop et al., 1999; Weijers et al., 1998). However, we cannot rule out selection 
bias because of low response rate (42%). Participants were a little older than non-
responders, which may have led to underestimation of family risk perceptions and 
reported worries. After all, older patients seemed to have lower risk perceptions 
and reported less concern about their relatives. Nevertheless, our results with regard 
to perceived familial risk and positive beliefs regarding T2D prevention are in line 
with earlier findings (Nishigaki et al., 2007; Pierce et al., 1999; Whitford et al., 
2009b). Yet, the number of participants expressing worries about their relatives’ 
health seems rather low in our study (Pierce et al., 1999; Whitford et al., 2009b). IRs 
were consistent with recent literature on T2D (Mc Sharry et al., 2011; Paschalides 
et al., 2004; Searle et al., 2007b). Diabetes symptom perception was rather low, but 
could be explained by the use of a generic version of the identity scale. It would be 
worthwhile to complement the generic symptoms of the identity scale by diabetes-
specific symptoms in future studies.
To enable comparison with earlier studies (Nishigaki et al., 2007; Pierce et al., 
1999; Whitford et al., 2009b), we used single-item measures to assess family risk 
perceptions of patients, worries and control beliefs. In future research, we would 
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suggest to use multi-item measures to increase the reliability and validity of the 
measured constructs (Cameron & Reeve, 2006; Cameron et al., 2009). Moreover, one 
should take into account that causality cannot be proven in a cross-sectional study 
design. Results in this study reflect correlations between variables. Suggested causal 
patterns between IRs and the outcome variables are based on theoretical constructs 
of the CSM (Leventhal et al., 2003). 
Finally, besides socio-demographic and diabetes-related characteristics, IRs have 
been analysed as the only ‘predictor’ variables. To unravel underlying mechanisms 
of patients’ perceptions of diabetes threat in their relatives, potential overlapping 
constructs and confounders, such as dispositional personality traits (e.g., neuroticism, 
optimism) and mental health (e.g., depression, anxiety disorder), should be included 
in the analyses (Lawson et al., 2010).
Nevertheless, we may conclude that IRs, as delineated by the CSM framework 
(Leventhal et al., 2003), could be helpful in understanding patients’ appraisal of 
T2D threat in their family. Findings may have practical implications related to the 
design of family-based diabetes prevention programmes and the way in which health 
messages could be tailored to the needs of individual patients.
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study in families with Dutch and Surinamese 
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Abstract
Objective To explore the possibility of utilising family communication as a diabetes 
prevention strategy, specifically targeting high-risk families with South-Asian 
ancestry in the Netherlands.
Methods In a cross-sectional study, type 2 diabetes patients from Dutch (n=311) 
and Surinamese South-Asian (n=157) origin filled in a questionnaire assessing 
socio-demographic characteristics, beliefs and concerns about familial diabetes risk, 
primary prevention and diabetes-related family communication.
Results Discussing diabetes is regarded acceptable in most families. Especially 
Surinamese South-Asian patients (68%) seemed motivated to convey risk messages 
to their relatives; they reported higher risk perceptions and expressed more concern 
than Dutch patients. While 40% in both groups thought relatives are able to prevent 
developing diabetes, 46% in Dutch and 33% in Surinamese South-Asian patients 
were unsure.
Conclusion Promoting family communication appears a feasible strategy in diabetes 
prevention in high-risk (Surinamese South-Asian) families. Health care providers 
should address concern of patients and emphasize opportunities for prevention.
Practice Implications Findings favour training of clinicians in utilising a family 
approach as prevention strategy. Patients (particularly Surinamese South-Asians) 
are in need of professional help in the process of family risk disclosure. (Online) 
educational tools should be made available at which patients can refer their relatives. 
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Introduction
Type 2 diabetes (T2D) is a serious chronic disease and has become a global health 
problem (Unwin et al., 2009). In the Netherlands, it has been predicted that around 
1.3 million people (8% of the population) will be diagnosed with T2D in 2025 (Baan 
et al., 2009), prompting the Dutch Government to define a National Diabetes Action 
Plan targeting at prevention of T2D, early diagnosis and lifestyle interventions for 
high-risk groups (2004). For that, identifying effective strategies is of key importance.
One relatively new idea in diabetes prevention is to make use of patients as health 
educators in the family. After all, family history is an important predictor of diabetes risk 
(Lyssenko et al., 2008a) and intervening in high-risk families is thought to be practical 
and (cost-)effective compared with population screening (Hariri et al., 2006; Uusitupa 
et al., 2011). Studies suggest that communicating familial diabetes risk increases family 
members’ perception of personal risk (Pierce et al., 2000; Whitford et al., 2009a). So far, 
behavioural outcomes have received limited attention; one European study reports a slight 
increase in relatives’ healthy behaviour after disclosure of familial risk (Nishigaki et al., 
2008; Pijl et al., 2009b), whereas a study in Japan indicated that parental advice seemed 
not to facilitate offspring’s preventive behaviour (Nishigaki et al., 2008; Pijl et al., 2009b). 
Yet, offspring appears receptive to be informed via the family system about reducing their 
T2D risk (Pierce et al., 2000; Whitford et al., 2009a) and patients do seem willing to 
disseminate risk messages in the family (Gnanalingham & Manns, 1997; Nishigaki et al., 
2009; Whitford et al., 2009b).
The question now is whether a family-based intervention would be feasible 
approaching high-risk groups in the Netherlands, in particular the Surinamese South-
Asian population. Similar to other native and migrant Asian populations living in 
urban areas (Barnett et al., 2006; Lee et al., 2011), the prevalence of T2D in people 
from Surinamese South-Asian descent is extremely high (a four-to-six fold increased 
risk compared to originally Dutch people (Middelkoop et al., 1999)). Given the strong 
familial aggregation of T2D in South-Asian families (Viswanathan et al., 1996), a family 
approach as prevention strategy targeting this high-risk group would seem legitimate 
(Ramachandran et al., 2006). However, it is known that health-care delivery in South-
Asian populations is challenging and education should take cultural and socio-economic 
factors into account (Hawthorne et al., 2008; Khunti et al., 2008). Indeed, determinants of 
patients’ disclosure of family risk, including family risk perceptions, worries about relatives’ 
health and knowledge about diabetes risk factors (Gnanalingham & Manns, 1997; 
Nishigaki et al., 2009; Whitford et al., 2009b), can significantly vary between different 
cultures (Pierce et al., 1999; Whitford & Al-Sabbagh, 2010). 
Considering the high prevalence of T2D, familial clustering and high morbidity 
and mortality rates in South-Asian populations (Bathula et al., 2010), we might assume 
relative high family risk perceptions and concern about relatives developing T2D. This 
may urge patients to disclose T2D risk information to relatives. On the other hand, 
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experiences with severe and highly prevalent T2D in the family may negatively affect 
control beliefs with regard to diabetes prevention. Moreover, the South-Asian culture is 
sometimes described as fatalistic, attributing illness to fate or the will of a higher power 
(Davison et al., 1992; Dickinson & Bhatt, 1994), making it less likely that patients take 
responsibility for health-promoting actions. Yet, the South-Asian culture, known for its 
collectivism and strong family cohesion (Sinha et al., 2001), may be particularly suited 
for a family-based approach. However, it remains unknown whether T2D is a topic in 
everyday communication in these high-risk families.
In this observational study, we aimed at exploring possible facilitating and 
impeding factors in utilising family communication as a strategy in primary 
prevention of diabetes, specifically targeting the high-risk Surinamese South-Asian 
community in the Netherlands. We compared family risk perceptions, concerns 
and control beliefs with regard to diabetes prevention in patients with a Dutch and 
Surinamese South-Asian ethnic background. In addition, we explored everyday 
familial communication about T2D, as well as intentions and perceived ability of 
patients to play a messengers’ role in the family. Results may help to decide whether 
promoting family risk communication is a feasible strategy in diabetes prevention 
and inform the development and implementation of educational programs.
Methods
Study design and recruitment of participants
Data were collected within the context of a larger cross-sectional study on family 
history and diabetes. Registered type 2 diabetes patients (aged >18 years) were 
recruited from four primary care practices (in Amsterdam and Haarlem), the 
diabetes outpatient clinics of the VU University medical center (VUmc, Amsterdam) 
and the Haaglanden Medical Center (HMC, The Hague). Participating physicians 
were asked to exclude patients who were not eligible due to severe medical and/
or emotional burden; the remaining patients (N=1312) received an invitation letter 
together with information about the study. Once written informed consent was 
obtained, participants were mailed a self-report questionnaire to be returned in a pre-
stamped envelope. A postal reminder followed four weeks later. The VUmc Ethics 
Committee granted ethical approval.
Patients with South-Asian ancestry in the Netherlands
In the Netherlands, most South-Asian inhabitants are immigrants from Surinam, a 
former Dutch colony in South-America. About a century ago, their ancestors came 
from South-Asia to Surinam to work as contract labourers. After the independence 
of Surinam in 1975, a large cohort of Surinamese South-Asian people settled in 
the Dutch governmental city The Hague. This group has a Hindustani cultural 
background and a six-to-ten times higher T2D prevalence than general Dutch 
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population (Middelkoop et al., 1999). In this study, participants with Surinamese 
South-Asian ethnic background (further referred to as ‘Surinamese patients’) were 
recruited from the HMC in The Hague. This Center provides culturally adapted 
diabetes care (involving secondary as well as primary care treatment) targeting 
Surinamese patients. The majority of the Surinamese population is fluent in Dutch 
since it is the national language in Surinam.
Measurements
Socio-demographics and diabetes-related characteristics
Socio-demographics were self-reported, including age, gender, marital status, having 
offspring, domestic situation, educational achievement and ethnicity. Participants 
were identified as ‘Dutch’ in case both parents were born in the Netherlands 
(according to the definition used by Statistics Netherlands). All participants recruited 
in the HMC were known to be from Surinamese South-Asian descent.
Diabetes-related background data were self-reported, including family history of 
T2D in first-degree and/or second-degree relatives, diabetes duration (less or more 
than ten years), treatment (diet, tables, insulin), diabetes complications (diabetes 
causing problems with eyes, feet /or kidneys) and co-morbid cardiovascular problems.
Worries, family risk perceptions and belief in primary prevention
Using a single item question (based on previous studies (Pierce et al., 1999; Whitford 
et al., 2009b)), participants were asked whether they worried about offspring 
developing T2D. The same question was asked with regard to other relatives 
(including siblings, grandchildren, aunts/uncles and nieces/nephews). Answers were 
provided on a four point Likert scale, ranging from ‘not at all’ to ‘a lot’. Similarly, 
participants were asked to estimate the likelihood of children and other relatives 
developing T2D. Responses ranged from ‘not very likely’ to ‘very likely’. Finally, 
participants were asked whether they thought there is anything that relatives can do 
to delay or prevent getting T2D. Response options were ‘yes’, ‘no’ or ‘don’t know’. See 
Table 2 for exact wording of questions.
Family communication
Participants were asked whether T2D is a topic that is discussed in everyday 
communication with, respectively, first-degree and second-degree relatives. Both questions 
were answered on a four point Likert scale, ranging from ‘never’ to ‘often’. Subsequently, 
participants were provided with six statements (based on Mesters et al., 1997); used 
as single item questions), to assess their ideas about ‘openness’ in the communication 
(items a-d) and familial emotional support (items e-f ) (see Table 3). Answers were 
provided on a five point Likert scale ranging from ‘strongly agree’ to ‘strongly disagree’. 
To examine ideas of patients about serving as a ‘messenger’ in the family, a question 
was developed asking participants whether they intended to talk about diabetes risk and 
primary prevention in their family. Additionally, four single item statements were provided 
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to explore the perceived ability of patients to inform relatives. Response options were 
‘agree’, ‘disagree’ or ‘don’t know’. See Table 4 for exact wording of questions.
Statistical analyses
The statistical package SPSS v16.0 (SPSS Inc., Chicago, IL, USA) was used for 
statistical analyses. Socio demographic and diabetes-related characteristics of 
Dutch and Surinamese patients were analyzed using exact tests for categorical 
variables and Student’s t-tests for normally distributed continuous variables. Crude 
percentages were tabulated to evaluate the number of participants reporting (quite) 
a lot of worries about relatives’ health, high family risk perceptions, positive control 
beliefs and diabetes-related family communication (representing the main outcome 
variables). Then (since assumptions for parametric tests were not met), the method 
of (multinomial/ordinal) logistic regression analysis was used to assess the relative 
influence of ethnic backgrounds (Dutch versus Surinamese) on (dichotomized, three-
part categorical and ordinal) outcome variables, controlling for age, domestic situation 
(which is highly correlated with having a partner) and education. Differences in 
family history, diabetes duration and complications were not adjusted for, since higher 
reports on these variables are typical for the Surinamese population (Bathula et al., 
2010). The probability level for statistical significance was set at ≤ 0.05 (two-tailed).
Results
Response and non-response
In the HMC in The Hague, 361 Surinamese patients were identified as fulfilling 
the inclusion criteria and were invited to participate in the study; 157 responded 
(response rate 43.5%). From 951 patients recruited in general practices and the 
VUmc, 383 patients returned a completed questionnaire (response rate 40.3%). 
Data from 72 patients in this group were excluded, since their ethnic backgrounds 
(originating from (non-)Western countries) were too diverse to permit any valid 
comparisons. This left 311 participants in the Dutch study population.
Non-respondent analyses revealed that Surinamese patients who chose not to 
participate did not differ in age and gender from participating Surinamese patients. Dutch 
non-participants were younger than participating Dutch patients (t= -4.735; p<.001).
Participants’ characteristics
Socio demographic and diabetes related characteristics are presented in Table 1. 
Dutch participants were statistically significant older than the Surinamese patients 
(67.5 vs. 58.1 yrs; t=8.913; p<.001). The male/female distribution was equal in 
both study groups. Dutch patients were more likely to be married/having a partner 
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Table 1. Socio-demographic and diabetes-related characteristics of Dutch (n=311) and Surinamese T2D patients (n=157)
Dutch patients Surinamese patients
Socio demographic characteristics
Mean age ± SD ***
Female
67.5 ± 10.5
148 (47.6)
58.1 ± 11.1
89 (56.7)
Family situation
Married/with partner ***
Having offspring
Domestic situation ***
Living alone
Cohabitation with partner
Living with offspring (and partner)
209 (67.4) 
255 (82.3) 
103 (33.3)
171 (55.3)
35 (11.3)
76 (48.7)
129 (84.9) 
61 (40.4)
42 (27.8)
48 (31.8)
Low education# * 188 (61.6) 108 (72.5)
Diabetes related characteristics 
Family history of diabetes **
No family history
First-degree or second-degree relatives
First-degree and second-degree relatives
Diabetes duration >10 years ***
Treatment
Diet and/or tablets
Insulin
Diabetes complicationsϯ ***
None
One
Two or more 
Co-morbid cardiovascular problems
106 (34.1)
107 (34.4)
98 (31.5) 
91 (29.4) 
195 (63.1)
114 (36.9) 
199 (64.0)
86 (27.7)
26 (8.4)
80 (26.1)
22 (14.0)
52 (33.1)
83 (52.9)
77 (49.7) 
85 (54.5)
71 (45.5) 
74 (47.1)
45 (28.7)
38 (24.2) 
41 (26.8)
Data are n (%) unless otherwise indicated.
* P-value obtained using t-tests and exact tests, significance is denoted by * p<0.05, ** p<0.01, *** p<0.001.
# Low education (no education, primary school and lower vocational/trade education) as compared to 
moderate or high educational achievement (secondary-, or tertiary school, bachelor- or master degree).
Ϯ Self-reported complications included retinopathy, neuropathy and nephropathy.
(X2=15.279; p<.001) and the majority of both study groups reported having offspring. 
Asking about participants’ domestic situation, Dutch participants appeared to 
cohabit more often with a partner whereas Surinamese offspring seemed to live more 
often with their parents (X2=41.552; p<.001). Dutch participants more often finished 
secondary or higher education (X2=5.188; p=.023).
Surinamese participants reported more frequently a family history of diabetes, 
especially in first-degree and second-degree relatives (X2=27.720; p=.001). Despite 
their younger age, more Surinamese patients were diagnosed with T2D more than 
ten years ago (X2=18.494; p<.001). There were no differences in diabetes treatment 
between the ethnic groups. Surinamese patients more often reported two or more 
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diabetes-related complications (X2=24.269; p<.001). In both groups, about a quarter 
reported co-morbid cardiovascular problems.
Worries, family risk perceptions and belief in primary prevention
As shown in Table 2, 14% (n=33) of the Dutch participants tended to worry (quite) 
a lot about their offspring developing T2D and 6% (n=17) expressed their worries 
about other relatives. Surinamese patients seemed to be more worrisome. Almost half 
of them (48%, n=61) expressed (quite) a lot concern regarding to their offspring’s 
health and 30% (n=46) worried about other relatives. Adjusted analyses revealed that 
the proportion of Dutch patients reporting ‘no’ or ‘little’ worries about the diabetes-
related health of offspring and other relatives is higher compared to Surinamese 
patients with little concern (both p<.001).
In the Dutch population, 39% (n=90) thought T2D onset is (highly) probable 
in offspring, compared to 58% (n=71) in the Surinamese population. High-risk 
estimations for other relatives are reported by 39% (n=114) of the Dutch and 
62% (n=93) of the Surinamese patients. Differences between both ethnic groups 
are confirmed in adjusted analyses, showing a higher number of Dutch patients 
indicating diabetes onset is not (very) likely in offspring (p<.01) or other relatives 
(p<.01) compared to the Surinamese patients.
When asked about the possibilities of primary prevention, 42% of the Dutch 
(n=122) and 44% (n=68) of the Surinamese participants were inclined to believe 
relatives might be able to postpone or prevent T2D onset. Interestingly, a relatively 
large number of participants was unsure about diabetes prevention (46%; n=136 
in Dutch and 33%; n=60 in Surinamese patients). Differences between Dutch and 
Surinamese patients were not statistically significant, after controlling for age, 
domestic situation and education.
Family communication
The majority of the Dutch patients (60%; n=166) reported to talk at least ‘sometimes’ 
with their first-degree relatives about T2D, whereas 44% (n=105) had conversations 
with second-degree relatives. Surinamese patients seemed not to differentiate 
between first-degree or second-degree relatives; 78% (n=114) discussed T2D with 
first-degree and 74% (n=95) with second-degree relatives. Adjusted analyses revealed 
that conversations about T2D are more common in Surinamese families relative 
to Dutch families (first-degree relatives, p<.05; second-degree relatives, p<.001). 
Notably, 18% of the Dutch (n=57) and 6% of the Surinamese patients (n=10) 
reported that T2D is never discussed within the family (see Table 2).
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Table 2. Patients’ concern about relatives developing type 2 diabetes, family risk perceptions, belief in primary 
prevention and family communication about diabetes; comparison between Dutch (n=311) and Surinamese 
(n=157) patients 
Question Response
Observed valuesϯ Logistic regression$
Dutch 
patients
Surinamese 
patients
Adjusted 
p-value
Odds ratio 
(95% CI)
Do you worry that your  
child(ren) might get T2D?i) 
Do you worry that other  
relatives might get T2D?ii) 
How likely do you think it is  
that your child(ren) will get T2D?i) 
How likely do you think it is that  
other relatives will get T2D?ii) 
Do you think there is anything  
that your relatives can do to  
delay or prevent getting T2D? 
Do you discuss T2D with  
first-degree relatives? 
Do you discuss T2D with  
second-degree relatives? 
Not at all/a little 
(Quite) a lot
Not at all/a little 
(Quite) a lot 
Not (very) likely 
(Very) likely
Not (very) likely 
(Very) likely
Yes 
No 
Don’t know
Never/rarely 
Sometimes/often 
Never/rarely 
Sometimes/often
212 (86.5) 
33 (13.5)
284 (94.4) 
17 (5.6)
142 (61.2) 
90 (38.8)
179 (61.1) 
114 (38.9)
122 (41.2) 
38 (12.8) 
136 (45.9)
113 (40.5) 
166 (59.5)
133 (55.9) 
105 (44.1)
66 (52.0) 
61 (48.0)
107 (69.9) 
46 (30.1)
52 (42.3) 
71 (57.7)
56 (37.6) 
93 (62.4)
68 (44.4) 
35 (22.9) 
60 (32.7)
33 (22.4) 
114 (77.6)
33 (25.8) 
95 (74.2)
<.001 
<.001 
.002  
.001 
 
.114#
.186#
.022 
<.001 
4.6 (2.5–8.2) 
5.5 (2.7-11.0) 
2.3 (1.4–3.9) 
2.3 (1.4–3.7) 
 
0.6 (0.3–1.1)
1.4 (0.8-2.3)
1.8 (1.1-2.9) 
3.4 (2.0-5.9) 
ϯ Data are n (%) and represent crude values.
i) Only subjects with children were asked this question.
ii) “Other relatives” includes siblings, grandchildren, aunts/uncles and nieces/nephews.
$ The method of logistic regression analysis was used to explore the association between outcome variables 
and ethnic backgrounds (Dutch versus Surinamese), controlling for age, domestic situation and education. 
Presented outcomes do not correspond with the observed (crude) values.
# Multinomial logistic regression analysis was used with ‘yes’ as reference category.
As represented in Table 3, slightly more than half of the Dutch patients (55%; n=164) 
and a smaller proportion of Surinamese patients (39%; n=57) indicated that they talk as 
little as possible about their diabetes, not wanting to upset their family. Adjusted analysis 
revealed that Dutch patients tend to refrain more often from talking with relatives 
(p<.01). On the other hand, most patients in both groups indicated that their relatives 
don’t seem to mind talking about T2D and that few relatives tend to be disturbed by 
such conversations. In general, responses referring to ‘openness to discuss T2D in the 
family’ (items a-d) show a trend towards more openness in Surinamese families. On the 
other hand, as far as familial emotional support is concerned (items e-f ), Dutch patients 
reported less often that family members want to hear positive stories (p<.01).
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Finally, from Table 4 it can be read that the majority of participants (55%; n=156 
in Dutch and 68%; n=98 in Surinamese patients) expressed the intention to inform 
family members about familial diabetes risk and primary prevention. The difference 
between both ethnic groups is confirmed in adjusted analyses (p<.05). Around 
seventy-five percent in both study populations indicated to know ‘what to tell’, ‘how 
to tell’ and ‘whom to inform’. Dutch patients reported having less problems deciding 
which relatives to inform (p<.05). Notably, almost twice as much Surinamese 
participants (68%; n=98) indicated that patients should receive professional help in 
the process of familial risk disclosure (p<.001).
Table 3. Openness to discuss (emotional aspects of) type 2 diabetes in the family; comparison between Dutch 
(n=311) and Surinamese (n=157) patients 
Statements Response
Observed valuesϯ Logistic regression$
Dutch 
patients
Surinamese 
patients
Adjusted 
p-value
Odds ratio 
(95% CI)
a.  I talk as little as possible about 
my diabetes because I don’t 
want to make my family uneasy 
b.  My relatives don’t like me  
to talk about my diabetes 
c.  If I talk about my diabetes,  
my relatives gloss over it 
d.  Talking about emotions  
related to my diabetes  
upsets my family
e.  My relatives often don’t  
know what to say or to do 
when I’m feeling down
f.  My family always wants to  
hear from me that I am  
doing well
(Strongly) agree 
Not (dis)agree 
(Strongly) disagree
(Strongly) agree 
Not (dis)agree 
(Strongly) disagree
(Strongly) agree 
Not (dis)agree 
(Strongly) disagree
(Strongly) agree 
Not (dis)agree 
(Strongly) disagree
(Strongly) agree 
Not (dis)agree 
(Strongly) disagree
(Strongly) agree 
Not (dis)agree 
(Strongly) disagree
164 (54.8) 
60 (20.1) 
75 (25.1)
34 (11.8) 
70 (24.2) 
185 (64.0)
34 (11.7) 
54 (18.6) 
202 (69.7)
23 (7.9) 
56 (19.3) 
211 (72.8)
42 (14.7) 
61 (21.3) 
183 (64.0)
128 (44.3) 
66 (22.8) 
95 (32.9)
57 (38.5) 
26 (17.6) 
65 (43.9)
13 (9.2) 
28 (19.9) 
100 (70.9)
14 (9.9) 
28 (19.9) 
99 (70.2)
13 (9.2) 
22 (15.5) 
107 (75.4)
29 (20.3) 
26 (18.2) 
88 (61.5)
144 (62.5) 
21 (14.6) 
33 (22.9)
.007 
 
.563 
 
.412 
 
.692 
 
.313 
 
.001 
 
1.7 (1.2-2.6) 
 
1.1 (0.7-1.7) 
 
0.8 (0.5-1.3) 
 
0.9 (0.6-1.4) 
 
0.8 (0.5-1.2) 
 
0.5 (0.3-0.8) 
 
ϯ Data are n (%) and represent crude values.
$ The method of ordinal logistic regression analysis (5 point Likert-scale) was used to explore the association 
between items concerning ‘openness to discuss’ T2D and ethnic backgrounds (Dutch versus Surinamese), 
controlling for age, domestic situation and education. Presented outcomes do not correspond with the 
observed (crude) values.
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Discussion and Conclusion
Discussion
The results of this study confirm the potential of utilising family communication as 
strategy in diabetes prevention, targeting high-risk families in the Netherlands. In line 
with common health behaviour theories (Weinstein, 1993), family risk perceptions of 
patients were identified as a motivator to inform relatives about their diabetes risk in 
earlier research (Gnanalingham & Manns, 1997; Nishigaki et al., 2009; Whitford et al., 
2009b). In our study, it appeared that Surinamese patients had significantly higher family 
risk perceptions than Dutch patients. This finding was in line with our expectations 
and might be explained by the higher prevalence and generally less favourable clinical 
T2D profile in this population (Bathula et al., 2010). However, a recent study showed 
that families in Bahrain do not consider themselves more susceptible to diabetes than 
families in Ireland, despite a higher prevalence of T2D in Bahrain (Whitford & Al-
Table 4. Willingness and perceived ability of patients to serve as a ‘messenger in the family’; comparison 
between Dutch (n=311) and Surinamese (n=157) type 2 diabetes patients
Observed valuesϯ Logistic regression$
Statements Response
Dutch 
patients
Surinamese 
patients
Adjusted 
p-value
Odds ratio 
(95% CI)
“I intend to inform my relatives about 
potential familial diabetes risk and 
possibilities of primary prevention”
“I know what to tell my relatives”
 
“I know how to inform my relatives”
 
“I know which relatives to inform”
 
“Patients should receive professional 
help when informing their relatives”
Agree 
Disagree 
Don’t know
Agree 
Disagree 
Don’t know
Agree 
Disagree 
Don’t know
Agree 
Disagree 
Don’t know
Agree 
Disagree 
Don’t know
156 (55.3) 
65 (23.0) 
61 (21.6)
221 (78.6) 
18 (6.4) 
42 (14.9)
211 (75.4) 
25 (8.9) 
44 (15.7)
215 (76.8) 
14 (5.0) 
51 (18.2)
107 (38.2) 
83 (29.6) 
90 (32.1)
98 (68.1) 
15 (10.4) 
31 (21.5)
109 (75.7) 
13 (9.0) 
22 (15.3)
101 (70.1) 
18 (12.5) 
25 (17.4)
103 (70.5) 
16 (11.0) 
27 (18.5)
98 (67.6) 
17 (11.7) 
30 (20.7)
 
.012 
.526
 
.201 
.817
 
.297 
.689
 
.049 
.924
 
<.001 
.001
 
2.3 (1.2-4.5) 
1.2 (0.7-2.1)
 
0.7 (0.2-1.3) 
0.9 (0.5-1.7)
 
0.7 (0.3-1.4) 
0.9 (0.5-1.6)
 
0.4 (0.2-0.9) 
1.0 (0.6-1.8)
 
4.6 (2.4-8.7) 
2.7 (1.5-4.6)
ϯ Data are n (%) and represent crude values.
$ The method of multinomial logistic regression analysis was used to explore the association between the 
willingness and perceived ability to function as a ‘messenger in the family’ and ethnic backgrounds (Dutch 
versus Surinamese), controlling for age, domestic situation and education. Reference category was ‘agree’. 
Presented outcomes do not correspond with the observed (crude) values.
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Sabbagh, 2010). Therefore, explanations from a cultural perspective also might be plausible, 
arguing that Asian people in general perceive themselves as more vulnerable to diseases 
than Western people (Heine & Lehman, 1995). 
In addition, Surinamese patients expressed more concern about their relatives 
than the Dutch patients. Especially the number of Surinamese patients being 
worried about the wider family (including second-degree relatives) is noticeable, 
which could be related to the fact that South-Asian families often consist of more 
members (grandparents, siblings and aunts/uncles) than just the nuclear family 
(parents and children) (Sue, 1998). A growing body of research indicates that 
disease-related worries and anxiety also play a motivational role in promoting 
health behaviours (Cameron, 2003). Indeed, worrisome diabetes patients appeared 
to be most willing to disseminate risk messages in their family in earlier research 
(Whitford et al., 2009b).
In contrast to what could be expected (Davison et al., 1992; Dickinson & Bhatt, 
1994; Grewal et al., 2010), Surinamese patients did not express more fatalistic beliefs 
than Dutch patients. About forty percent of both study populations in our study was 
inclined to believe that relatives might be able to postpone or prevent T2D onset. A 
similar percentage on positive control beliefs was reported a decade ago (Pierce et al., 
1999). Notably, a large group of Dutch (46%) and Surinamese patients (33%) reported 
that they were unsure about the possibilities to prevent or delay T2D onset in relatives.
With regard to family communication, results indicated that T2D is discussed in 
everyday conversations in most families. More than half of the Dutch participants 
and almost seventy percent of the Surinamese participants expressed their 
willingness to educate relatives about increased T2D risk and primary prevention. 
These percentages are in line with earlier research (Nishigaki et al., 2009; Whitford 
et al., 2009b). Open and supportive communication among family members seems 
to be of crucial importance in applying a family approach in diabetes prevention 
(Wiseman et al., 2010). As we expected, considering the strong family bonding in 
Surinamese families (Sinha et al., 2001), our findings suggest a trend towards more 
‘openness’ in discussing T2D in Surinamese families. However, Dutch patients more 
often reported familial emotional support.
Finally, participants were positive about their ability to disseminate risk- and 
preventive messages in the family. Around three-quarter of all patients indicated they 
are well informed about T2D risk and prevention, knowing “what to tell, how to tell 
and whom to inform”. However, the content and accuracy of risk- and preventive 
messages that patients disseminate in their families remains unknown.
Strengths and limitations
Our study was strengthened by the fact that participants in both study populations 
speak Dutch, limiting linguistic problems and facilitating comparison. We also 
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included large enough samples of Dutch and Surinamese patients to correct for 
socio demographic differences between the groups. However, the study was limited 
by a relatively low response rate and we cannot rule out selection bias; participants 
may be more enthusiastic about engaging with their families than non-responders. 
Low response rates have also been reported in previous research about family 
communication (Whitford et al., 2009b). Non-response analyses in our study 
revealed that 18% (n=27) of the reported reasons for not participating in the study 
referred to ‘lack of family contact’, ‘being the only diabetes patient in the family’, 
or ‘not wanting to bother relatives’. Besides, over reporting of diabetes-related 
communication in the Surinamese sample should be taken into account, since social 
desirability is known in populations with Asian background (Zane & Yeh, 2002).
The study’s generalizability with regard to other South-Asian populations might 
be limited. Our study population represents a specific sub group of South-Asian 
people, migrated via the former Dutch colony Surinam. Unfortunately, we do not 
have data on participants being first-degree or second-generation migrants. Future 
research should explore whether other populations from South-Asian descent show 
similar opportunities in utilising family communication as prevention strategy. 
Conclusion
Our results did not reveal specific barriers targeting high-risk Surinamese families; 
in fact, Surinamese patients reported higher risk perceptions, expressed more concern 
about relatives than the Dutch patients and seemed highly motivated to communicate 
with their family. Around forty percent, in both the Dutch and the Surinamese 
population, had positive control beliefs with regard to diabetes prevention.
Clearly, knowledge is essential to facilitate the delivery of accurate messages in 
the family. To enhance the effect of family-based interventions, patients should be 
educated about increased familial risk and the effectiveness of lifestyle modification 
on diminishing T2D risk. After all, a large group of Dutch as well as Surinamese 
patients seemed not to know whether T2D prevention is possible in relatives.
Providing family risk information may arouse (new) concern in patients about 
their relatives’ health. In fact, a significant number of Surinamese patients was 
already worried about their relatives developing T2D. Professionals should address 
these concerns and reassure patients. On the other hand, as suggested by Whitford 
and colleagues, emphasizing worries in patients may lead to increased discussion 
of T2D risk within families (Whitford et al., 2009b). It is known that some fear 
arousal is necessary to trigger protective actions; however, arousing fear may be 
counterproductive when people do not perceive themselves able to engage in risk 
reducing actions (Witte & Allen, 2000). Therefore, emphasizing possibilities of T2D 
prevention in this process is essential, as well as providing recommendations about 
how, when and which relatives to inform.
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Finally, we must not overlook the fact that in some families T2D is never discussed 
and patients might resent being a health messenger in their family. Stimulating 
diabetes related communication is obviously not appropriate in those families. 
Practice Implications 
Clinicians should be trained in utilising a family approach as primary prevention 
strategy and learn to coach patients to carry out a messengers’ role in the family. The 
majority of Surinamese patients explicitly demanded professional help in the process 
of family risk disclosure. Indeed, patients’ needs and the challenge of integrating the 
inheritable character of common diseases into the regular practice of medicine have 
been indicated before (Scheuner et al., 2008).
To optimize acceptance of information about T2D risk and prevention in the 
Surinamese population, cultural adaptation might be needed. After all, culturally 
sensitive, enhanced interventions appeared most effective when targeting South-
Asian populations (Bellary et al., 2008). In the Netherlands, a family approach 
may fit in targeted interventions that take the Surinamese traditions into account 
(Middelkoop et al., 2001). As for content, it is important to be aware of assumptions 
of patients with regard to etiological recognition of T2D. After all, illness beliefs 
with regard to causal attributions and personal control appeared to be different 
between South-Asian and Caucasian populations (Bean et al., 2007; Macaden & 
Clarke, 2006), which may affect ideas about T2D susceptibility and prevention 
(Heine & Lehman, 1995; Råberg Kjøllesdal et al., 2011). 
Finally, as long as the content of risk- and preventive messages delivered by 
patients is unknown, (online) information should be made available at which patients 
can refer family members who are interested in their T2D risk and possibilities of 
prevention (van Esch et al., 2010). Subsequently, health professionals should be 
accessible to advice those relatives motivated to engage in preventive activities.
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Abstract
Background Family history (FH) is considered an important factor to detect 
individuals at increased risk developing type 2 diabetes (T2D). Moreover, FH 
information could be used to personalise risk messages, which are assumed to 
increase risk-reducing behaviours. In this study, we aimed to explore Dutch health 
care professionals’ attitudes regarding current or future uptake of a more extensive 
use of FH information and the family system in diabetes prevention.
Methods Semi-structured interviews were conducted with a purposive sample of 
nineteen health care professionals, including general practitioners, practice nurses, 
diabetes specialists and diabetes nurses. The use of FH information in preventive 
consultations was explored, as well as the usability of a direct versus patient-mediated 
targeting strategy to reach persons with a FH of T2D. Three researchers analysed the 
interview transcripts separately.
Results Dutch health care professionals expressed positive attitudes with regard 
to using FH to promote and motivate health-protective behaviour. Directly 
targeting and educating patients known to have a FH of T2D was desirable for 
most primary care professionals, but not considered feasible. Findings indicated 
that FH information was not systematically gathered and Electronic Medical 
Records were not equipped to retrieve persons with T2D running in their family. 
The idea of asking patients to pass on risk and preventive information was new to 
all interviewees, but was considered an acceptable strategy to reach persons with a 
FH of diabetes. Nevertheless, practical barriers with regard to time, expertise and 
financial reimbursement were mentioned.
Conclusions Evidence showing the (cost-)effectiveness of family-oriented strategies 
in the prevention of T2D could stimulate health care professionals in primary 
as well as secondary care to use FH information, the family system and family 
communication to promote health-protective behaviour. Besides increasing skills and 
expertise in professionals, more insight is needed in cultural aspects regarding the 
disclosure of family risk, the effect of low health literacy and negative modelling in 
families at high risk developing T2D.
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Background
Type 2 diabetes (T2D) is a serious chronic disease causing considerable burden on 
patients as well as health care systems (American Diabetes Association, 2008). The 
rapidly increasing prevalence of T2D warrants major efforts to explore effective tools 
and strategies to detect, inform and motivate individuals at high risk to engage in 
preventive actions (Herman & Zimmet, 2012).
T2D is best described as a multi factorial disease, which means disease onset is 
triggered by the interaction of multiple genes and environmental factors (Lyssenko 
et al., 2008b). Research has convincingly demonstrated that T2D is highly prevalent 
in some families and a positive family history predicts the development of T2D, even 
after adjustment for common risk factors (Arslanian et al., 2005; Hemminki et al., 
2010; Meigs et al., 2000). Consequently, a family history (FH) of T2D is seen as a 
valuable tool in preventive activities (Guttmacher et al., 2004). FH information can 
help to detect persons at increased risk developing T2D: the chance of developing 
diabetes is two-to-five times higher for people with a FH of the disease (Annis et al., 
2005; Valdez et al., 2007). Moreover, evidence suggests that preventive messages 
tailored to a person’s FH can increase risk awareness and risk-reducing behaviours 
(Chang et al., 2011; Qureshi & Kai, 2008; Ruffin et al., 2011). Yet, lifestyle 
interventions specifically aiming at prevention of T2D in people with a FH seem to 
be scarce (Heideman et al., 2011a).
In most Western countries, the use of opportunistic screening targeting 
patients at risk for T2D is encouraged (American Diabetes Association, 2011). In 
combination with other risk factors, FH is recognized as an important element in 
the risk stratification procedure. Directly targeting and educating people known 
to have T2D running in their family, however, is not current in clinical practice 
(Chang et al., 2011; Qureshi & Kai, 2008). At present, there is an increasing need 
for structured preventive activities linked to primary care (Assendelft et al., 2012). 
A targeting approach that might be worthwhile to explore in this context is patient-
mediated cascading, as is used in screening for familial hypercholesterolemia 
(Hallowell et al., 2011). This means that relatives are reached via the index patient, 
who informs them about increased familial susceptibility to a disease and the 
preventive options. Indeed, research already has indicated that the majority of 
patients with T2D seemed willing to disseminate risk and preventive information 
in their family (van Esch et al., 2012b; Whitford et al., 2009b) and adult offspring 
generally seemed receptive to be informed about reducing their diabetes risk via the 
family system (Whitford et al., 2009a).
In this study, semi-structured interviews with Dutch health care professionals 
were conducted to investigate opinions, attitudes and practices with regard to the 
current and future use of FH in preventive consultations. Ideas with regarding 
two potential strategies to reach persons with T2D running in their family were 
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explored: 1) directly targeting patients known to have a FH of T2D and 2) a 
patient-mediated approach, asking patients with T2D to pass on risk information in 
their family. Although preventive activities usually are carried out in primary health 
care, we also considered opinions of secondary care professionals of relevance in 
this study. Patients receiving diabetes treatment in secondary care visit outpatient 
clinics regularly, which might provide opportunities to discuss the familial character 
of the disease. Findings may provide insight in the uptake of FH as a tool in T2D 
prevention and the conditions that are needed to apply a family-oriented approach 
in routine care.
Methods
Design and participants
Between February and April 2010, two researchers (SvE and WH) conducted 
nineteen semi-structured interviews with Dutch health care professionals. A 
purposive sampling strategy was used, aiming to achieve maximum variation in 
the characteristics of the included affiliations and professionals. General practices 
were recruited via the regional network of the Academic General Practice of the 
VU University Medical Center. Six practices in three cities in the urban area of 
Amsterdam were willing to participate. Interviews were conducted with five general 
practitioners (GPs) and six practice nurses (PNs). The term ‘general practice’ is 
commonly used in the Dutch health care system and is considered synonymous to 
‘family medicine’ and ‘family practice’.
Diabetes specialists (DSs) and diabetes nurses (DNs) in secondary care were 
approached via contacts of the authors in four outpatient diabetes clinics in 
Amsterdam. Interviews were conducted with five DSs and three DNs. The study 
sample included professionals of both sexes and varying years of clinical experience, 
affiliations varied in size and characteristics of patient populations (see Table 1). 
All interviewees gave informed consent prior to the interview. The VU University 
Medical Center Ethics Committee approved the study.
Interview guide
The interviews were semi-structured and based on a topic guide that was pilot 
tested in two interviews. In the first part of the interview, interviewees were asked 
to describe current practice with regard to the use of (opportunistic) screening for 
T2D, assessment and registration of FH and structured education targeting patients 
at risk developing T2D. Individual opinions with regard to bringing up FH as a 
topic of conversation in preventive consultations were explored. Next, two potential 
strategies to reach relatives of T2D patients were discussed: 1) directly targeting 
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Table 1. Characteristics of the interview sample 
General 
Practice
Professionals’ 
identification 
number Gender 
Years of 
clinical 
experience Characteristics patient populationϯ
1 GP1 
PN1
Female Female 16-20 
6-10
Average SES 
Autochthonous population
2 GP2 
PN2
Male Female 6-10
0-5
Low SES
Autochthonous population, mostly >65 years
3 GP31
PN31
Female Female 21-25
6-10
Average/high SES
Autochthonous population & a substantial 
group from Moroccan origin
4 GP4 
PN4&52
Male Female > 30
6-10
Low SES
Most patients from Moroccan or Turkish origin, 
mostly >65 years
5 GP5 
PN4&52
Male Female > 30
6-10
Low SES
Most patients from Moroccan or Turkish origin
6 PN6a3
PN6b3
Female
Female
0-5
6-10
Low/average SES
Autochthonous population
Outpatient 
clinic
Professionals’ 
identification 
number Gender 
Years of 
clinical 
experience Characteristics patient populationϯ
1 DS1 
DN1
Male Female 6-10
6-10
Average/high SES
Autochthonous population
2 DS2 
DN2
Male Male 11-15
6-10
Low SES
High proportion immigrants
3 DS3a
DS3b
Male
Male
21-25
11-15
Low SES 
High proportion immigrants
DN3 Female 21-25
4 DS4 Female 0-6 Low SES
High proportion immigrants 
GP=General practitioners, PN=Practice Nurses, DS=Diabetes Specialists, DN=Diabetes Nurses
Ϯ Professionals were asked to define their patient population according to socioeconomic status (SES), age 
distribution, and ethnic backgrounds.
1 GP3 and PN3 were interviewed at the same time
2 PN4&5 worked in both general practice 4 and 5
3 PN6a and PN6b were interviewed at the same time
patients known to have FH of diabetes and 2) indirectly targeting, i.e. asking patients 
to pass on information in their family. The interview guide is presented in Table 2. 
Considerable flexibility during the interviews allowed interviewees to discuss and 
elaborate on issues that were most important to them. Each interview lasted about 
half an hour and took place in the participants’ work environment. 
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Table 2. Topic list used in semi-structured interviews 
Introduction
With the increasing incidence, primary prevention of type 2 diabetes is of key importance. Clinical and public 
health efforts are generated to assist in reducing the burden of diabetes in the population. In this interview, 
we aim to explore the current and future uptake of proactive patient education about familial susceptibility to 
type 2 diabetes.
A. Mapping current practice
•	 Are patients at risk developing type 2 diabetes systematically screened in this general practice?* 
•	 In case of opportunistic screening: which risk factors are assessed?
•	 Can you describe the practical implications of the screening process
•	 Is family history of type 2 diabetes systematically assessed (if yes, how registered)?
•	 Is education about risk factors and preventive options systematically offered when patients are at risk 
developing type 2 diabetes (but not yet diagnosed)?*
•	 Which risk factors are emphasized?
•	 To which extent is family history discussed? 
B. exploring Perceptions and attitudes
•	 What is your opinion about using family history as a topic of conversation to promote health protective 
behaviour?*
•	 Do you use family history to personalize preventive messages?
•	 Do you think it is effective (e.g., with regard to promote healthy behaviour)?
•	 What is your opinion about proactively targeting patients with a family history of type 2 diabetes to 
educate them about preventive options?*
•	 What will be the potential effect (e.g., patient empowerment/responsibility/privacy)?
•	 Do you think it is feasible?
•	 What is your opinion about asking patients to deliver diabetes risk and preventive messages in their 
family? Elaborate on:
•	 Patients’ willingness
•	 Potential effect on relatives
•	 Feasibility
•	 Familial and/or cultural aspects
•	 What would be needed to implement a family-oriented approach in diabetes prevention?
•	 Are you familiar with the information that is provided by mass media campaigns and websites aiming to 
raise public awareness about familial susceptibility to type 2 diabetes?
•	 Do you use this information and/or refer patients to these websites?
* Topic only discussed with primary care professionals
Data analysis 
All interviews were digitally recorded, transcribed verbatim (WC) and checked 
for errors (SvE and WH). Qualitative data indexing software (ATLAS.ti 5.2) was 
used for data coding and retrieval. The transcripts were analysed using thematic 
content-analytical techniques. Main codes were established for the core questions 
in the interview guide; sub-codes were inductively formulated to identify emerging 
sub-themes. Two investigators (SvE and WC, or WH and WC) independently coded 
each transcript. Ambiguities in the final code-lists were discussed until consensus was 
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reached. Subsequently, (sub-)codes were grouped in thematic matrices and similarities, 
variations and patterns amongst the professional groups were summarized. Main 
findings were discussed with all members of the study group. The quotations that 
follow were chosen to reflect a range of both consensual and dissenting views.
Results
Mapping current practice
All included GPs work in accordance with the Dutch guideline for diabetes 
treatment, which include opportunistic screening for T2D (Bouma et al., 2006). One 
GP participated in a trial to implement the screening protocol for cardio-metabolic 
prevention, targeting all patients >55 years old (Assendelft et al., 2012; Dekker et al., 
2011). All interviewees perceive FH as important factor in the risk stratification 
procedure. However, according to the interviewees in primary care, the assessment 
of FH is not standardized; a person’s FH of diabetes is inquired the moment it 
is thought to be of relevance. In diabetes outpatient clinics, FH is systematically 
assessed during the first consultation. Both in primary and secondary care, FH 
information is registered in electronic medical records (EMRs), but not with a 
retrievable code. When patients are diagnosed with (pre)diabetes, they are regularly 
monitored and receive education about T2D risk factors and lifestyle modifications 
to prevent diabetes complications (secondary prevention).
Using family history information in preventive actions
Data revealed that the extent to which the multifactorial aetiology of T2D is 
explained varied between professionals: ‘It depends on the patient, whether (s)he is 
interested. But I try to explain that some people are more at risk than others.’ [GP4]. 
Some GPs and NPs do not emphasize the role of FH as a risk factor, as it is not a 
factor that can be controlled: ‘We think monitoring weight and blood glucose levels in this 
population is most effective. We don’t emphasize family history.’ [GP3] ‘Understanding the 
balance between food consumption and energy expenditure, that’s what counts.’ [GP5]. 
None of the interviewees used FH information to promote health-protective 
behaviour. The clarification of what FH could mean to a person seemed to be 
minimal. Professionals could not bring up absolute or relative risk estimates of 
developing T2D in persons with a FH. Nevertheless, they agreed that personal 
perceptions about diabetes running in the family could be discussed more thoroughly 
and knowledge about familial susceptibility to diabetes could be improved: ‘There is 
a lot of ignorance. […] People don’t recognize diabetes symptoms, despite the –sometimes 
high- diabetes prevalence in their family.’ [GP4]. The idea of using FH information 
to motivate risk-reducing behaviour was new to all interviewees, but it was 
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acknowledged that for some relatives, personalized risk messages could be a cue to 
action: ‘I think, targeting family members could be effective. However, I think you should 
reach them in a neutral and thoughtful manner. People don’t want you to interfere with 
their personal life too much.’ [GP2].
However, in practices with many patients from ethnic minority groups, cultural 
and linguistic barriers were mentioned. GPs and PNs do not expect benefits from 
illuminating the familial character of T2D in ethnic minority groups because of 
differences in perceived controllability with regard to health and illness, causal 
attributions, generational conflicts and low literacy: ‘The illness burden of first 
generation migrants might not impress the younger generations. These youngsters do not 
identify with their parents as far as health-related issues are concerned.’ [GP5].
Nevertheless, all primary care professionals reported to be interested in new 
strategies and tools to inform people about the importance of a healthy lifestyle. 
Interestingly, with exception of one PN, none of the interviewees had paid attention 
to or used the information provided by renowned Dutch health organizations. 
Between 2009 and 2013, diverse mass medial campaigns and an informative website 
were launched (Dutch Diabetes Federation, 2009), providing a diabetes risk test that 
generates personalized preventive information (Alssema et al., 2012).
Directly targeting patients at familial risk developing type 2 
diabetes
Most GPs and PNs indicated that directly targeting and educating populations at 
risk, including persons with a FH, would be desirable and worthwhile: ‘We plan to 
set up more preventive activities targeting patients with an extensive family history of 
cardiovascular disease and type 2 diabetes.’ [GP4]. However, they foresee practical 
problems; lack of time, finance and organizational barriers were reported: ‘What 
we need is a continuing approach. Our PNs are trained to provide patient education and 
motivate patients in the process of behaviour change. […] We could organize and facilitate 
a structured programme, on condition that financial resources are available.’ [GP2]. Most 
importantly, however, directly targeting patients with a FH is not possible because 
EMRs are not equipped to retrieve persons with a FH: ‘The most important barrier is 
to identify and reach patients with an extensive family history.’ [PN6b].
Asking patients to pass on risk and preventive messages in their 
family 
The idea of asking patients to inform relatives about familial susceptibility to T2D 
appeared to be new to all interviewees. During the interviews, the professionals 
became more and more interested in this potential approach to reach relatives at risk: 
‘When you think about prevention, you have to reach as much people as possible. I do not 
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disapprove this kind of targeting approach.’ [PN4&5]. Interviewees referred to patients 
who bring up inheritance and concern about the future health of their relatives 
themselves. They commended on the possibility of contacting otherwise unreachable 
healthy individuals and thought that a specific group of patients seems willing to 
disseminate information in their family: ‘Patients who adequately handle their disease 
will be motivated to participate. Other patients are into denial and/or struggling with their 
disease. You can’t ask these patients to deliver diabetes risk messages in their family.’ [PN6a].
However, for some GPs it was difficult to think about targeting a population 
that does not necessarily include their own patients: ‘I think it is difficult to manage, 
sometimes I ask about relatives, but most relatives are not registered as a patient in our 
practice.’ [GP1]. Moreover, besides a lack of time during their consultations, they 
indicated that they would need expertise and skills to guide and educate patients 
who are willing to serve as a messenger in their family.
Family-based diabetes prevention in secondary care
Most interviewees in secondary care do not think they should have an active role 
in the primary prevention of T2D, however, they are open to the idea of informing 
patients and their relatives about familial susceptibility to T2D: ‘Indeed, we talk about 
family history. When patients or relatives ask about it, I inform them about the importance 
of a healthy lifestyle and advice relatives to consult their GP for a yearly check-up.’ [DS2]. 
One DS realized that in other situations, they have a more active role with regard 
to prevention in families at high risk developing a disease: ‘We always inform patients 
about familial susceptibility in case of monogenetic disorders. The problem with T2D is its 
multifactorial aetiology; the message is not clear and more difficult to explain.’ [DS1].
One DN thinks every health care professional should be concerned about a population 
at risk, but emphasized that there are little opportunities to act upon that in secondary 
care. Other professionals were interested in the idea of initiating conversations in families 
at risk: ‘I think patients can tell from their own experience what it’s like to have the disease 
[…] Most of my patients have adult offspring. That would be a good target population.’ [DS4]. 
They emphasized the importance of repeating health-protective messages: ‘Repetition is 
important in health education. [...] It seems a good idea that people hear the same message over 
and over again: from public health communications, in general practice, from dieticians and 
from us.’ [DS1]. Another professional, however, stated that a patient-mediated targeting 
approach is not appropriate in secondary care: ‘Some patients in secondary care are quite sick. 
You can’t ask them to inform their relatives.’ [DN2].
Perceived barriers regarding a patient-mediated targeting approach
Notwithstanding the interest and enthusiasm of most interviewees, some questioned 
the feasibility and benefits of a patient-mediated approach in diabetes prevention: 
‘Patients don’t want to deliver bad news and relatives don’t want to receive such messages.’ 
101
Health care providers’ perspective on family-oriented diabetes prevention
7
[DS3a]. They doubted whether patients will be able to pass on accurate messages and 
whether relatives will be alarmed: ‘Will the messages be delivered? To be honest, considering 
our patient population, I suppose a substantial amount will not.’ [PN4&5]. As T2D is 
a lifestyle related disease, many patients would not fulfil a role model with regard to 
health behaviour: ‘I think the most important factor is how patients experience and cope 
with their disease and how visible it is for relatives.’ [PN1]. Interestingly, nurses (PNs and 
DNs) seemed to be more hesitative than medical professionals (GPs and DSs).
Different professionals mentioned strong family bonding in ethnic minority 
families as a potential advantageous factor: ‘Family tights seems to be stronger in 
immigrant families.’ [DS3]. However, according to other professionals, asking 
non-Dutch patients to pass on information seems not feasible: ‘It’s the other way 
around. Those children are used to translate during consultations and provide their parents 
with health information. They won’t listen to their parents and will search for information 
themselves when they need it.’ [GP5]. Moreover, according to the interviewees, the 
younger generation in general would not be admissible to risk messages via the 
family system: ‘I question whether it’s effective. Younger offspring is not concerned with 
future health risks.’ [GP1] ‘Do children listen to their parents? [...] I think a person will be 
interested the moment (s)he is confronted with the problem.’ [DS3a].
Discussion
Findings in this study indicated that, although interviewees were unacquainted with, they 
did not decline the idea of discussing a person’s understanding of familial risk in order 
to promote and motivate health-protective behaviour. Nonetheless, some professionals 
questioned the effectiveness of illuminating FH, especially with regard to patients of 
non-Dutch descent and younger generations. Targeted diabetes education, however, seems 
to increase the recognition of diabetes risk, screening possibilities, perceived personal 
control and the need of healthy behaviour in persons with a FH of T2D (Chang et al., 
2011; Pijl et al., 2009; Qureshi & Kai, 2008; Ruffin et al., 2011; Zlot et al., 2009). 
Relatives, who were informed via the family system, perceived themselves at increased 
risk developing diabetes (Pierce et al., 2000; Whitford et al., 2009). Professionals are 
right stating that the effect of using FH in preventive communications targeting specific 
populations remains unknown (Chang et al., 2011; Qureshi & Kai, 2008; Ruffin et al., 
2011). Earlier research, however, has indicated that in families with different ethnic 
backgrounds (e.g., South-Asian, Middle-Eastern), family communication about T2D is 
not a taboo and patients seem willing to pass on risk and preventive information in their 
family (Esch et al., 2012; Whitford & Al-Sabbagh, 2010).
Generally, the study findings lend support for the adoption of direct as well as 
indirect strategies targeting persons with T2D running in their family. Both methods 
seem effective in other disease areas (Hallowell et al., 2011). In Dutch primary care 
102
Chapter 7
practice, an active and personal invitation of the GP increased the screening uptake 
of participants for a lifestyle intervention on T2D risk reduction (Assendelft et al., 
2012; Vermunt et al., 2010). According to some interviewees, however, proactively 
targeting individuals with a FH was not considered feasible. Besides practical 
barriers with regard to time, expertise and financial reimbursement, they indicated 
that FH is not systematically gathered and EMRs are not equipped to retrieve 
persons with a FH. These findings are in line with was declared in the US National 
Institutes of Health (NIH) statement on ‘Family history and improving health’ (Berg 
et al., 2009). In the future, the development of tools to collect standardized FH 
that are compatible with EMRs may solve this problem (Valdez et al., 2010). In the 
Netherlands, the implementation of proactive disease prevention linked to primary 
care may create opportunities to initiate conversations about FH more systematically 
(Assendelft et al., 2012; Dekker et al., 2011). A lifestyle intervention that uses FH 
to motivate relatives of T2D patients to maintain good health is currently being 
evaluated (Heideman et al., 2011b).
The idea of asking patients to pass on risk information was new to all 
interviewees, but was considered an acceptable strategy to reach persons with a FH. 
Nevertheless, quite a lot of professionals (especially nurses) were sceptical about the 
potential benefits of such a strategy. They doubted whether patients would be able to 
deliver accurate messages in their family. Research already has demonstrated that it 
would be advisable to provide patients with written information when they are asked 
to deliver risk and preventive messages in their family. Written information about 
familial hypercholesterolemia reduced patients’ hesitation and appeared to be helpful 
in the disclosure of family risk. In another study, information packages served as a 
cue to action for relatives and legitimated them to ask for a medical check-up (van 
den Nieuwenhoff et al., 2006). 
A study in Japan has indicated that booklets with information about T2D risk 
and prevention, which were handed over by patients, worked effectively on attitudes 
and preventive behaviours in relatives. Yet, the reliability of patients as information 
deliverers appeared to be limited (Nishigaki et al., 2011). This latter finding underlines 
the doubts that some interviewees expressed in our study. Professionals’ concern 
that patients may fulfil a negative role model in their family was also indicated as a 
barrier in the disclosure of family risk by patients themselves (Whitford et al., 2009b). 
Nevertheless, patients diagnosed with familial hypercholesterolemia seem to prefer a 
patient-mediated approach more than a direct targeting approach, as they consider it 
less threatening for relatives (Hallowell et al., 2011).
Limitations
In this study, data were collected from a maximum variation sample of diabetes care 
professionals in the Netherlands, representing most important disciplines in primary 
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and secondary diabetes care. Interviews were conducted in an urbanised area, though 
there are no indications that this may limit the study’s generalizability to all diabetes 
professionals in the Netherlands. The Dutch health care system, however, might 
restrict generalizability to an international context. 
Next, it should be noticed that the idea of asking patients to inform relatives about 
familial susceptibility to T2D was new to all interviewees. It would be interesting to 
explore opinions of professionals who have considered these issues more thoroughly, as 
(in)directly targeting relatives of index patients may raise ethical questions (Hallowell 
et al., 2011). In addition, more insight is needed in cultural aspects regarding the 
disclosure of family risk, the effect of low health literacy and negative modelling in 
families at risk when utilizing a family-oriented approach in diabetes prevention.
Conclusions 
The results of this study suggest that health care professionals in primary, as well 
as secondary care are open to the idea of using FH in preventive activities. To 
start, professionals could be stimulated to use the (online) information that is 
made available by national public health initiatives to inform populations at risk 
developing T2D, including persons with a FH of the disease (Federation, 2003). In 
Dutch primary care, the future implementation of a protocol for proactive prevention 
of non-communicable diseases (Assendelft et al., 2012; Dekker et al., 2011) might 
provide opportunities to systematically discuss patients’ interpretation of familial 
susceptibility to a disease and potential effects on health-related behaviour.
Importantly, however, for professionals to adopt family-oriented strategies in the 
prevention of T2D, convincing evidence is needed regarding the (cost-)effectiveness. 
Subsequently, professionals (especially nurses) should be educated on how to use 
FH information, the family system and family communication to promote health-
protective activities.
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Type 2 diabetes (T2D) is a serious chronic disease and has become a global health 
problem (Herman & Zimmet, 2012). In the Netherlands, around 1.3 million people (8% 
of the population) will be diagnosed with diabetes in 2025 (Baan et al., 2009). In response 
to that, the Dutch Government has defined highly ambitious goals aiming at reducing the 
incidence of T2D (Dutch Ministry of Health, 2006). Clinical and public health efforts are 
made to inform the Dutch public about risk factors for T2D and preventive options.
Research has demonstrated that the family matters, is of importance, in diabetes 
prevention. A family history of T2D can help to detect persons at increased risk 
(Valdez et al., 2007), but can also raise the level of awareness about the role of 
shared genes and environments in families and the need for risk-reducing behaviours 
(Chang et al., 2011; Pijl et al., 2009b; Qureshi & Kai, 2008; Ruffin et al., 2011; Zlot 
et al., 2009). The main objective of this thesis is to provide insight in the current 
and potential use of communication about familial risk of T2D to promote health-
protective behaviour in families where T2D is (highly) prevalent. Six sub-studies 
were presented, in which we set out to explore this question from three perspectives: 
1) online public health communications, the point of view of 2) patients with T2D, 
and 3) health care professionals.
This final chapter summarizes and reflects on the main findings of this thesis. 
The methodology that was applied in the studies, practice implications and future 
research will be discussed. To conclude, five key messages are formulated.
Reflection on the main findings
Public health communication
The public availability of information about familial susceptibility to diabetes
More than a decade ago, patients with T2D and their family members seemed to 
be aware of ‘some’ increased familial susceptibility, but generally underestimated the 
actual risk percentage and had little knowledge of primary prevention (Adriaanse 
et al., 2003; Farmer et al., 1999; Forsyth & Goetsch, 1997; Gnanalingham & Manns, 
1997; Kemple et al., 2005; Pierce et al., 2001; Pierce et al., 1999). Findings from our 
study (described in Chapter 2) underline that T2D risk and prevention were of little 
interest before 2005. Information on the familial character of diabetes provided by 
renowned diabetes organizations on their websites appeared to be very brief and hard 
to find. Less than half of the websites provided preventive information that included 
healthy lifestyle recommendations. 
Recent research, however, indicate a growing awareness of family risk and worries 
about the development of T2D in persons with a family history (Hariri et al., 2006; 
Nishigaki et al., 2008; Whitford et al., 2009a). After 2005, various (inter)national 
public health initiatives to promote risk-reducing behaviour were launched and 
(online) risk assessment tools that include family history of T2D are flourishing 
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(Alssema et al., 2012; Holmberg et al., 2011; O’Neill et al., 2009; Orlando et al., 
2011; Yoon et al., 2009). Even direct-to-consumer genetic tests for diabetes are 
available on the Internet (van El & Cornel, 2011). We may assume that the (online) 
availability of information about diabetes risk factors and preventive options has 
increased in recent years. The quality of the current (online) information, however, 
has to be confirmed in further research.
Public need for information on diabetes and inheritance
People are increasingly searching for online information about diabetes (Thakurdesai 
et al., 2004) and genetics (Taylor et al., 2001). When searching the Internet for 
information about ‘diabetes and inheritance’ in Dutch (diabetes en erfelijkheid), at least 
until 2005, Google’s first hit directed to the website of the Dutch National Genetic 
Research and Information Centre (Erfocentrum.nl). This not-for-profit organization 
provides online information about inheritable diseases, including all diabetes 
subtypes and offers visitors the opportunity to ask questions by email. 
Using content analysis, we investigated emailed questions of website visitors 
(Chapter 3). Findings could prove helpful in tailoring clinical and public (online) 
information to the needs of an increasing population at risk for diabetes. For 
instance, we learned that not only patients, but also relatives and partners should be 
addressed and provided with information about the inheritable character of T2D. In 
line with other research, persons seeking for information were relatively young (<30 
years) and predominantly female (Powell et al., 2011). Most questioners appeared to 
be in need of risk information; others were looking for clarifying information about 
the genetics of diabetes or advice. The genetics of type 1 diabetes, (future) pregnancy 
and family planning were the most queried topics. Although we observed an 
increase in emailed queries between 2005 and 2009, the number of questions asked 
about T2D and inheritance remained relatively low. In line with that, health care 
professionals also indicated that patients rarely ask questions about the inheritable 
character of T2D (Chapter 7). Nor could professionals recall patients referring to 
or asking questions about the information about diabetes risk and prevention that 
was provided by mass media campaigns of the Dutch National Action Programme 
(NAD) (Dutch Diabetes Federation, 2009) and the Dutch Diabetes Foundation. 
This seemingly lack of (public) interest seems at odds with the increasing awareness 
of familial risk and worries about the development of T2D in persons with a family 
history (Hariri et al., 2006; Nishigaki et al., 2008; Whitford et al., 2009a).
The patients’ perspective
Patients as messenger in the family
In line with earlier research (Nishigaki et al., 2009; Whitford et al., 2009b), sixty per 
cent of the patients in our study sample was willing to disclose familial diabetes risk 
(Chapter 4). Discussing T2D in everyday communication appeared to be acceptable 
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in 80% of the families. Moreover, communication about T2D with family members 
seems to be open and supportive in most of the participants’ families (Chapter 6), 
which is considered of crucial importance in applying a family approach in diabetes 
prevention (Wiseman et al., 2010). 
Patients appeared to be positive about their ability to disseminate risk and 
preventive messages in their family. Around three-quarter of all patients indicated 
they are well informed about diabetes risk and prevention, knowing “what to tell, 
how to tell and whom to inform”. According to these findings, asking patients to pass 
on risk and preventive information in their families seems to be a feasible strategy 
targeting high-risk relatives of patients with T2D. However, one must not overlook 
the fact that in approximately 20% of the families, T2D is never discussed and 40% 
of the patients resent being a health messenger in the family (Chapter 4). Stimulating 
diabetes-related communication seems not be appropriate in these families.
Worry seems to be an important determinant in the process of family risk disclosure
It appeared that a majority of the participants in our study (61%) considered 
the development of T2D (very) likely in their first-degree and/or second-degree 
relatives. Less than half of the patients (41%) reported positive beliefs regarding 
the possibility of their relatives to prevent or postpone T2D onset (Chapter 4, 5). 
Similar percentages were reported in earlier research (Pierce et al., 1999; Whitford 
et al., 2009b). Worry about the future health of relatives appeared to be an important 
motivator of patients’ willingness to serve as a health educator in their family, as was 
also reported by Whitford et al. (2009). In addition, perceived self-efficacy of patients 
(Schwarzer & Fuchs, 1996), expressed in knowing what to tell, whom to notify and 
the presence of everyday conversations about diabetes, appeared to be predisposing 
factors regarding family risk disclosure (Chapter 4).
Interestingly, family risk perceptions of patients appeared not to have a direct 
effect on their intentions to inform relatives, rather perceived risk exerts an indirect 
effect through worries about relatives’ health and personal beliefs about T2D 
prevention (Chapter 4). Research carried out in the area of cancer control behaviours 
has reported considerable variability in the observed relationships of perceived 
risk, worries and control beliefs with cancer protective behaviours (Cameron & 
Reeve, 2006; Consedine et al., 2004). There are studies reporting situations in which 
worries and fear predict breast cancer screening behaviours, whereas risk judgments 
do not (Cameron & Diefenbach, 2001; Diefenbach et al., 1999). Also in the area 
of influenza vaccination, anticipated worry and regret were stronger predictors of 
vaccination than perceived risk (Chapman & Coups, 2006).
Research from clinical, physiological and (subfields of ) psychology demonstrated 
that emotional reactions and cognitive evaluations typically work in concert to guide 
reasoning and decision making. However, emotional reactions to risky situations 
sometimes diverge from cognitive evaluations and, when they do, emotional reactions 
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may drive behaviour. In other words, feelings may be more than just an important 
input into decision-making under uncertainty; they may be necessary and, to a large 
degree, mediate the connection between cognitive evaluations of risk and risk-related 
behaviour (Loewenstein et al., 2001). In line with that, a hypothesis described in 
cancer-related research suggests that if the effectiveness of a health-protective action 
is unknown or modest, then cognitive risk appraisals may be only weakly associated 
with the use of that action, whereas emotional appraisal may motivate behaviour due 
to hopes that it might provide some protection (Cameron, 2003).
Personal illness representations of patients underpin perceived diabetes 
threat in relatives
Asking patients to pass on risk and preventive information puts them within an 
active role to discuss familial diabetes threat in their family. It was argued that 
insight is needed to guide –and potentially improve- patients in the process of 
disclosure of familial T2D risk (Hallowell et al., 2011). Diverse health behavioural 
theories describe that people react to the prospect of risk at two levels: they evaluate 
the risk cognitively and they react to it emotionally. Although the two reactions 
are interrelated, with cognitive appraisals giving rise to emotions and emotions 
influencing appraisals, the two types of reactions may have different underlying 
determinants (Leventhal et al., 2003; Loewenstein et al., 2001; Weinstein, 1993).
The study in Chapter 5 indicated that personal illness representations of patients 
appeared to be useful in understanding their family risk perceptions, worries and belief 
in preventive options in relatives. Patients who perceived their diabetes as a serious, 
unpredictable disease appeared to have higher family risk perceptions and more worries 
about relatives developing T2D. Reporting serious daily consequences and high emotional 
impact were most strongly associated with elevated levels of concern. Moreover, patients 
with coherent illness beliefs and perceiving control over their disease reported positive 
beliefs about the possibilities for relatives to postpone or prevent diabetes onset, whereas 
patients attributing to chance/bad luck reported less positive control beliefs. These findings 
are in line with the mental contents underlying a person’s own health risk appraisal 
(Cameron, 2008; Kaptein et al., 2007; Leventhal et al., 2003).
A family-oriented prevention strategy targeting Surinamese-South Asian families
As described in Chapter 6, patients from Surinamese South-Asian descent expressed 
a higher motivation to inform their relatives about T2D risk than Dutch patients 
did. Findings also suggested a trend towards more ‘openness’ in discussing diabetes 
in Surinamese families. The family bonding seemed to be strong, not only with 
offspring but also with the wider family (siblings, aunts/uncles and grandparents). 
According to these results, a patient-mediated prevention strategy targeting at-risk 
relatives in Surinamese South-Asian families seems justifiable. A recent study among 
another Surinamese population in the Netherlands confirmed the willingness in this 
group to talk about diabetes with family members and friends (Kohinor et al., 2011). 
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Interestingly, it was noticed that Surinamese-South Asian patients expressed 
higher family risk perceptions and more worries than Dutch patients (Chapter 6). In a 
multivariate regression analysis, however, ethnic backgrounds as such appeared not to be 
associated with increased family risk perceptions. Other characteristics, as family history 
and age, largely explained the variance in familial diabetes risk perceptions instead. Being 
of non-Dutch descent, on the other hand, appeared to be an independent determinant of 
patients’ increased worries about relatives developing T2D (Chapter 5). In contrast to what 
could have been expected based on reported severe diabetes burden (Bathula et al., 2010) 
and cultural ideas about the role of fate in life (Davison et al., 1992; Dickinson & Bhatt, 
1994), Surinamese patients did not express more fatalistic beliefs than Dutch patients did. 
About forty per cent of both study populations was inclined to believe that relatives might 
be able to postpone or prevent diabetes onset (Chapter 6). 
The interplay between family risk perceptions of patients, their worries and 
control beliefs in the process of family risk disclosure, as investigated in Chapter 4, 
was adjusted for ethnic backgrounds. Neither did we differentiate between ethnic 
groups investigating illness beliefs of patients in relation to perceived diabetes 
threat in relatives (Chapter 5). Differences in illness beliefs with regard to causal 
attributions and personal control, however, may be assumed in South-Asian and 
Caucasian populations (Bean et al., 2007; Macaden & Clarke, 2006). Therefore, the 
applicability of the study findings (Chapter 4 and 5) in Surinamese South-Asians 
patients merits further investigation.
Health care professionals’ perspective
Using family history in preventive consultations
In Dutch medical practice, family history information is not structurally used to 
promote health-protective behaviour. Health care professionals were not aware of the 
potential positive effect of personalized education on the recognition of diabetes risk, 
screening possibilities, perceived personal control and the need of healthy behaviour 
(Chang et al., 2011; Pijl et al., 2009b; Qureshi & Kai, 2008; Ruffin et al., 2011; Zlot 
et al., 2009). Nevertheless, primary care professionals were open to the idea of using 
family history in preventive activities, as they were interested in new strategies to 
promote and motivate health-protective behaviour in patients at risk developing 
T2D (Chapter 7). Currently, however, proactively targeting individuals with a family 
history was not considered feasible. Besides practical barriers with regard to time, 
expertise and financial reimbursement, findings suggest that professionals lack 
expertise and tools to assess, register and use family history accurately. 
The potential of a patient-mediated approach targeting relatives at risk
The idea of asking patients to pass on risk and preventive information was new to all 
interviewed professionals, but was considered an acceptable strategy to reach persons 
with a family history of T2D. Nevertheless, quite a lot of professionals in first as 
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well as secondary care (especially nurses) were not convinced of the benefits of such 
a targeting strategy (Chapter 7). Targeted diabetes education, however, seems to 
increase the recognition of diabetes risk, screening possibilities, perceived personal 
control and the need of healthy behaviour in persons with a family history of T2D 
(Chang et al., 2011; Pijl et al., 2009; Qureshi & Kai, 2008; Ruffin et al., 2011; Zlot 
et al., 2009). Relatives, who were informed via the family system, perceived themselves 
at increased risk developing diabetes (Pierce et al., 2000; Whitford et al., 2009a). 
Behavioural outcomes, on the other hand, have received limited attention yet. A study 
in Japan has indicated that booklets with diabetes risk and preventive information, which 
were handed over by patients, worked effectively on attitudes and preventive behaviours 
in relatives, however the reliability of patients as information deliverers appeared to 
be limited (Nishigaki et al., 2011). This latter observation stresses the importance of 
professional guidance in the process of family risk disclosure. Professionals are right in 
stating that more insight is needed in cultural aspects regarding the disclosure of family 
risk, the effect of low health literacy and negative modelling in families at risk when 
utilizing a family-oriented approach in diabetes prevention.
Reflection on research methods and theory
Several methods were used to answer the research questions as outlined in the 
Introduction. All studies in this thesis were observational and explorative in nature. 
In the interpretation of the main findings, some strengths and limitations of the 
research methods warrant further consideration.
Qualitative research methods
In the studies reported in Chapter 2, 3 and 7, we used a qualitative study design. 
Data consisted of, respectively, website information, emailed questions and interview 
transcripts. In all three studies we conducted thematic content analyses, which is 
an established social science methodology concerned with thematically analysing 
qualitative data (Boyatzis, 1998). This means that a priori coding labels were 
formulated based on the research questions in the study. In addition, new themes 
were generated inductively from the raw data with constant comparison between 
researchers. In Chapter 2 and 3, after qualitative classification, data were quantified 
in order to observe the distribution of coding labels within the emerged categories. 
In Chapter 7, (sub-)codes were grouped in thematic matrices and similarities, 
variations and patterns among the professional groups were summarized.
Subjectivity in data collection and analyses
To enlarge the reliability and validity of the study outcomes, data were analysed by 
representative interpreters with expertise in the field. In each study, two researchers 
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established the initial code list for fragments and the coding process was exercised. 
Data were analysed twice by different researchers and checked for inter-coder 
consensus concerning the assignment of text segments to major themes. Ambiguities 
were resolved in discussion with the research team, which included two senior 
researchers and the main results of the study were discussed to receive feedback 
about the plausibility of the conclusions. However, in qualitative studies, researchers 
make decisions in the data retrieval and analysing process that may encompass 
subjective elements. For instance, data collection and analysis in Chapter 2 and 
Chapter 7 was done by the researchers themselves and, consequently, may have 
generated researcher bias. Researchers’ knowledge and ideas might contribute to 
blind spots and disproportional focus on specific elements. 
The use of Atlas.ti software (Muhr, 1994 ) enabled us to make notes about decisions 
in the analysing process and reflections on the data. In that way, consistency of the data 
analyses could be verified by examination of the steps taken in the process.
Use of secondary data
In Chapter 3, we conducted content analysis on secondary data. Data from secondary 
sources have been collected by others and not specifically for the research question at hand. 
(Hakim, 1982). Our study was strengthened by the fact that data were collected from 
a registry of people searching for information in a ‘natural’ setting, as opposed to using 
questionnaires to explore knowledge and information needs on genetics in a (high-risk) 
clinical setting or in general public. We were able to explore questions based on individual 
perceptions and interests, described in people’s own words. Because of this unobtrusive 
data collection, social desirability response bias was reduced considerably (Hakim, 1982). 
Moreover, the research methods using secondary data are often more easily amenable 
to replication and to validity and reliability checks than some methods used to collect 
primary data in social settings (Frankfort-Nachmias & Nachmias, 1996).
A limitation of this method, however, is that we could not exercise any control over the 
data generation and recording. We were unable to expand our understanding further by 
posing additional questions, for example, about the amount of visitors actually reading the 
information provided on the website, the degree of understanding provided information 
and perceived utility of the expert answers received. This may restrict the quality and depth 
of the contextual nature of the data (Szabo & Strang, 1997).
Generalization
The selection of 34 websites in Chapter 2 was restricted by choice of languages 
and limited the study’s generalizability. Furthermore, the Internet is a fast-moving 
medium and results from a study conducted in 2005 are no longer applicable to 
the current situation. The generalizability of the findings derived from emailed 
questions that we explored (Chapter 3) is limited as well, because of its reliance on 
data gathered by only one web based supplier of genetic information. Noticeably, 
people submitting questions via the Internet may represent a selective group and we 
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cannot exclude selection bias. On the other hand, the 172 queries that were available 
generated a study sample that was rich enough to emerge categories reflecting 
interesting themes and tendencies to describe. 
In the interview study described in Chapter 7, data were collected from a 
maximum variation sample of diabetes care professionals in the Netherlands, 
representing most important disciplines in primary and secondary diabetes care. 
Interviews were conducted in an urbanised area, covering only a small part of the 
Netherlands. We have no indications that this might limit the study’s generalizability 
to all diabetes professionals in this country. However, the Dutch health care system 
might restrict generalizability to an international context.
Quantitative research methods
In the studies reported in Chapter 4, 5 and 6, we used a quantitative approach to 
explore factors that may influence the process of family risk disclosure. These studies 
relied on data obtained through self-report questionnaires. 
Study design
It is important to notice that causality cannot be proven in a cross-sectional study 
design. Results of multivariate logistic regression and multiple mediation analyses 
reflect correlations between variables. Causal patterns were assumed, based on the 
Common-Sense Model (CSM) of self-regulation of health and illness (Cameron, 
2003; Leventhal et al., 2003), in which risk perceptions, worries and control beliefs 
precede (the intentions towards) health-protective behaviour. However, we have 
to take into account that the CSM is described as a dynamic processing system, in 
which illness representations, behaviour and emotions evolve and change over time 
(Leventhal et al., 2003). Moreover, a problem with self-report questionnaires is that 
they may be susceptible to social desirability bias and poor patient recall (King & 
Bruner, 2000). Indeed, over-reporting of diabetes-related communication in the 
Surinamese sample should be taken into account, since social desirability is known in 
populations with Asian background (Zane & Yeh, 2002).
Participants
Patient recruitment in primary as well as secondary care resulted in a study sample that 
resembled the population with T2D in the Netherlands with regard to socio-demographic 
and diabetes-related characteristics (van Dam et al., 1991). A mixed population was 
included, representing minority groups in the Netherlands with high diabetes prevalence 
(Weijers et al., 1998). Because of exceptional high diabetes risk (Middelkoop et al., 1999), 
the Surinamese South-Asian population was purposefully over-sampled, which may limit 
the study’s generalizability with regard to other ethnic populations. 
Another drawback is that we could not rule out selection bias. The response rate was 
low at 41%, but not too far from other questionnaire studies (e.g., Whitford et al., 2009b). 
116
Chapter 8
On the other hand, the study sample was relatively large. There were no differences 
between responders and non-responders in gender and treatment in primary- or 
secondary care. Non-responders, however, were on average five years younger than 
respondents were. Non-response analyses revealed that only a minority of the reported 
reasons for not participating in the study referred to ‘lack of family contact’, ‘being the 
only diabetes patient in the family’, or ‘not wanting to bother relatives’. Another possible 
source of selection bias is the motivation of the participating patients. Presumably, the 
study sample consisted of highly motivated patients being more enthusiastic about 
engaging with their families than non-responders. 
Measurement instruments
We used single-item measures to assess patients’ cognitive and emotional appraisal 
of diabetes threat in their relatives. Although the reliability of a measure may be 
compromised by single-item measures, we decided to use these measures to enable 
comparison with earlier studies conducted in the field of diabetes. Indeed, family 
risk perceptions of patients and beliefs about diabetes prevention are consistent with 
these studies, although the number of participants expressing worries about their 
relatives’ health in our study seemed rather low (Nishigaki et al., 2007; Pierce et al., 
1999; Whitford et al., 2009b). 
Illness representations were assessed using the Dutch version of the Illness 
Perception Questionnaire Revised (IPQ-R; Moss-Morris et al., 2002), adapted for 
T2D. The IPQ-R scales have been tested in a variety of patients, including T2D and 
have been found to have adequate test-retest reliability and internal validity (Moss-
Morris et al., 2002; Skinner et al., 2003). The internal consistency of the IPQ-R 
subscales was acceptable or good (Cronbach’s alpha >.7 or >.8), except for personal 
and treatment control (α = .66 and α = .58 respectively) (George & Mallery, 2003). 
The internal reliability of these subscales could not be improved by item reduction. 
Generally, illness representations in our study sample were consistent with recent 
literature on T2D, although scores on the identity dimension appeared to be rather 
low (Paschalides et al., 2004; Searle et al., 2007b).
Implications and recommendations
Some implications and recommendations for public health communications, clinical 
practice and research follow from the findings described in this research project.
Public health communications should be combined with 
interpersonal interactions
The World Wide Web may offer a unique opportunity to disseminate diabetes risk 
and preventive information on a large scale. It seems important that information 
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on the contribution of genetics to type 1 diabetes, (future) pregnancy and family 
planning becomes more readily available, as these topics are inquired most of the 
time. More effort seems needed to promote awareness around familial clustering and 
primary prevention of T2D (Chapter 3). 
Targeted and well-executed mass media communications can have small-to-
moderate effects on health knowledge, beliefs and attitudes and are considered 
an effective initial strategy to raise awareness of health related risks (Noar, 2006). 
Additional interpersonal interactions, however, are needed to reach low literate 
groups (Birru et al., 2004), like ethnic minorities and people in low social classes, 
who are at increased risk developing T2D (Allgot et al., 2003; Everson et al., 2002; 
King & Rewers, 1993; Mather & Keen, 1985; Rich, 1990). Moreover, face-to-
face interactions are required to produce the desired behaviour change (Rimer & 
Kreuter, 2006; Wanyonyi et al., 2011; Westmaas et al., 2007). Therefore, it seems 
important that Dutch health care professionals adopt and continue the efforts made 
in national public health initiatives. Currently, however, only a small minority of the 
professionals that were interviewed was familiar with mass media campaigns of the 
Dutch National Action Program (NAD) (Dutch Diabetes Federation, 2009) and 
the Dutch Diabetes Foundation. None of the professionals, except for one nurse 
practitioner, paid attention to these public health initiatives nor did they visit or refer 
patients to the websites (Chapter 7). 
Family matters 
Research has demonstrated that the family matters, is of importance, in diabetes 
prevention. In the literature, it is demonstrated that family history not only can 
be used to detect persons at risk developing T2D, but evidence also suggests that 
preventive messages tailored to a person’s FH can increase risk awareness and 
risk-reducing behaviours (Chang et al., 2011; Qureshi & Kai, 2008; Ruffin et al., 
2011). In addition, studies in this thesis shed light on family matters, e.g., family 
risk perception, family relations and concern about relatives that might influence the 
usability of a family-oriented approach in the prevention of T2D.
Findings indicated that the family system could be used as an additional strategy to 
reach and educate persons at risk developing diabetes in Dutch as well as Surinamese 
South-Asian families. Generally, family communication about diabetes is not a taboo 
in most families and patients seem willing to pass on risk and preventive information 
in their family (Chapter 4 and 6). These findings could encourage professionals to 
initiate conversations about familial susceptibility to T2D in families at high risk.
An active role for patients in the prevention of diabetes in their family requires 
professional guidance (Hallowell et al., 2011). The results in our study learn that 
health care professionals should address worries when they guide their patients in 
the process of disclosure of T2D family risk. Yet, efforts to develop interventions to 
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promote health-protective behaviour will still require attention to risk cognitions. 
First, knowledge of risk factors is essential to facilitate the delivery of accurate 
messages in the family. Secondly, promoting health-protective behaviour cannot 
successfully target worries alone, because worries cannot be altered permanently 
without changing the risk cognitions that elicit this affective response (Cameron, 
2003). However, arousing fear may be counterproductive when people do not 
perceive themselves to be able to engage in risk reducing actions and believe that 
their actions will work in averting or minimizing the threat (Witte & Allen, 2000). 
Therefore, providing risk information that may generate perceptions of threat always 
should be combined with information about how to control the threat.
The study in Chapter 5 indicated that personal illness representations of patients 
appeared to be useful in understanding their family risk perceptions, worries 
and belief in preventive options. Eliciting the patient’s perspective and illness 
representations will optimize the acceptance of information that could correct 
patients’ cognitions (Phillips et al., 2012; Rimer & Kreuter, 2006). Addressing 
unhelpful beliefs regarding to, for instance, causal attribution and the controllability 
of T2D (onset) seems most important targets when guiding patients in the process 
of family risk disclosure. In addition, assessment of illness representations may help 
professionals to identify patients who are assumed to be most successful as messenger 
in their family. Findings suggest that patients with positive control beliefs seem 
able to deliver accurate risk messages in their family as they reported causal factors 
(like diet/eating habits, lacking exercise, stress/worry and one’s own behaviour) that 
are in accordance with known risk factors (American Diabetes Association, 2007; 
Pyykkonen et al., 2010) (Chapter 5). Unfortunately, only less than half of the study 
population did express positive beliefs about diabetes prevention. Possibilities of T2D 
prevention in relatives should be emphasized, specifically in low educated patients.
Ethical considerations 
Systematically approaching relatives of patients affected by an inheritable disease, 
like in cascade screening, is subject of ethical discussion. Objections include that it 
undermines the autonomy of relatives. It might be interpreted as an invasion of their 
privacy, particularly their right ‘not to know’ that they are at risk (de Wert, 2005). 
Professionals in our study did not report ethical objections targeting patients with 
a family history of T2D. It was argued that reaching and informing relatives in a 
neutral and thoughtful manner will give them the opportunity to make informed 
decisions regarding the uptake of preventive actions. One diabetes specialist in 
secondary care indicated that, in case of monogenetic disorders, they always inform 
patients about familial susceptibility to the disease. The only difference, according to 
this specialist, is the multifactorial aetiology of T2D, which makes the message more 
difficult to explain (Chapter 7). Noticeably, the idea of asking patients to inform 
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relatives about familial susceptibility to T2D was new to all interviewees. Opinions 
of professionals who have considered the idea of utilizing cascade screening in 
diabetes prevention in more detail should be explored in future research.
A substantial part of the patients (about 40%) was not willing to serve as a 
messenger in their family (Chapter 4 and 6). Stimulating diabetes-related family 
communication is not appropriate in those families. Unfortunately, we have no 
information about the reasons for rejecting disclosure of family risk in our study, besides 
the finding that diabetes was not a topic of conversation in 20% of the families. In 
other research, it was argued that patients might struggle between ideas about their 
duty to inform versus not wanting to upset their family (Forrest et al., 2003). However, 
there is no evidence that informing individuals about their familial risk might cause 
psychological harm (Pierce et al., 2000; Pijl et al., 2009b; Qureshi et al., 2001). A recent 
study indicated that patients diagnosed with familial hypercholesterolemia preferred 
to be involved in risk disclosure in their family, as they considered a direct targeting 
approach by professionals more threatening for their relatives (Hallowell et al., 2011).
Implementation strategies
The National Diabetes Action Programme (NAD), which was instigated by the Dutch 
Government (Dutch Ministry of Health, 2006), will operate until 2013 (Dutch Diabetes 
Federation, 2009). After that, medical professionals will have to continue the activities that 
were initiated in the past years, aiming at the prevention of T2D. Clinically and practically, 
however, it seems (cost-)effective to aim at primary prevention of a broader spectrum of 
multi factorial diseases, like obesity and cardiovascular disease. Family history is a risk 
factor for many lifestyle-related diseases and can be incorporated into efforts to address 
many diseases of public health importance.
Currently, family history information seems not actively used to promote health-
protective behaviour in Dutch medical practice. Most professionals that were 
interviewed, however, were interested in discussing the understanding of familial 
risk in relatives of patients with T2D to motivate them to engage in risk-reducing 
behaviours (Chapter 7). In the Netherlands, a new Practice Guideline entitled 
‘Prevention Visit’ (het Preventieconsult) has been developed for the prevention of 
cardio metabolic diseases in primary care (Assendelft et al., 2012; Dekker et al., 
2011). This programmatic prevention protocol might provide opportunities to use 
family history to personalize health-promoting information. It also appeared that 
an active and personal approach increased the screening uptake of participants for 
a lifestyle intervention on T2D risk reduction (Assendelft et al., 2012; Vermunt 
et al., 2010). Therefore, the use of a family-oriented approach may appear useful as 
additional strategy to reach the target population. For that, however, professionals 
should be educated on how to use family history information, the family system and 
family communication adequately to promote health-protective activities.
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When asking patients to deliver risk and preventive messages in their family, 
it would be advisable to provide them with written information. After all, written 
information packages about familial hypercholesterolemia reduced patients’ 
hesitation and appeared to be helpful in the disclosure of family risk. Moreover, the 
information packages served as a cue to action for relatives and legitimated them to 
ask for a medical check-up (van den Nieuwenhoff et al., 2006). In addition, a study 
in Japan has indicated that booklets with diabetes risk and preventive information, 
which were handed over by patients, worked effectively on attitudes and preventive 
behaviours in relatives (Nishigaki et al., 2011). When designing preventive activities 
targeting families at risk from different ethnic backgrounds, it seems inevitable that 
professionals have to identify cultural and community conventions and work with 
factors that influence the disclosure of familial susceptibility to diabetes in these 
populations (Hawthorne et al., 2008).
Next, when persons with a family history of diabetes turn to their physician for 
advice, preferably, they should be enrolled in preventive programmes. As yet, lifestyle 
interventions specifically aiming at prevention of T2D in people with a family history 
are scarce (Heideman et al., 2011a). Currently, however, a lifestyle intervention that 
uses family history to motivate relatives of T2D patients to maintain good health is 
being evaluated (Heideman et al., 2011b). A culturally adapted version targeting the 
migrant population from Turkey in the Netherlands is underway.
Future directions in research
Several issues raised in this thesis deserve more attention in further research. 
Learning from the limitations in our research (Chapter 4, 5 and 6), we would 
suggest to use multi-item measures to increase the reliability and validity of the 
measured constructs of family risk perceptions, worries and control beliefs in future 
research. For instance, multi-item measures of risk-related cognitions and affect are 
constructed and used in the field of genetic susceptibility (Cameron & Diefenbach, 
2001; Cameron & Reeve, 2006; Cameron et al., 2009). Moreover, repeated measures 
would provide more insight into the dynamic relationships between patients’ 
cognitive and emotional appraisal of diabetes threat in relatives and the effect on 
intentions of patients to protect their relatives’ health (Chapter 4).
One of the main topics for further research and debate include the feasibility and 
the (cost-)effectiveness of direct as well as patient-mediated approaches, targeting 
persons with a family history of T2D and/or other common multifactorial diseases, 
like obesity and cardiovascular disease. It should be explored whether utilising family 
communication as prevention strategy shows similar opportunities in families from 
different ethnic backgrounds, as was found in Surinamese South-Asian families.
Next, we know too little about the content, process and impact of familial 
communications about disease risk initiated by index patients. For example, what 
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factors influence decisions to communicate risk information to some relatives and 
not to others? How detailed is increased familial risk communicated and how 
accurate is this information? How does it affect relatives being confronted with risk 
estimations regarding diseases occurring in their family? Does family communication 
about diabetes threat encourage or discourage health-protective actions in relatives? 
Do relatives feel overloaded with risk information and does it lead to avoidance and 
defensive reactions? What is the best timing to discuss familial susceptibility; shortly 
after diagnosis, when patients are confronted with increased diabetes burden and/or 
complications or when special events occur in the family?
More insight is needed into ethical issues, the cultural aspects in family 
communication, the effect of low health literacy and negative modelling of patients 
in families at high risk. Finally, medical professionals generally seem to support a 
more extensive use of family history and family communication, but how can they 
best be trained to carry out family-oriented strategies in diabetes prevention?
Key messages
The studies presented in this thesis have provided better insight into the usability of 
family history and family communication to promote health-protective behaviour in 
families where T2D is (highly) prevalent. Five key messages can be formulated.
1.  More effort seems needed to explain the multifactorial aetiology of type 2 
diabetes and to promote opportunities to delay or prevent disease onset. Health 
care professionals should adopt and continue the efforts made in public health 
initiatives and motivate behaviour change in a growing population at risk 
developing diabetes, including persons with a family history of T2D.
2.  The studies described in the thesis show that family communication about 
diabetes is not a taboo in most families. Asking patients to pass on risk 
information might be a potential additional strategy to reach persons in Dutch 
as well as Surinamese South-Asian families at high diabetes risk. However, 
outcomes also underscore the complexities colouring the disclosure process, 
including family-related issues and the personal coping mechanisms of patients. 
3.  To facilitate the delivery of accurate messages by patients in high-risk families, 
health care professionals should not only provide risk information, but they 
also should address patients’ worries and emphasize the possibilities of T2D 
prevention in relatives. Moreover, to optimize the acceptance of information, 
(unhelpful) illness representations of patients with diabetes should be discussed. 
4.  The study’s results underline professionals’ willingness to give family history a 
more profound role in preventive activities. Outcomes also lend support for the 
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adoption of direct as well as patient-mediated methods to target persons with 
a family history. Professionals should be educated on how to use family history 
information, the family system and family communication adequately.
5.  Studies are needed to investigate the feasibility and (cost-)effectiveness of a 
family-oriented approach in T2D prevention, especially when targeting persons 
with different ethnic backgrounds and/or low literacy. 
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Summary & Samenvatting
9

Family matters in diabetes prevention 
Communication about familial risk to type 2 diabetes
Type 2 diabetes (T2D) is a progressive disorder characterised by chronically elevated 
blood glucose levels (hyperglycaemia). As the diabetes epidemic spreads worldwide, there 
is a growing need for preventive actions targeting populations at high risk. Family history 
is considered an important risk factor; the chance of developing T2D is two-to-five 
times higher for people with affected relatives. Importantly, T2D onset can be delayed or 
prevented by means of lifestyle modifications, even in persons with a family history. 
Research has demonstrated that the family matters, is of importance, in diabetes 
prevention. A family history of T2D can help to detect persons at increased risk, but 
can also raise the level of awareness about the role of shared genes and environments in 
families and the need for risk-reducing behaviours. Studies in this thesis shed light on 
family matters (e.g., family risk perception, family relations and concern about relatives) 
that might influence the usability of a family-oriented approach in the prevention of T2D.
The main objective was to provide insight in the current and potential use of 
communication about familial risk of T2D to promote health-protective behaviour 
in families where T2D is (highly) prevalent. From the viewpoint of public health 
initiatives, the online availability of and public need for information about familial 
susceptibility to diabetes was investigated. Subsequently, personal and familial 
factors were investigated to further understand the mental constructs that underlie 
the process of family risk disclosure in patients with T2D. The usability of such 
a patient-mediated targeting strategy in diabetes prevention was investigated in 
patients of Dutch as well as Surinamese South-Asian descent, as diabetes prevalence 
and disease burden is extremely high in the latter group. Finally, opinions of health 
care professionals were explored with regard to current and future uptake of the use 
of family history and family communication in diabetes prevention.
Type 2 diabetes and inheritance: what information do diabetes 
organizations provide on the Internet?
The first study that is described in this thesis (Chapter 2) was conducted in 2005. 
The aim was to explore what information on inheritance, T2D and primary 
prevention was provided on websites of renowned diabetes organizations, whether 
this information was targeted at high-risk groups based on family history and/or 
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ethnic backgrounds and to what extent patients with T2D were urged to notify 
relatives on their increased familial susceptibility. Using qualitative content 
analysis, 34 websites of national diabetes patient organizations (associated member 
organizations of the International Diabetes Federations; IDF) that provided health-
related information on diabetes in English, German, French, Dutch, Spanish, 
Portuguese, Swedish, Norwegian, Finnish, Danish and Japanese were investigated. 
It appeared that most websites mentioned family history as a risk factor. However, 
the information that was provided was very brief, not explaining the interaction 
between genes and environment and importantly, it was hard to find on most websites. 
Ethnicity as a risk factor was mentioned by only half of the included websites; 
ethnic groups were not specified or when specified sometimes of little relevance to 
that specific region. Most websites did provide information on the importance of 
a healthy lifestyle; however, they did not address specific groups at high risk. This 
would imply that people have to combine risk information (‘do I belong to a group 
at high risk?’) and preventive information (‘is this preventive information relevant 
for me?’) themselves. Despite the recommendations of the IDF, only two websites 
took up the challenge of stimulating patients to inform relatives about their increased 
susceptibility. No recommendations were made about what information should be 
conveyed by patients, how and to which relatives. It was concluded that efforts should 
be made by diabetes organizations to disseminate information on heredity of T2D 
and preventive options to the general public and populations at high risk.
Questions asked by email about the role of genetic 
susceptibility to diabetes
In the Netherlands, the National Genetic Research and Information Centre (Erfocentrum) 
provides online information about more than 600 inheritable disorders, including all 
diabetes subtypes. Moreover, the website offers visitors the opportunity to ask questions 
per email. Chapter 3 presents a qualitative study, investigating the need of (additional) 
information of website visitors about the role of inheritance in diabetes. Using secondary 
content analysis, 172 emailed questions about diabetes and inheritance, posted in 2005-
2009, were investigated. Depending on whether or not visitors did read the provided 
information, the emailed questions reflect their information needs, unaddressed issues, 
areas of uncertainty or difficult to understand concepts. 
It appeared that visitors utilising the opportunity to ask questions were relatively 
young and predominantly female. Questioners were diabetes patients, as well as 
relatives or partners of patients with diabetes. Most queries related to type 1 diabetes 
and concerned topics related to (future) pregnancy and family planning. Questioners 
mainly asked for risk estimation, but also clarifying information (about genetics of 
diabetes in general) and advice (mostly related to family planning) was requested. 
Preventive advice to reduce own diabetes risk was hardly sought. 
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It was concluded that information on the contribution of genetics to type 1 
diabetes should be more readily available. In addition, considering the high prevalence 
of type 2 diabetes with strong evidence for a genetic predisposition, more effort seems 
needed to promote awareness around familial clustering and primary prevention.
Patients’ intentions to inform relatives about type 2 diabetes 
risk: the role of worries in the process of family risk disclosure
The study in Chapter 4 aimed to obtain further understanding of determinants that 
influence the decisional process of familial risk disclosure in patients with diabetes. 
In a cross-sectional study, patients with T2D (N=546) filled in a questionnaire 
assessing family risk perceptions, worries, personal beliefs regarding diabetes 
prevention, diabetes-related family communication, intentions and perceived 
ability to inform relatives about familial risk of diabetes. Data were analysed using 
hierarchical logistic regression and multiple mediation analyses.
Sixty percent of the patients were willing to inform relatives about familial 
diabetes risk; 61% reported high family risk perceptions, 31% expressed serious 
concern about relatives developing diabetes and 41% had positive control beliefs 
with regard to preventive options in relatives. Worries about relatives, knowing what 
to tell, whom to notify and communication about diabetes in general appeared to 
facilitate the disclosure of family risk. Unexpectedly, high family risk perception 
in itself did not significantly increase the intentions of patients to inform relatives; 
rather, risk perceptions appeared to exert an indirect effect through worries and 
beliefs about diabetes prevention. Findings in this study underscore the importance 
of worries as determinant in the process of family risk disclosure. When professionals 
guide their patients in this process, they should not only provide risk information, 
but also address worries and emphasize opportunities for diabetes prevention. 
Illness representations of type 2 diabetes patients are 
associated with perceptions of diabetes risk in their relatives
The next study (Chapter 5) aimed to identify illness representations of patients 
with T2D that underlie their cognitive and emotional appraisal of diabetes threat 
in close relatives. Data were gathered from 546 T2D patients in a cross-sectional 
design. Measures of illness representations (IPQ-R), perceived diabetes risk in 
relatives, believes regarding diabetes prevention in relatives and worries about 
relatives developing the disease were assessed using self-report questionnaires. 
Multiple logistic regression analyses were conducted, adjusting for demographics and 
diabetes-related characteristics. 
Findings indicated that, generally, patients perceived their T2D as a chronic illness that 
was controllable and they mentioned no serious daily consequences or emotional impact. 
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Patients, however, who perceived their diabetes as a serious, unpredictable disease appeared 
to have higher family risk perceptions and more worries about relatives developing T2D. 
Reporting serious daily consequences and high emotional impact were most strongly 
associated with elevated levels of concern. Moreover, patients with coherent illness beliefs 
and perceiving control over their disease reported positive beliefs about the possibilities for 
relatives to postpone or prevent diabetes onset, whereas patients attributing to chance/bad 
luck reported less positive control beliefs. 
In line with the mental contents underlying a person’s own health risk appraisals, 
illness representations of patients with T2D may serve as the basis for their cognitive 
and emotional appraisal of diabetes threat in relatives. When patients are asked to 
play a more active role in the prevention of diabetes in their family, findings could 
help medical professionals to address potential unhelpful cognitions with regard to, 
for instance, causal attribution and the controllability of T2D (onset) and improve 
the information that patients might communicate with their relatives.
Family communication as strategy in diabetes prevention; 
a multi ethnic observational study in families with Dutch 
and Surinamese South-Asian ancestry
Chapter 6 presents the results of a study that explored possible facilitating and 
impeding factors in utilising family communication as a strategy in primary 
prevention of diabetes, specifically targeting families with South-Asian ancestry 
in the Netherlands at high T2D risk. In this study, data from 311 T2D patients 
from Dutch origin and 157 from Surinamese South-Asian descent were analysed. 
The results did not reveal specific barriers targeting Surinamese families at high 
risk. In fact, discussing diabetes is regarded acceptable in most families. Especially 
Surinamese South-Asian patients (68%) seemed motivated to convey risk messages 
to their relatives, as compared to 55% in Dutch patients. Surinamese South-Asian 
patients reported higher risk perceptions and expressed more concern than Dutch 
patients. While 40% in both groups thought relatives are able to prevent developing 
diabetes, 46% in Dutch and 33% in Surinamese South-Asian patients were unsure. 
Clearly, knowledge is essential to facilitate the delivery of accurate messages in 
the family. To enhance the effect of family-oriented interventions, patients should 
be educated about increased familial risk. Thereby, it is important that health care 
deliverers address concern of patients, emphasize opportunities for prevention and 
provide recommendations about how, when and which relatives to inform. Finally, 
we must not overlook the fact that in some families diabetes is never discussed and 
patients might resent being a health messenger in their family. Stimulating diabetes-
related communication would obviously not be appropriate in these families. 
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Health care providers’ perspective on using family history in 
the prevention of type 2 diabetes: a qualitative study including 
different disciplines
Chapter 7 presents the results of a qualitative study among Dutch primary and 
secondary care professionals. The study aimed to explore attitudes of professionals 
with regard to current or future uptake of a more extensive use of family history 
information and the family system in diabetes prevention. After all, family history 
not only has been recognized as an important risk stratification factor, but also can 
be used to personalize risk messages to motivate risk-reducing behaviours. 
Semi-structured interviews were conducted with a purposive sample of nineteen 
health care professionals, including general practitioners, practice nurses, diabetes 
specialists and diabetes nurses. The use of family history in preventive consultations 
was explored as well as the usability of a direct versus indirect, patients-mediated 
targeting strategy to reach persons with a family history of T2D. Three researchers 
analysed interview transcripts separately.
It was found that, generally, Dutch health care professionals expressed positive 
attitudes with regard to using family history information to promote health-protective 
behaviour. Directly targeting patients known to have a family history of T2D was 
desirable for most primary care professionals, but not considered feasible. Practical 
barriers with regard to time, expertise and financial reimbursement were mentioned. 
Findings also indicated that family history information was not systematically 
gathered and electronic medical records were not equipped to retrieve persons with 
T2D running in their family. The idea of asking patients to pass on risk and preventive 
information was new to all interviewees, but was considered an acceptable strategy to 
reach persons with a family history of diabetes. Nevertheless, practical barriers with 
regard to time, expertise and financial reimbursement were mentioned.
It was concluded that showing evidence on the (cost-)effectiveness of family-
oriented strategies in the prevention of T2D could stimulate health care professionals 
in primary as well as secondary care to use FH information, the family system and 
family communication to promote health-protective behaviour. Besides increasing 
skills and expertise in professionals, more insight is needed in cultural aspects 
regarding the disclosure of family risk, the effect of low health literacy and negative 
modelling in families at high risk developing T2D.
The final chapter (Chapter 8) summarizes and reflects on the main findings of this 
thesis. The methodology that was applied in the studies, practice implications and 
directions in future research are discussed. Five key messages were formulated.
To start, it seems important that health care professionals adopt and continue the 
efforts made in public health initiatives and motivate behaviour change in a growing 
population at risk developing diabetes, including persons with a family history of T2D. 
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The studies described in this thesis show that family communication about diabetes 
is not a taboo in most families. Asking patients to pass on risk information might 
be a potential additional strategy to reach persons in Dutch as well as Surinamese 
South-Asian families at high risk. However, outcomes also underscore the complexities 
colouring the disclosure process, including family-related issues and personal coping 
mechanisms of patients. To facilitate the delivery of accurate messages by patients in 
high-risk families, health care professionals should not only provide risk information, 
but they also should address patients’ worries and emphasize the possibilities of 
T2D prevention in relatives. Moreover, to optimize the acceptance of information, 
(unhelpful) illness representations of patients with T2D should be discussed.
Generally, professionals are willing to give family history a more profound role 
in preventive activities and outcomes lend support for the adoption of direct as well 
as patient-mediated methods to target persons with a family history. The future 
implementation of a programmatic prevention protocol in Dutch primary health care 
might provide opportunities to discuss a person’s family history more systematically 
and to use a family-oriented approach as additional strategy to reach the target 
population. Importantly, however, the feasibility and (cost-)effectiveness of a family-
oriented approach in T2D prevention should be demonstrated in further research, 
especially when targeting persons with different ethnic backgrounds and/or low 
literacy. In addition, professionals should be educated on how to use family history 
information, the family system and family communication adequately to promote 
health-protective activities.
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Diabetes preventie in de familie 
Communicatie over familiair risico op diabetes type 2
Diabetes type 2 (DM2) is de meest voorkomende soort diabetes. De ziekte wordt 
gekenmerkt door een chronisch verhoogde bloedsuikerspiegel (hyperglykemie) en 
heeft een progressief verloop. Door de wereldwijde toename van het aantal patiënten 
met DM2 ontstaat er een groeiende behoefte aan preventieve acties, die zich bij 
voorkeur richten op groepen met een hoog risico op het krijgen van DM2. Naast 
bijvoorbeeld ouder worden en een ongezonde leefstijl, is familiegeschiedenis een 
belangrijke risicofactor. De kans op het ontwikkelen van DM2 is twee tot vijf keer 
groter voor mensen met een familiegeschiedenis, dan voor mensen waar DM2 niet in 
de familie voorkomt. Wetenschappelijk onderzoek heeft aangetoond dat het krijgen 
van DM2 kan worden uitgesteld -of misschien zelfs voorkomen- door gezond eten 
en voldoende beweging, ook bij mensen met een familiegeschiedenis.
Door de familiegeschiedenis in kaart te brengen kunnen mensen met een 
verhoogd risico op DM2 opgespoord worden. Bovendien zijn er aanwijzingen dat het 
bespreken van de familiegeschiedenis mensen bewust kan maken van een mogelijk 
verhoogd risico op DM2 en de noodzaak van een gezonde leefstijl. Een relatief 
nieuw idee om mensen met een familiegeschiedenis te bereiken is patiënten te vragen 
om informatie binnen hun familie te verspreiden over risicofactoren voor DM2 en de 
mogelijkheden van primaire preventie.
De doelstelling van dit proefschrift was inzicht te krijgen in het huidige en 
mogelijk toekomstige gebruik van communicatie over familiair risico op DM2, ten 
einde gezond gedrag te stimuleren in families waar DM2 (zeer) veel voorkomt. 
Om te beginnen is vanuit het perspectief van de algemene volksgezondheid (‘public 
health’) de online beschikbaarheid van en de publieke behoefte aan informatie over 
diabetes en erfelijkheid onderzocht. Vervolgens is gekeken naar persoonlijke en 
familiegerelateerde factoren die invloed hebben de bereidheid van patiënten om als 
boodschapper in hun familie op te treden. De mogelijkheid om familiecommunicatie 
te gebruiken voor de preventie van DM2 is onderzocht in families van Nederlandse 
en Surinaams-Hindostaanse afkomst. Het is belangrijk laatstgenoemde groep 
te bereiken met preventieve acties, omdat de prevalentie en ziektelast van DM2 
in deze groep erg groot is. Tot slot zijn de ideeën en meningen van artsen en 
verpleegkundigen met betrekking tot het gebruik van familiegeschiedenis en 
familiecommunicatie in preventieve consulten in kaart gebracht.
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Diabetes type 2 en erfelijkheid: welke informatie geven 
gerenommeerde diabetes organisaties op hun websites?
Hoofdstuk 2 beschrijft de analyse van gezondheidsgerelateerde informatie, die in 
2005 verstrekt werd op 34 websites van nationale diabetes patiëntenorganisaties 
in Engels-, Duits-, Frans-, Nederlands-, Spaans-, Portugees-, Zweeds-, Noors-, 
Fins-, Deens- en Japans-sprekende landen (allen leden van de International Diabetes 
Federation; IDF). De meeste websites noemden familiegeschiedenis als risicofactor 
voor DM2. Echter, de informatie die werd verstrekt was beknopt en het samenspel 
tussen genetische aanleg en de invloed van omgevingsfactoren werd niet uitgelegd. 
Etniciteit als risicofactor werd door de helft van de onderzochte websites genoemd. 
Specifieke groepen met een verhoogd risico werden niet vermeld of waren weinig 
relevant voor de regio waar de online informatie verstrekt werd.
De meeste websites gaven informatie over het belang van een gezonde leefstijl, 
maar mensen met een verhoogd risico werden niet direct aangesproken en van advies 
voorzien. Bezoekers van de websites moesten zelf informatie combineren (‘behoor 
ik tot een risicogroep’) en ‘doorklikken’ op de website (‘welke preventieve adviezen 
zijn relevant voor mij’). Ondanks de aanbevelingen van de IDF bleken slechts twee 
websites patiënten te stimuleren om familieleden te informeren over hun familiair 
verhoogde risico op DM2. Er werden daarbij geen aanbevelingen gedaan over wat 
patiënten zouden moeten vertellen, aan wie en hoe ze dat zouden kunnen vertellen.
Opgemerkt moet worden dat momenteel de informatievoorziening op de 
websites van diabetes organisaties waarschijnlijk aanzienlijk verbeterd is. In veel 
Westerse landen zijn er vanuit een integraal gezondheidsbeleid initiatieven ontplooid 
en is er op grote schaal aandacht gevraagd voor de groeiende diabetes epidemie, de 
risicofactoren voor het ontwikkelen van DM2 en het belang van een gezonde leefstijl 
om de ziekte uit te stellen of te voorkomen.
De informatiebehoeften van mensen die op zoek zijn naar 
(online) informatie over diabetes en erfelijkheid 
In Nederland biedt het Erfocentrum online informatie over meer dan 600 erfelijke 
aandoeningen, waaronder alle diabetes subtypen. Bovendien biedt de website 
bezoekers de mogelijkheid om  per e-mail vragen te stellen. In hoofdstuk 3 wordt 
een kwalitatief onderzoek beschreven naar de behoefte aan (aanvullende) informatie 
van website bezoekers over de rol van erfelijkheid bij het krijgen van diabetes. Met 
behulp van secundaire inhoudsanalyse zijn172 e-mails met vragen over diabetes en 
erfelijkheid, verstuurd in de periode 2005-2009, onderzocht.
Het bleek dat met name jonge en vrouwelijke bezoekers gebruik maken van de 
mogelijkheid om vragen te stellen. De helft van de vragenstellers was zelf patiënt, 
eenderde was een familielid en de overige vraagstellers waren partners van patiënten 
met diabetes. De meerderheid van de verzoeken om informatie ging over erfelijkheid 
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van diabetes type 1, voornamelijk gerelateerd aan een (toekomstige) zwangerschap 
en/of gezinsplanning. In de meeste e-mails werd gevraagd om een risico-inschatting, 
maar er werd ook om uitleg (genetica en diabetes in het algemeen) en advies (meestal 
met betrekking tot gezinsplanning) gevraagd. In ongeveer tachtig procent van de 
e-mails uitten de vraagstellers op één of andere hun zorgen.
Er werden weinig vragen gesteld over diabetes type 2 en erfelijkheid. Preventief 
advies werd nauwelijks gevraagd. De vraag is of deze bevinding erop duidt dat mensen 
geen vragen hebben over een mogelijk familiale aanleg voor diabetes type 2, dat zij daar 
überhaupt niet van op de hoogte zijn, of dat zij wél vragen hebben maar de antwoorden 
niet op de website van het Erfocentrum zoeken. Opgemerkt moet worden dat Google 
ten tijde van het onderzoek de website van het Erfocentrum als eerste hit toonde 
wanneer er gezocht werd naar informatie over diabetes (type 2) en erfelijkheid.
De bereidheid van patiënten om familieleden in te lichten over 
een mogelijk verhoogd risico op diabetes type 2: de rol van 
zorgen in het proces van familiecommunicatie
De studie die is beschreven in hoofdstuk 4 geeft inzicht in de complexe 
samenhang van determinanten die van invloed zijn op de intentie van patiënten 
om gezondheidsrisico’s te communiceren binnen hun familie. De resultaten in 
dit onderzoek zijn gebaseerd op de gegevens van 546 patiënten met DM2 die de 
vragenlijst getiteld ‘diabetes en uw familie’ invulden.
Over het algemeen was 60% van de patiënten bereid om familieleden over een 
familiair risico op diabetes te informeren, dacht 61% dat het (zeer) waarschijnlijk was 
dat familieleden DM2 zouden krijgen en toonde 31% zich daar (zeer) bezorgd over. Een 
minderheid (41%) dacht dat het mogelijk zou zijn voor familieleden om het krijgen van 
DM2 uit te stellen of te voorkomen. Uit aanvullende analyses bleek dat de intentie van 
patiënten om familieleden in te lichten samenhing met de mate waarin patiënten zich 
zorgen maakten over hun familieleden. Ook de mate waarin zij zichzelf in staat achtten 
om de boodschap over te brengen (d.w.z. weten wat te vertellen en wie in te lichten) en de 
mate waarin DM2 in het algemeen bespreekbaar was binnen de familie bleken belangrijke 
motiverende factoren. Een opvallende bevinding was dat een hogere risicoperceptie niet 
direct in relatie stond met een grotere bereidheid om als boodschapper in de familie op te 
treden. Een mediatie-analyse liet echter zien de risicoperceptie van patiënten samenhang 
vertoonde met de zorgen die zij rapporteerden en ideeën over de mogelijkheden van 
primaire preventie. Een hogere risicoperceptie bleek indirect -via zorgen en geloof in 
preventie- effect te hebben op de intentie van patiënten om informatie in de familie 
te verspreiden. Het dynamische karakter van dit proces kan echter niet in een cross-
sectioneel studiedesign onderzocht worden. 
De emotionele beoordeling van het risico op DM2 voor familieleden (de 
zorgen die patiënten zich maken) lijkt de belangrijkste factor te zijn die patiënten 
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aan kan zetten tot het inlichten van familieleden. Het verstrekken van risico-
informatie kan de zorgen van patiënten doen toenemen. Echter, in de literatuur 
is beschreven dat een hoge mate van zorgen en angst averechts kan werken 
als mensen geen mogelijkheden zien om het risico het hoofd te bieden. Het 
benadrukken van handelingsopties voor de preventie van DM2 en het vergroten 
van het zelfvertrouwen van patiënten om de boodschap over te brengen (weten wat 
te vertellen, aan wie en op welke manier) zijn daarom van wezenlijk belang in de 
begeleiding van patiënten tijdens het proces van familiecommunicatie.
Ligt de beleving van de eigen ziekte ten grondslag aan de 
perceptie van het risico op diabetes type 2 bij familieleden?
In hoofdstuk 5 is gekeken in hoeverre de ideeën en ervaringen van patiënten 
met hun eigen ziekte invloed hebben op de perceptie van het risico op DM2 bij 
familieleden. Met behulp van de ‘Illness Perception Questionnaire’ (IPQ-R) zijn bij 546 
patiënten met DM2 ziektepercepties in kaart gebracht. 
Over het algemeen zien patiënten hun DM2 als een chronische aandoening die 
beheersbaar is en ze melden geen grote praktische en/of emotionele belemmeringen in 
het dagelijkse leven. Echter, uit multiple logistische regressieanalyses komt naar voren 
dat patiënten die hun DM2 wél als ernstige en onvoorspelbare ziekte ervaren, het risico 
op DM2 bij familieleden hoog inschatten en dat zij zich veel zorgen maken over de 
toekomstige gezondheid van hun familieleden. Ook patiënten die fysieke belemmeringen 
en een grote emotionele impact van hun ziekte ervaren, rapporteren dat zij zich (zeer) 
veel zorgen maken over de mogelijkheid dat familieleden DM2 krijgen. Patiënten die 
hun ziekte toeschrijven aan toeval of pech hebben vaker negatieve ideeën ten aanzien 
van de mogelijkheden van primaire preventie. Patiënten daarentegen die aangeven hun 
ziekte goed te snappen en vinden dat zij controle kunnen uitoefenen op het ziekteverloop, 
zijn over het algemeen positief over de mogelijkheden van familieleden om invloed uit te 
oefenen op het wel of niet krijgen van DM2. 
Wanneer patiënten gevraagd wordt een actieve rol te spelen bij de preventie van DM2 
in hun familie, kan het bespreekbaar maken van de ervaringen en ideeën van patiënten 
ten aanzien van hun eigen DM2 zorgverleners helpen om patiënten op te sporen die een 
correcte boodschap in hun familie zouden kunnen verspreiden, of kan aandacht besteed 
worden aan mogelijke hiaten in kennis en/of onjuiste ideeën van patiënten.
Familiecommunicatie als strategie in de preventie van diabetes type 
2 in families van Nederlandse en Surinaams-Hindostaanse afkomst
Hoofdstuk 6 toont de resultaten van een onderzoek naar de mogelijkheid om 
familiecommunicatie te gebruiken als strategie in de primaire preventie van DM2 in 
Nederlandse en Surinaams-Hindostaanse families waar DM2 (veelvuldig) voorkomt. 
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Zoals verwacht op basis van de hoge prevalentie en ziektelast van DM2 binnen 
de Surinaamse gemeenschap in Nederland, schatten Surinaamse patiënten het 
risico op DM2 voor familieleden hoger in en rapporteren zij meer zorgen over de 
diabetesgerelateerde gezondheid van hun familieleden dan Nederlandse patiënten. 
Er bleek echter geen verschil te zijn in de mate waarin beide groepen patiënten 
geloven in de mogelijkheden van diabetes preventie. Het bespreken van DM2 blijkt 
binnen de meeste families geen taboe. Binnen Surinaamse families lijkt er meer 
openheid te bestaan in het bespreken van diabetes; in vergelijking met Nederlandse 
patiënten rapporteren Surinaamse patiënten een sterkere familieband met zowel 
kinderen als andere familieleden (broers/zussen, ooms/tantes, grootouders). Vooral 
Surinaamse (68%), maar ook Nederlandse (55%) patiënten bleken gemotiveerd om 
hun familieleden in te lichten over een mogelijk verhoogd risico op DM2. 
Op basis van deze bevindingen kan geconcludeerd worden dat 
familiecommunicatie als strategie gebruikt kan worden om mensen met een 
verhoogd risico op DM2 op te sporen en te bereiken in een groot deel van 
Nederlandse en Surinaamse families waar DM2 (veelvuldig) voorkomt.
Ideeën van Nederlandse zorgverleners over het gebruik van 
familiegeschiedenis in de preventie van diabetes type 2
In de studie in hoofdstuk 7 is het draagvlak onder zorgverleners in Nederland 
geïnventariseerd ten aanzien van het gebruik van familiegeschiedenis en 
familiecommunicatie als strategie om mensen te bereiken met een verhoogd risico op 
het krijgen van DM2. Negentien semi-gestructureerde interviews zijn afgenomen onder 
huisartsen, praktijkondersteuners, diabetes specialisten en diabetesverpleegkundigen. 
De geïnterviewde zorgverleners stonden over het algemeen positief tegenover 
het idee om diabetesgerelateerde familiegeschiedenis met patiënten te bespreken om 
hen bewust te maken van een mogelijk verhoogd risico op DM2 en te motiveren tot 
een gezonde leefstijl. Systematisch en direct aanspreken van mensen met DM2 in 
de familie bleek wenselijk voor veel zorgverleners, maar volgens hen in het huidige 
zorgsysteem niet haalbaar. Familiegeschiedenis wordt niet structureel uitgevraagd 
en elektronische patiëntendossiers zijn niet toegerust om patiënten met een 
familiegeschiedenis te selecteren. Het idee om patiënten te vragen familieleden in te 
lichten over DM2 risico’s en primaire preventie was nieuw voor alle geïnterviewden. 
Echter, zorgverleners in zowel de eerste- als de tweedelijnszorg vonden het een 
aanvaarbare strategie om een risicogroep te bereiken. 
De resultaten in deze studie onderstrepen de interesse van zorgverleners om nieuwe 
strategieën te gebruiken om mensen met een verhoogd risico op DM2 te bereiken en te 
motiveren tot gedragsverandering. Naast het oplossen van praktische belemmeringen met 
betrekking tot tijd en financiële vergoeding, zijn vaardigheden en expertise nodig bij de 
zorgverleners om het gebruik van familiegeschiedenis en familiecommunicatie doelmatig 
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in te zetten. Maar bovenal moet de (kosten)effectiviteit van familiegeoriënteerde 
preventiestrategieën op het gebied van DM2 aangetoond worden.
Het laatste hoofdstuk (hoofdstuk 8) vat de bevindingen in het proefschrift samen, 
reflecteert op de gebruikte onderzoeksmethoden en beschrijft praktische implicaties 
en vragen die in toekomstig onderzoek aan de orde zouden moeten komen. De 
belangrijkste bevindingen worden in vijf kernpunten samengevat.
Gezien het snel groeiende aantal mensen met DM2 is het belangrijk om het 
bewustzijn van een mogelijk verhoogd risico op DM2 te vergroten en risicogroepen 
te attenderen op het belang van een gezonde leefstijl om het krijgen van diabetes 
uit te stellen of wellicht zelfs te voorkomen. Zorgverleners zouden meer gebruik 
kunnen maken van bestaande initiatieven op het gebied van de volksgezondheid; in 
Nederland hebben diverse voorlichtingscampagnes het risico om DM2 te krijgen 
en het belang van een gezonde leefstijl onder de aandacht gebracht bij een groot 
publiek. Informatieve websites zijn beschikbaar en zouden gebruikt kunnen worden 
in preventieve consulten in de eerstelijnszorg.
Voorts laten de studies in dit proefschrift zien dat communicatie over diabetes 
geen taboe is de meeste families. Patiënten vragen om risico-informatie in hun 
familie te verspreiden kan een mogelijke aanvullende strategie zijn om mensen 
met een verhoogd risico op DM2 te bereiken in zowel Nederlandse als Surinaams-
Hindostaanse families. Echter, de resultaten onderstrepen ook de complexiteit van 
het proces van familiecommunicatie over gezondheidsrisico’s. Zorgverleners zullen 
rekening moeten houden met omstandigheden in de familie en persoonlijke coping-
mechanismen van de patiënt. Het is van belang dat niet alleen risico-informatie 
verstrekt wordt, maar ook ruimte geboden wordt voor het bespreken van eventuele 
zorgen van de patiënt. De mogelijkheden voor de preventie van DM2 moeten 
benadrukt worden, alsook de manier waarop de patiënt de boodschap zou kunnen 
brengen in de familie (wie inlichten, wat te vertellen en hoe/wanneer dat te doen). 
Om de acceptatie van informatie door patiënten te verbeteren doen zorgverleners er 
goed aan om aan te sluiten bij de ideeën en ervaringen van patiënten met hun ziekte. 
Op die manier kunnen eventueel onjuiste ideeën worden bijgesteld.
Over het algemeen zijn zorgverleners geïnteresseerd in nieuwe strategieën om 
mensen met een hoog risico op DM2 te bereiken en hen te attenderen op het belang 
van een gezonde leefstijl. De toekomstige implementatie van een programmatisch 
preventieprotocol in de Nederlandse eerstelijnszorg kan de mogelijkheid bieden om de 
familiegeschiedenis systematischer in kaart te brengen en te bespreken met patiënten. 
Zorgverleners staan niet negatief tegenover het gebruik van familiecommunicatie als 
aanvullende strategie om een risicogroep te bereiken. Echter, de haalbaarheid en (kosten-)
effectiviteit van een familiegeoriënteerde aanpak in de preventie van DM2 moet worden 
aangetoond. Daarnaast moeten zorgverleners worden opgeleid in het doelmatig bespreken 
van familiegeschiedenis en adequaat gebruik van familiecommunicatie.
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Woord van dank
As you set out for Ithaka 
hope the voyage is a long one, 
full of adventure, full of discovery.
En een lange reis was het. Bergen zijn beklommen en dalen overwonnen. En dat ik 
veel geleerd heb, dat staat vast. 
Maar onderzoek doe je niet alleen en een proefschrift schrijven al helemaal niet. 
Op de eerste plaats ben ik dank verschuldigd aan alle respondenten die de moeite 
hebben genomen om de (omvangrijke) vragenlijst over diabetes en hun familie in te 
vullen. Ik waardeer de openhartigheid waarmee patiënten mij een inkijkje hebben 
gegeven in hun leven met diabetes en de communicatie daarover in hun familie. 
De deelnemende (huis)artsen ben ik zeer erkentelijk voor het gestelde vertrouwen 
en hun bereidheid om patiënten uit te nodigen voor het onderzoek. Dank ook aan 
de huisartsen, praktijkondersteuners, internisten en diabetes verpleegkundigen in 
Amsterdam, Haarlem en Weesp die bereid waren om aan onze interviewstudie deel 
te nemen. De terugkoppeling van onderzoeksresultaten aan mensen uit de praktijk 
heeft het project echt een meerwaarde gegeven.
Ithaka gave you the marvellous journey. 
Without her you would not have set out.
Prof. dr. Snoek, beste Frank, als promotor en eerste aanspreekpunt was jij nauw 
betrokken bij het hele proces. Ik werd min of meer met mijn onderzoeksplan in jouw 
schoot geworpen. En hoewel het onderwerp niet zonder meer in je onderzoekslijn 
paste, heb je het met veel interesse opgepakt. Je vermogen om te brainstormen 
is ongekend en ik vind het mooi om te zien dat je altijd op zoek bent naar de 
toepasbaarheid van onderzoeksresultaten in de (klinische) praktijk. Dank je dat je je 
kennis en kunde op het gebied van de psychosociale diabetologie hebt willen delen.
Prof. dr. Cornel, beste Martina, als tweede promotor heb ook jij een grote 
bijdrage geleverd aan het opzetten en uitwerken van het onderzoeksplan. Tijdens 
de wekelijkse researchbespreking van de sectie Community Genetics hield je de 
vinger aan de pols, wat ik als beginnend onderzoeker als zeer prettig heb ervaren. 
Ik bewonder je maatschappelijke betrokkenheid, pragmatisme en je vermogen 
om bruggen te bouwen. Ik denk dat we het project op het raakvlak van twee 
wetenschappelijke disciplines geslaagd mogen noemen.
Professor Henk van der Ploeg, emeritus hoogleraar medische psychologie, jij was het 
die mij dat laatste zetje gaf om aan een promotieonderzoek te beginnen. Dat het over 
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(familie)communicatie zou gaan, was meteen duidelijk. De keuze voor diabetes type 
2 was spannend, want een familiebenadering in de preventie van leefstijlgerelateerde 
aandoeningen was in die tijd vernieuwend.
Hooggeleerde leden van de leescommissie, Jacqueline Dekker, Cecile Janssens, 
Ad Kaptein, Barend Middelkoop en Daniëlle Timmermans, ik wil jullie hartelijk 
danken voor het beoordelen van het manuscript. Dear professor Nadeem Qureshi, 
I feel honoured by the fact that you accepted the invitation to be part of the review 
committee and that you will be present at the public ceremony.
and may you visit many Egyptian cities 
to gather stores of knowledge from their scholars.
Prof. dr. Henriette van der Horst en Sietske Grol, dank voor jullie inzet om gebruik 
te mogen maken van het netwerk van huisartsen, aangesloten bij de Universitaire 
Huisartsen Praktijk van het VUmc. Paulien Hoekstra leverde de verzendlijsten aan 
van de diverse huisartsenpraktijken. De samenwerking met het Diabetes centrum 
Haaglanden verliep fijn. Dr. Nel Geelhoed zorgde ervoor dat we een groot aantal 
patiënten van Surinaams-Hindostaanse afkomst konden includeren. Mandy 
Kleywegt bood praktische ondersteuning bij het versturen van de vragenlijsten en 
Carla Autar-Jaggoo hielp patiënten met het invullen van de vragenlijsten.
Ik wil de leden van de multidisciplinaire projectgroep ‘diabetes, erfelijkheid en 
perceptie van familiair risico’ (Martina Cornel, Frank Snoek, Jacqueline Dekker, 
Daniëlle Timmermans, Lidewij Henneman, Liesbeth Claassen, Miranda Pijl, 
Marcel Adriaanse, Ton Maassen en Leen ’t Hart) danken voor hun deelname aan de 
brainstormsessies, de feedback, het delen van expertise en de prettige samenwerking. 
Het Diabetesfonds heeft niet alleen het onderzoek financieel mogelijk gemaakt, 
maar ook de expertmeeting die we organiseerden in Utrecht. Manu, Elise, Monique, 
Frederique en Frieda, ik vond het leuk om met jullie samen te werken en input te 
mogen leveren voor de campagnes van het Diabetesfonds waarin aandacht werd 
gevraagd voor ‘diabetes en de familie’. Ook de medewerkers van het Erfocentrum 
dank ik voor de fijne samenwerking en Nienke Speet voor haar assistentie bij het 
verwerken van de kwalitatieve data.
may you stop at Phoenician trading stations 
to buy fine things, 
mother of pearl and coral, amber and ebony, 
sensual perfume of every kind— 
as many sensual perfumes as you can;
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Een groot voorrecht van een promovendus is het bezoeken van (buitenlandse) 
congressen. I would like to thank all (inter)national colleagues for the supportive and 
stimulating environment they created during the PSAD and BRIDGE meetings. 
Louise en Celeste van Artisa Academic & Arts Retreat, wat een fijne en inspirerende 
ambiance hebben jullie weten te creëren tijdens mijn schrijfweek in Griekenland! 
Zo ontzettend welkom op dat moment. Hélène van den Nieuwenhoff, dank voor je 
tips en literatuursuggesties. Marjan Nijkamp, jij verstaat de manier van motiverende 
feedback geven. Dank je voor je waardevolle bijdragen aan twee artikelen. 
Collega’s en oud-collega’s van de afdelingen Community Genetics en Sociale 
geneeskunde. Dank voor jullie steun en praktische tips! Ik heb goede herinneringen 
aan de congressen en bijeenkomsten waar we elkaar steeds weer tegenkwamen. 
Lidewij, jouw betrokkenheid en optimisme is echt heel bijzonder en stimulerend. 
Liesbeth en Miranda, hoewel ieder van ons was ondergedoken in haar eigen project, 
wisten we elkaar op cruciale momenten te vinden. Marianne, dank je voor de 
praktische hulp en interesse die verder reikte dan werk alleen.
Laistrygonians and Cyclops, 
wild Poseidon—you won’t encounter them 
unless you bring them along inside your soul, 
unless your soul sets them up in front of you.
Collega’s en oud-collega’s van de afdeling Medische Psychologie, en speciaal de 
collega’s van de D-3 gang, dank voor de prettige werkomgeving. José, hoewel ik 
nogal eens gemopperd heb op onze nachtelijke-vlak-voor-de-vakantie schrijfsessies, 
waardeer ik het dat je mij de ruimte gaf om mijn onderwijsbijdrage flexibel in te 
vullen. Karin en Louise, altijd staan jullie klaar om te helpen. Jessica, als er een 
‘gezelligste-collega-medaille’ bestond, kreeg jij hem. 
 (Ex-)dipsy collega’s, Frans, Marcel, Alette, Marloes, Anita, Isabel, Maartje, 
Wilmy, Kim, Noortje, Nancy, Eelco, Wieke, Tibor, Stefanie, Michael, Minke, 
Suzanne Bader, Emine en Fatma. Menig ander onderzoeksgroep kan jaloers op ons 
zijn: wat fijn om zo’n klankbord te hebben met ruimte voor discussie en overleg (en 
gezelligheid natuurlijk). Yvonne, dank je voor de administratieve ondersteuning bij 
het versturen van de vragenlijsten. Wilmy, jij bent de ‘constante’ binnen de groep: jij 
was er al toen ik als student data kwam invoeren op de afdeling! Naast dat je bergen 
werk verzet (invoeren van vragenlijsten, uittypen van de interviews), bezit je het 
vermogen om te relativeren. Wieke, onze projecten lagen inhoudelijk het dichtst 
bij elkaar. Je bent een fijne collega om mee samen te werken. En als het binnen de 
wetenschap niet lukt, kunnen we altijd nog een ‘bedrijfs-uitjes-op-maat’-bureautje 
beginnen… Maartje, wat een geluk om jou als kamergenoot te hebben. Je staat altijd 
klaar om te helpen en te luisteren. Naast de serieuze gesprekken over werk en ‘het 
leven’, lachen we gelukkig heel wat af. 
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Hope the voyage is a long one. 
May there be many a summer morning when, 
with what pleasure, what joy, 
you come into harbours seen for the first time;
Naast de werkomgeving heb ik veel steun gekregen van lieve mensen om mij heen. 
Evelien en Marc, Wieteke en Marco, Liesbeth en Hans: een goede buur is beter 
dan een verre vriend. De spijker op z’n kop. Mirjam, wat fijn dat jouw deur altijd 
openstaat voor onze meiden, zelfs wanneer we op het laatste nippertje je hulp vragen.
Lieve Erna, ‘partner in crime’. We hebben heel wat ‘hoe-combineer-ik-in-
godsnaam-gezin-werk-studie-promotie’-gesprekken gevoerd. Ook jij kiest niet altijd 
de makkelijkste weg, maar het einde van de rit is ook voor jou in zicht! Lieve Gusje, 
als ‘maximizers’ begrijpen wij elkaar. Ingrid & Ingrid, we kennen elkaar al bijna 30 
jaar. Jullie betrokkenheid vind ik echt heel bijzonder. Super dat we straks met z’n 
drieën op het podium staan.
Better if it lasts for years, 
so you are old by the time you reach the island, 
wealthy with all you have gained on the way, 
not expecting Ithaka to make you rich.
Family matters! Fred en Mieke Reijerse en Maayke, dank voor jullie interesse en 
steun al die jaren. Bart en Annemarie, Koen en Paula, Ilse en Jeroen, de afgelopen 
jaren hebben we over en weer kunnen merken waar familiebanden goed voor zijn. 
Bart, als ‘grote broer’ ben jij altijd mijn lichtend voorbeeld geweest. Koen, vanuit 
Portugal leef jij mee (een paar dagen vorst en ik weet dat jij gaat bellen om te vragen 
of we al geschaatst hebben…). Ilse, het is fijn om jou als zus te hebben. Jij zorgt er 
vaak voor dat ik de boel weer in perspectief kan zien. Papa en mama, dank voor jullie 
onvoorwaardelijke steun. Mam, aan jouw dapperheid neem ik een voorbeeld. Pap, 
jouw bezorgdheid is tekenend; wanneer ik op reis was zat jij er altijd een beetje over 
in of Joost zich wel zou redden thuis… J. 
Lieve Sophie en Madelon, dit is ‘m dan: mama’s ‘boekje’. Ik heb jullie geduld 
behoorlijk op de proef gesteld (‘Oh. Zit je weer hier… [lees: in de studeerkamer]’). 
Zonder het te weten brachten jullie soms mijn twijfel onder woorden (‘Mam, waarom 
heb je niet gewoon een beroep gekozen?’). Jullie begrip (‘Wij gaan wel met papa zwemmen 
hoor, kan jij lekker rustig werken’) en opbeurende woorden bij tegenslag (‘Ach, hoe 
maakt het uit…’) waren hartverwarmend. 
Keep Ithaka always in your mind. 
Arriving there is what you are destined for.
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Lieve Joost, eerlijk is eerlijk, jij verdient de meest eervolle vermelding. Van alle ballen 
die ik hoog probeerde te houden, ving jij er velen op. Zonder jouw hulp en geloof in 
een goede afloop zou ik dit traject niet tot een goed einde hebben kunnen brengen. 
Dank je dat je me, vooral de laatste maanden, alle ruimte hebt gegeven om het 
karwei af te maken. Ik zou zeggen; trek die fles maar open!
Wise as you will have become, so full of experience, 
you will have understood by then what these Ithakas mean.
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